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Abstract 
Physical isolation of large segments of chromosomal DNA is a major 
goal of human genetics. This would be greatly assisted by a generalizable 
technique for the cleavage of chromosomal DNA at a single site. Pyrimidine 
oligonucleotide directed triple helix formation is a generalizable motif for the 
site specific recognition of duplex DNA. The pyrimidine oligodeoxy-
ribonucleotide is bound in the major groove parallel to the purine strand 
through formation of specific Hoogsteen hydrogen bonds. Specificity is 
derived from thymine (T) recognition of adenine-thymine (AT) base pairs 
(TeAT triplet) and N3 protonated cytosine (C+) recognition of guanine-
cytosine (GC triplet). Theoretically, the binding site size is sufficient to specify 
a unique site in gigabase DNA, yet the binding motif is sufficiently 
generalizable to recognize an endogenous site every 1000 base pairs. 
This thesis describes the application of oligonucleotide directed triple 
helix formation to bind unique target sites in bacteriophage A, yeast, and 
human genomic DNA. Cleavage at the binding sites are achieved by affinity 
cleaving with EDTAeFe(II) derivatized oligonucleotides, alkylation with 
bromoacetyl derivatized oligonucleotides, and by site specific triple helix 
mediated methylase inhibition followed by digestion with the cognate 
endonuclease. Cleavage of genomic substrates with progressively greater 
complexity is described. Bacteriophage A genomic DNA (48.5 kilobase pairs) 
was targeted at a single endogenous homopurine site within the origin of 
replication. This substrate was also used to demonstrate cooperative binding 
of heterologous oligonucleotides to duplex DNA at contiguous binding sites. 
An engineered target site on yeast chromosome ill .(340 kilobase pairs) was cut 
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quantitatively at a single site within total yeast genomic DNA (14 megabase 
pairs) by both chemical and enzymatic techniques. 
Techniques for the identification of endogenous triple helix target sites 
within unsequenced genetic markers were developed and successfully used to 
characterize a target site on human chromosome 4, proximal to the 
Huntington disease gene. As a test for the site specific cleavage of gigabase 
DNA, this site near the end of human chromosome 4 was cleaved by triple 
helix mediated enzymatic cleavage. This generated a specific 3.6 Mb fragment 
in greater than 80% yield that contained the entire candidate region for .the 
Huntington mutation. 
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Chapterl 
Introduction 
Direct physical isolation of specific segments of DNA from the 
human genome is a major goal in human genetics. A number of 
technologies have recently been developed to manipulate and characterize 
increasingly large DNA fragments with the intention of generating 
detailed genetic and physical maps of the human genome (reviewed in 1-
3). These technologies have revolutionized the way DNA is separated, 
cloned, and mapped. To complement these efforts, rare cleaving strategies 
are being developed to infrequently cleave large chromosomal DNA at 
specific sites (3). 
Genetic and Physical Mapping of Human Chromosomal DNA. 
Mapping of human genetic disorders was originally limited to sex linked 
diseases or those resulting from cytogenetically detectable chromosomal 
aberrations (1, 4). Techniques utilizing linkage between restriction 
fragment length polymorphisms (RFLP) have facilitated detailed genetic 
mapping of human chromosomal DNA (5, 6). Polymorphisms such as 
single base changes that disrupt restriction enzyme cleavage sites or 
variations in the number of tandem repeats (reviewed in 7) have served 
as physical signals to test for the rate of recombination between two linked 
loci (8). A rough estimate of the physical distance between two markers 
can be determined by analyzing a number of recombination events to 
access the frequency at which two RFLP are segregated. The distances are 
measured in percent recombination or centimorgans. Through multipoint 
linkage analysis the relative order of a number of genetic markers on a 
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chromosome can be assigned. Disease genes have been cloned solely by 
their map position by analyzing genetic markers for linkage with genetic 
diseases (1,9-11). 
The rate of recombination along the length of a chromosome is not 
constant, resulting in genetic maps that grossly under and over estimate 
the distance between genetic markers (12). Physical maps, however, 
measure the distance between genetic markers in base pairs, providing an 
accurate measure of the physical linkage between RFLPs and disease genes. 
Physical maps are generated by either a top-down or a bottom-up 
approach (reviewed in 3). In the bottom-up approach, chromosomal DNA 
is cloned into cosmid or yeast artificial chromosome (13) vectors to create a 
library of small (less than 45 kb) to medium (400 kb average) sized DNA 
inserts. Maps are generated by ordering the library into a single contig for 
each chromosome, identifying the order of clones in the library by 
detecting overlap between each clone. In the top-down approach the 
chromosomes are broken into a few large pieces that are characterized and 
ordered. These pieces are then cut into progressively smaller pieces which 
are again characterized and ordered. Physical mapping by the top-down 
approach was originally limited by separation of the cleavage products and 
the availability of rare cutting agents capable of generating a small number 
of large cleavage products. Strategies to eliminate both these limitations 
have now been developed. 
Physical mapping of human chromosomal DNA was facilitated by 
the development of pulsed-field gel electrophoresis for the separation of 
large DNA fragments (reviewed in 14, 15). Conventional electrophoresis 
in a constant electric field was limited to resolution of DNA smaller than 
50 kb in size. By periodically reversing the polarity of the current, the 
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resolution power of electrophoresis has improved to the point that 
megabase DNA fragments can be resolved (16, 17). Separation is based 
upon the reorientation of DNA in the electric field as a function of 
fragment size, field strength, and pulse time. Larger molecules require a 
longer amount of time to reorient to the altered current vector, and 
therefore migrate more slowly through the matrix. 
Physical Mapping by Rare Cutting Restriction Enzymes. The 
development of pulsed-field gel electrophoresis enabled 50 kb to 5 Mb 
DNA to be resolved, spurring efforts to create long range physical maps of 
chromosomal DNA to complement the genetic maps that were being 
developed. The quality of physical maps was limited by the paucity of rare 
cutting cleaving agents capable of generating large chromosomal 
fragments. Common endonucleases cut with sufficient frequency that 
maps could not be extended more than a few thousand base pairs. 
However, 6 bp endonucleases with CpG sequences were found to cut less 
frequently than statistically predicted. These enzymes (Table 1.1) 
combined with the discovery of a few CpG recognition enzymes with 7-8 
bp specificities (18, 19) have enabled physical maps to be completed for E. 
coli (4.5 Mb) (20) and some regions of human chromosomal DNA (12). 
While powerful and simple to use, rare cutting endonucleases 
suffer from a number of limitations. Because they predominantly cut 
within CpG rich sites, a rare dimeric sequence often found at the 5' end of 
genes (21, 22), all the endonucleases tend to cut multiple times within 
clustered "CpG islands" (23). This produces fragments of very large and 
very small sizes, making it difficult to detect overlap between different 
digests, and resulting in Significant gaps in physical maps. An additional 
problem with rare cutting restriction enzymes is that CpG sequences are 
Enzyme 
Notl 
Mlul 
Nrul 
SgrAl 
Pvul 
RsrII 
SfiI 
AatII 
AsuII 
BssI-DI 
Clal 
Eagl 
Fspl 
Sadl 
Saii 
Smal 
SnaBl 
Xhol 
Pad 
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Recognition Sequence 
GCGGCCGC 
ACGCGT 
TCGCGA 
CRCCGGYG 
CGATCG 
CGG(A/T)CCG 
GGCCNNNNNGGCC 
GACGTC 
TTCGAA 
GCGCGC 
ATCGAT 
CGGCCG 
TGCGCA 
CCGCGG 
GTCGAC 
CCCGGG 
TACGTA 
CTCGAG 
TTAATTAA 
Average Product 
Size (kb) 
1000 
500 
500 
500 
300 
200 
200 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
20 
Table 1.1. The names, recognition sequences and average 
fragment sizes of restriction enzymes commonly used for 
genomic mapping. Note that with few exceptions the enzymes 
contain a CpG sequence (underlined) in their recognition site. 
frequently methylated at the S-position of cytosine in mammalian DNA 
(21,22), and many of the restriction enzymes are sensitive to the 
methylation state of the recognition sequence. This causes the observed 
cleavage pattern to vary with the cell passage and the tissue from which 
the DNA was isolated, significantly complicating data interpretation. 
Additionally, only a few rare cutting enzymes have been discovered, 
limiting the sequences that can be targeted. 
Alternate Strategies for Rare Cutting Reagents. DpnI Cleavage of 
Methylated DNA. A number of strategies have been developed to extend 
the recognition site size, reduce the cleavage frequency, and improve the 
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generalizability of sequence recognition. Initial efforts for creation of rare 
cutting reagents used combinations of methylases with Dpnl, a restriction 
enzyme that only cuts the sequence 5'_GMeATC-3' in which adenines on 
both strands are methylated. The 8 bp sequence 5'-TCGMeATCGA-3' could 
be uniquely targeted by modifying each 5'-TCGA-3' half site with Taql 
methylase (24). This generated a central Dpnl recognition sequence for 
cleavage (underlined). Using a similar approach with different 
methylases, larger specificities were achieved. Ten bp sequences 5'-
ATCGMeATCGAT-3' and 5'-GAAGMeATCTTC-3' were uniquely cut by 
Dpnl using Clal methylase (5'-ATCGMeAT-3') and Mhol methylase (5'-
GGAGMeA-3'), respectively (24, 25). Simultaneous methylation with both 
Clal and Mhol, resulted in cleavage at the previous two sites and at 5'-
ATCGMeATCTTC-3'. Finally, a 12 base pair target site (5'-
TCTAGMeATCTAGA-3') was achieved with Xbal methylase (5'-
TCTMeAGA-3') and Dpnl endonuclease (26). The 2.9 Mb circular genome 
of Staphylococcus aureus was cut into two fragments using Clal methylase 
and Dpnl (27). A number of additional specificities could also be 
developed through the use of other methylases (24). The technique is 
limited, however, by Dpnl cleavage at hemimethylated sites, resulting in 
partial digestion and significantly smaller specificities than predicted. 
Protein Mediated Achilles Heel Cleavage. Modification of 
restriction enzyme specificity through the use of methylases formed the 
basis of a more robust rare cutting strategy, protein mediated Achilles heel 
cleavage (28, 29). A number of DNA binding proteins have recognition 
sites greater than 10 bp in size, but do not cleave the DNA. Specific 
cleavage can be directed to these sequences by conferring the specificity of 
the DNA binding protein upon a restriction enzyme. If the recognition 
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sequenc;e of the DNA binding protein contains a restriction enzyme site, 
that site can be uniquely cut by forming the protein/DNA complex and 
methylating to completion with the cognate methylase. The single site 
bound by the protein remains unmodified. Following protein removal 
the site is uniquely susceptible to digestion by the cognate restriction 
enzyme. The 20 bp site 5'-AATTGTGAGCGCTCACAATT-3' was targeted 
for cleavage using lac repressor, HhaI methylase (5'-GCGC-3'), and Haell 
endonuclease (5'-AGCGCT-3'). The 17 bp target site 5'-TACCACTGG-
CGGTGA T A-3' was cut using)" repressor and the HphI cognate enzymes 
(28). This approach to site specific cleavage was successfully employed on 
plasmid DNA, and the genomes of E. coli and Saccharomyces cerevisiae 
(29). 
Protein mediated Achilles heel cleavage formed the basis for 
general rare cutting techniques (30-34), but was itself limited by a paucity of 
target sites and compatible proteins. The large recognition sites of the 
technique were not amenable to standard protocols for physical mapping 
because cleavage was too infrequent. Statistically, the 20 bp recognition 
site is predicted to occur only once every 1012 bp, or once in a genome 300 
times larger than that of man. Therefore, to cut even once within total 
human genomic DNA the target site must be physically inserted. 
Although this is a fairly straightforward task in bacterial and yeast 
genomes, it is much more difficult in the human genome. Nevertheless, 
it produced quantitative single site cleavage of large genomic DNA at 
engineered target sites and could be useful for physical mapping 
techniques that utilize random transposon insertion of the target site. 
Very Rare Cutting Restriction Enzymes. Other rare cutting reagents 
have also been developed. Boehringer Mannheim has recently 
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announced the discovery of a restriction enzyme with 18 bp specificity. 
Although this might suffer the same problems as the Achilles heel 
technique, i.e., it is too specific and not generalizable, it could also be 
useful for transposon based mapping strategies. A similar application 
could be found for the intron encoded maturases that have specificities 
exceeding 15 bp (35,36). 
Radiation Hybrid Mapping. A technique based upon a significantly 
different cleaving strategy might also be considered a rare cutting reagent 
(37). Radiation hybrid mapping is a method used to randomly cut 
chromosomal DNA by high dose x-rays and recover broken chromosomal 
fragments in somatic cell hybrids. The frequency at which two markers 
are recovered together in the rodent-human hybrid clones is a direct 
measure of the distance between the markers. By estimating the frequency 
of breakage, a physical distance and order can be estimated. Although 
irradiation does not generate cleavage at a single region or target sequence, 
the recovery of single molecules in individual hybrid clones is equivalent 
to single site cleavage. The technique has been used to create a long range 
radiation map of human chromosome 21 spanning 20 Mb (37). The cell 
lines that result from the technique have proven useful for high 
frequency generation of region specific clones (38). Unlike the previous 
rare cutting strategies, radiation hybrid mapping does not rely on pulsed-
field gel electrophoresis for resolution of the cleavage products, but it does 
facilitate the recovery and mapping of large regions of genomic DNA. 
Microdissection. A crude technique to generate specific 
chromosomal fragments is chromosomal microdissection (39). Using 
either laser obla tion or a high precision scalpel, physical regions of 
chromosomes marked by cytogenetic banding are cut out, pooled and 
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specific regions of the excised DNA amplified using the polymerase chain 
reaction. Although not satisfactory for many applications on genomic 
DNA, and not technically a mapping technique, it was able to generate 
flanking markers that lead to the successful isolation of the fragile site on 
the X-chromosome (40, 41). 
Each of these techniques has been used for the mapping and 
isolation of genomic DNA. The effort would be significantly assisted, 
however, by the development of an efficient rare cutting strategy that 
could be specifically targeted to any of a large number of endogenous 
sequences throughout the human genome. Oligonucleotide directed 
triple helix formation is capable of unique molecular recognition of 
duplex DNA at binding sites greater than 12 base pairs in size, and is 
sufficiently general to recognize endogenous target sites at high frequency. 
Oligonucleotide Directed Triple Helix Formation. Based upon work 
in polynucleotide mixing studies, Moser and Dervan demonstrated that 
pyrimidine oligodeoxyribonucleotides bind duplex DNA sequence 
specifically at homopurine sites to form a local triple helix structure (42). 
The pyrimidine oligomer is oriented in the major groove of DNA parallel 
to the Watson-Crick purine strand and binds by Hoogsteen hydrogen 
bonding. The "code" for triple helix specificity is derived from thymine 
(T) binding to adenine-thymine base pairs (T-AT base triplet) (43) and 
protonated cytosine (C+) binding to guanine-cytosine base pairs (C+GC 
base triplet) (Fig. 1.1) (44-47). By attaching the nonspecific affinity cleaving 
molecule EDTA-Fe(II) (48) to an oligonucleotide, Moser and Dervan 
demonstrated the binding of an oligonucleotide to a 15 bp purine target 
site. They found that the binding specificity was sufficient to define a 
single target site in plasmid DNA (4.0 kb) (Fig. 1.2) (42). As a function of 
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T'AT Triplet 
• 
C+GC Triplet 
Fig. 1.1. Isomorphous TeAT and C+GC base triplets formed by 
Hoogsteen hydrogen bonding of a pyrimidine strand in the major groove 
of double helical DNA. The relative orientations of the three strands are 
indicated as + or -, and the bases are in the anti conformation. 
the temperature of the binding reaction, the oligonucleotide could 
differentiate the target site from a similar site containing a single base 
mismatch by at least a factor of ten. They also demonstrated the 
importance of neutral to acidic pH and the requirement for a polycation 
such as spermine or cobalt-hexamine Co(NH3)63+ for efficient complex 
formation. 
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3' S' 3' S' 
oC T-A 
~ A-T 
N 
= 
G-C 
• C-G .-( 
3' T-A 
T-A-T 
C+G-C 
T-A-T 
C+G-C 
T-A-T 
C+G-C 
T-A-T 
C+G-C 
T-A-T 
C+G-C 
T-A-T 
oC T-A-T ~ T-A-T ~ 
= T-A-T ~ * T-A-T 
T-A 
A-T 
T-A 
A-T 
T-A 
A-T 
T-A 
A-T 
T-A 
A-T 
Fig. 1.2, Schematic of oligonucleotide directed triple helix formation . 
showing the binding of a 15 base pyrimidine oligomer to a 15 bp homopurine 
target site, The third strand is bound in the major groove of the DNA duplex 
parallel to the purine strand, Moser and Dervan used this system to 
demonstrate site specific cleavage of plasmid DNA mediated by triple helix 
formation, 
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The structure of the triple helix was initially estimated by fiber 
diffraction of polynucleotide complexes (49, 50). It suggested that the 
triplex was in an A' conformation usually observed for double helical 
RNA under high salt conditions. While a high resolution image of the 
complex was not possible, the studies indicated some salient structural 
features including Hoogsteen hydrogen bonding for complexation. The 
bases of the helix were predominantly flat with a base tilt of =8.5°, and all 
three strands were in a C-3' endo sugar conformation with anti glycosidic 
bonds. The helix had a 30° rotation about the helical axis per residue, an 
axial rise per residue of 3.26 A, and a pitch height of 39.1 A. 
Two dimensional HI NMR of an oligonucleotide triple helix 
complex provided additional insight into the structure of the triple helix 
(51-53). NMR directly observed the imino proton at the C3 position of 
cytosine in the third strand. The protonation of this position had been 
implicated by the marked pH sensitivity of the C+GC triplet. While both 
pyrimidine strands were found in the C-3' en do sugar conformation, the 
purine strand adopted a different conformation that appears to be 
sequence dependent (54-58). 
Thermodynamics of the pyrimidine triple helix motif was studied 
using UV melting, NMR, CD, and differential scanning calorimetry (59, 
60). Estimates for the enthalpic contributions (DoHa) to triple helix 
formation at pH 6.5 and 200 mM NaCI indicated that the complex is 
stabilized by apprOximately 2.0 kcal/mol base triplet compared to 6.1 
kcallmol base pair for duplex DNA (59). Entropically the triplex is more 
favored than duplex formation, owing to the fewer degrees of freedom 
eliminated by the binding of a single stranded molecule to a stiff duplex. 
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The values are approximately 6.5 cal/mol-"K for the triplex transition 
compared to 18.5 cal/mol·oK for the duplex transition (59). 
The ability of an oligonucleotide to sterically inhibit the activity 
of DNA binding proteins at a single target site was demonstrated by 
Maheret al. (30). These studies showed that a local triple helix complex 
can inhibit methylases, restriction endonucleases, and transcription factors 
when the triplex overlaps the protein binding site. Restriction enzyme 
inhibition facilitated a complete kinetic analysis of triple helix formation 
(61). Maher et aI. demonstrated that the oligonucleotide binding reaction 
kinetics were pseudo-first order in oligonucleotide concentration with a 
comparatively slow on rate (1.8 x 103 L.(mol of oligomer)-1.s-1l and an 
equilibrium dissociation constant of 10 nM. An increase in the pH of the 
binding reaction from pH 6.8 to 7.2 resulted in a small reduction in the 
association rate, but a significant increase in the dissociation rate (61). The 
specific inhibition of a transcription factor was subsequently studied in 
vitro for possible use of the triplex as an artificial gene-specific repressor 
(62). 
Techniques for Oligonucleotide M ediated Cleavage of DNA. 
Oligonucleotides were chemically modified to facilitate triple helix 
mediated cleavage of DNA. Moser and Dervan generated double strand 
cleavage at a single site in plasmid DNA (4.0 kb) by affinity cleaving using 
an EDTA-Fe(II) substitution at the C5 position of a single thymidine (T*) 
in the oligonucleotide (42, 48) (Fig. 1.3). The DNA backbone was cut by 
oxidation of the deoxyribose backbone by a short-lived nonspecific 
diffusible hydroxyl radical with double strand cleavage efficiencies of less 
than 10%. Perrouault et al. achieved photo-induced double strand 
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NH ............... NH-f'0 
EtOOC ............... N) ( 
EtOOC ............... k~Cllbt 
Fig. 1.3. DMT-protected T*-phosphoramidite-triethylester used for 
automated synthesis of affinity cleaving oligonucleotides containing 
EDTA. 
cleavage of a 32-mer duplex by covalently attaching an ellipticine 
derivative to the 3' phosphate of the pyrimidine oligonucleotide and 
irradiating at wavelengths greater than 300 nm (63). Double strand 
cleavage efficiencies were not reported. Enzymatic cleaving function ali ties 
were also used for triple helix mediated cleavage. Pei et al. synthesized a 
pyrimidine oligonucleotide conjugated at the 5' phosphate with 
staphylococcal nuclease and generated target specific double strand 
cleavage of plasmid DNA in greater than 75% yield (64). The cleavage 
occurred predominantly at A+T rich sites to the 5' side of the target 
sequence. The linker arm was sufficiently long, however, to accommodate 
cleavage at several base positions. 
Cleavage by each of these oligonucleotide conjugates showed 
specificities mirroring that of the triple helix. Two additional approaches 
combined oligonucleotide binding specificity with a sequence specific 
cleaving function. Povsic and Dervan synthesized an oligonucleotide 
containing a bromo-acetyl moiety attached at the S-position of the 5' 
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terminal thymidine (65). They observed sequence specific alkylation at the 
N7 position of G, two bases to the 5' side of the triple helix binding site 
(65). Presumably no alkylation would have occurred if a base other than G 
were present at this position. Work up with piperidine resulted in near 
quantitative cleavage of a single strand within the duplex (65). Double 
strand cleavage was achieved by positioning two single strand cleavage 
sites near each other, but on opposite strands (66). Alkylation of G was 
also achieved using a N4, N4-ethano-5-methyldeoxycytidine derivative, 
though its position within the binding site did not lead to additional 
specificity from the cleaving function (67). 
Enzymatic cleavage of a target site could be achieved through the 
use of triple helix mediated Achilles heel cleavage. Maher et al. 
demonstrated that an oligonucleotide could prevent modification of an 
overlapping methylase recognition site (30). Following methylase 
inactivation and triplex disruption, the triple helix binding site was the 
only site susceptible to digestion by the cognate restriction enzyme. 
Cleavage specificity was the nonoverlapping sum of the oligonucleotide 
binding and the restriction enzyme specificities. Maher et al. used a 21 
base oligonucleotide to mediate near quantitative double strand cleavage 
of a 23 bp target site using TaqI methylase and restriction enzyme (30). 
Using EcoR! methylase and endonuclease, Hanvey et al. cut a 15 bp target 
site with a 12 base oligonucleotide (31). Inhibition of methylase activity at 
a single site in plasmid DNA suggested that triple helix mediated Achilles 
heel cleavage could find application for the site specific cleavage of large 
genomic DNA. The combinatorial approach to target site recognition and 
cleavage in the later two strategies was critical to the achievement of single 
site cleavage in genomic DNA (32, 33, 66). 
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Recognition of Additional Sequences by Triple Helix Formation. 
Oligonucleotides utilizing base triplets ToAT and C+GC can be designed to 
bind only a small fraction of all potential 16 bp target sites. Binding is 
limited by the lack of a recognition "code" for sequences containing 
pyrimidines within the purine strand, and the inability to recognize 
sequences containing contiguous G's. The number of sequences now 
targetable by pyrimidine oligonucleotide directed triple helix formation 
has been greatly extended by the discovery of additional triplet specificities, 
the synthesis of novel heterocycles, and synthetic modifications in the 
DNA backbone. 
• ~k 
C€ti)Nt\=O 
rN'H H-N , H H , 
··· .. 0 .. H-N N, 
CHY," ~ -N,@) 
II H----l Y R r N- "=N k~ 0 
I 0 
• R@) 
G·TA Triplet 
Fig. 1.4. Model proposed by Griffin and Dervan (68) for G 
recognition of a TA base pair within the pyrimidine motif. 
The recognition of mixed purine/pyrimidine sequences was first 
achieved by the discovery of a specific interaction between guanine and a 
thymine-adenine base pair (GoTA base triplet) (68). Although the nature 
of the interaction awaits characterization by NMR, the simplest model for 
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the G.TA triplet places G in the anti conformation forming at least one 
hydrogen bond between G and T, likely N-2 of G with 0-4 of T (68). Sites 
containing up to two T A bp were targetable by triplex formation using this 
novel triplet (68). Subsequent studies suggested that recognition might 
not be in the same plane as the rest of the base triplets resulting in a 
requirement for an AT base pair to the 5' side of the TA base pair (69). 
Although the affinity of G for the TA bp was low, it did show high 
specificity. 
R-N 
~k 
N 
I 
H 
o 
0 3: 3-benzamidophenylimidazole 
R-N 
~k 
N 
I 
H 
o 
0 8: 3-napthamidophenylimidazole 
Fig. 1.5. Chemical structure of 03 and 08 novel heterocycles for the 
recognition of TA and CG base pairs within the pyrimidine triple helix 
motif. 
Novel heterocycles were also designed to recognize pyrimidine base 
pairs within purine rich sequences. The novel base 3-
benzamidophenylimidazole (03) showed specificity for T A and CG base 
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pairs with a requirement for a AT base pair to the 3' side of the pyrimidine 
base (69, 70). Increasing the size of the phenyl ring to a napthyl group (08) 
increased the binding affinity of the oligonucleotides high enough that 
mixed purine pyrimidine sites could be targeted at near neutral pH (71). 
Weak, but surprisingly specific binding, was achieved by incorporating an 
abasic sugar into the oligonucleotide (72). Although the binding affinity of 
the molecule was very low, it showed some specificity for pyrimidines at 
the base pair opposite the abasic position (72). 
The recognition of G rich sequences in the pyrimidine motif was 
achieved by two novel heterocycles. Cytosine protonation destabilizes the 
C+GC triplet at slightly acidic or neutral pH (42). 2'-O-methyl-
pseudoisocytidine and 3-methyl-5-amino-lH-pyrazolo-[4,3-dlpyrimidine-7-
one (PI) were each designed to include a proton donor for the N7 position 
of G (73, 74). Oligonucleotides containing either of these bases facilitated 
the efficient targeting of sequences containing a high G to A ratio at 
neutral or slightly basis pH. 
Although the canonical base triplets only provided recognition of 
half the base pairs present in duplex DNA, it included a recognition "code" 
for the purine half of all base pair combinations. If the oligonucleotide 
could bind the purine half of each base pair by alternately binding to either 
face of the major groove, a generalizable solution to duplex recognition 
could be achieved. The parallel orientation of the third strand is such that 
binding to alternating faces of the groove requires the synthesis of 
oligonucleotides containing 3'3' and 5'5' linkages of the DNA backbone. 
Horne and Dervan described alternate strand triple helix formation using 
a 3'3' linkage that could target sequences of the class 
(purine)mN2(pyrimidine)n (75, 76). Ono et al. synthesized a 5'5' linkage 
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capable binding weakly to sequences of type (pyrimidine)n(purine)m (77). 
They also designed an oligonucleotide containing both a 5'5' and a 3'3' 
linkage capable of binding to alternate faces of the major groove by making 
two crossovers (77). Extension of this strategy could facilitate binding to a 
wide variety of target sites. 
A Second Triple Helix Motif using Purine Oligonucleotides. In 
addition to a pyrimidine third strand, polynucleotide studies detected a 
three stranded complex containing a ratio of two purine strands per one 
pyrimidine strand. Hogan et at. reported transcription inhibition by a C 
rich oligonucleotide targeted to a promoter region of the c-myc gene 
parallel to the purine strand using putative C-CC, A-AT, T-TA, and 
C-CC triplets (78). Affinity cleaving experiments demonstrated that the 
actual orientation of the oligonucleotide was antiparallel to the purine 
strand and involved the formation of C-CC, A-AT, and T-AT base 
triplets (79) (Fig. 1.5). The complex was found to be pH insensitive because 
none of the triplets required protonation, but there was a requirement of 
polycation (79,80). Beal and Dervan postulated that the most reasonable 
structure of the complex placed the phosphate backbone near the center of 
the major groove and the bases in the anti conformation (79). Although 
this structure has not been extensively characterized, thermodynamic 
parameters on a single sequence suggest this structure is significantly more 
stable than the pyrimidine triple helix, and has thermal stability and free 
energy of formation comparable to duplex formation (81). 
Beal and Dervan have demonstrated that linear combinations of 
the purine and pyrimidine motifs are capable of binding to sequences of 
the type targeted by alternate strand triple helix formation (82). Because 
the binding orientation of the two triplex motif is reversed, there is no 
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A·AT Triplet 
G·GC Triplet 
Fig. 1.6. Models proposed by Beal and Dervan (79) for G-GC, A-AT, 
and T-AT base triplets with a purine-purine-pyrimidine triple helix motif 
where the third strand is antiparallel to the purine Watson-Crick strand 
and the bases are in the anti conformation. 
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requirement for novel linkages at the crossover junctions. 
Oligonucleotide Directed Triple Helix Formation Target Site 
Frequency. The binding site size of triple helix formation is sufficiently 
large to suggest that it might find application in the single site cleavage of 
genomic DNA, but sufficiently generalizable to suggest that it could be 
targeted to endogenous sequences within most genetic markers. The 
frequency of sequences targetable by triple helix formation is an important 
consideration in the possible utility of this technique. 
A 16 bp recognition site (n = 16) defines 2,147,516,416 unique 
sequences (5) as determined from equations 3.1 and 3.2. 
4n S = 2" (n is odd) (Eq.l .l) 4n 4
n/ 2 
5 = 2" +2 (n is even) (Eq. 1.2) 
This number is equivalent to the size of the human genome (=3 x 109 bp) 
and indicates that a 16 bp recognition sequence is necessary to define. a 
single site in human genomic DNA. Pyrimidine oligonucleotide directed 
triple helix formation utilizing T-AT and C+GC base triplets could 
recognize 65,536 (216) homopurine sequences (42). A second triplex motif 
utilizing G-GC, A-AT, and T-AT triplets statistically recognize the same 
subset of 65,536 sequences, but G-rich sequences would be recognized more 
efficiently with this motif (79, 80). The ability to recognize one TA base 
pair (sequence class RI5Tl) by the use of a single G-TA base triplet within 
the pyrimidine motif (68) increases the number of 16-bp sequences 
recognized by 524,288 (16.215). Recognition of one CG base pair within the 
pyrimidine motif (sequence class RI5C}) by the novel heterocycles D3 or D8 
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Included Within # of New 
Sequence Class NA NB Earlier Sequence Class: Sequences 
RINANBY13 R R - 65,536 
R Y - 65,536 
Y R - 65,536 
Y Y 
-
65,536 
R2N ANBY12 R R - 65,536 
R Y RINANBY13 0 
Y R - 65,536 
Y Y RINANBY13 0 
R3N ANBYll R R - 65,536 
R Y R2NANBY12 0 
Y R - 65,536 
Y Y RINANBY13 & R2NANBY12 0 
RtNANBYIO R R - 65,536 
R Y R3N ANBYll 0 
Y R 
- 65,536 
Y Y R2NANBY12 & R3NANBYll 0 
RsNANBY9 R R - 65,536 
R Y R4N ANBYlO 0 
Y R - 65,536 
Y Y R3N ANBYn & R4N ANBYlO 0 
R6NANBYS R R - 65,536 
R Y RsNANBY9 0 
Y R - 65,536 
Y Y RtNANBYlO & RsNANBY9 0 
R7NANBY7 R R RsNANBY9 & R6N ANBYS 0 
R Y R6N ANBYS 0 
Y R - 65,536 
Y Y RsNANBY9 & R6NANBYS 0 
Total Sequences: 983,040 
Table 1.2. Calculation of the number of sequences potentially 
recognized by 3'-3' alternate strand triple helix formation. The two base 
degenerate region in the center of the binding site, represented by NA and 
NB, complicates the calculation by causing significant sequence 
duplication when using simpler algorithm. 
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(70,71) increases the number by an additional 524,288 (16.215) sequences. 
These sites could also be recognized by a T-CG triplet within the purine 
motif (82). Binding to sites containing CG would not be unique. D3 and 
D8 also have affinity for TA base pairs in the pyrimidine motif (70, 71), and 
T has affinity for AT base pairs within the purine motif (82). 
Alternate strand triple helix formation, in which junctions are 
incorporated into the oligonucleotide to facilitate binding to homopurine 
sequences that are alternatively on the Watson and the Crick strands (75-
77), significantly increases the number of sites targetable by triplex 
formation. Oligonucleotides containing a 3'-3' linkage bind sequences of 
the type (purine)nNN(pyrimidineh4_n (1:5:n<14) affording 983,040 target 
sites (Table 1.2) (75, 76). Binding to these sites is not single sequence 
specific as the base pairs at the binding junction are not defined, i.e., a 
single 14 bp oligonucleotide with a 3'-3' junction can bind 16 different 16 
bp sequences. Oligonucleotides with a 5'-5' linkage bind sequences of class 
(pyrimidine)n(purineh6-n (1:5:n<16) affording 524,288 single sequence 
specific target sites (8.216) (77). These sequences can also be targeted by 
linear combinations of the purine and the pyrimidine motifs (82). While 
statistically this does not expand the number of recognizable sequences, it 
provides a second approach to binding the sites listed in this calculation. 
The total number of sites recognized by triple helix formation is the 
sum of each sequence class less the sequence duplications. The calculation 
yields a total of 2,490,368 sites (Table 1.3). This represents 0.12% of all 
possible 16 bp sequences and suggests that a site targetable by triple helix 
formation will occur with an average frequency of once every 860 bp. The 
number of sequences recognized would increase exponentially if the 
motifs were combined, i.e., a double crossover, a crossover with a novel 
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# of Sequences # of Duplicated # of Unique 
Sequence Class Recognized Sequences Sequences 
R16 65,536 0 65,536 
R1ST1 524,288 0 524,288 
R1SC1 524,288 0 524,288 
Rn(NN)Y14-n 983,040 -65,536 917,504 
YnR16-n 524,288 -65,536 458,752 
Total Sequences: 2,490,368 
Table 1.3. List of five major sequence classes recognized by 
oligonucleotide directed triple helix formation. Rand Y represent purine 
and pyrimidine, respectively (Column 1). 3'-3' and 5'-5' alternate strand 
triplex motifs duplicated a portion of the sequences recognized by novel 
base triplets requiring an adjustment in the totals (Column 3). 
base triplet, two novel base triplets, etc. While sequence composition 
effects will significantly affect the validity of these calculations, the value 
is possibly an underestimate of the total because it does not include 
combinations of the sequence classes and homopurine sequences are 
observed to occur at greater than statistical frequency (83,84). This 
calculation demonstrates that triple helix formation has become 
sufficiently generalized that targetable sites will occur in high frequency 
within human chromosomal DNA. 
Description of Work . This thesis describes the use of 
oligonucleotide directed triple helix formation for the site specific cleavage 
of large genomic DNA. The work predominantly uses the pyrimidine 
triplex for target site recognition. Cleavage is achieved by affinity cleaving 
with oligonucleotides containing EDTA-Pe(II), double strand alkylation 
with oligonucleotides containing a bromo-acetyl electrophile, and Achilles 
heel cleavage with cognate methylases. and restriction enzymes. The 
chapters are grouped according to the substrate of the cleavage reaction. 
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Chapter II describes the site specific cleavage of bacteriophage A DNA 
by affinity cleaving. Strategies for optimization of cleavage yields are 
explored, and the specificity of triplex formation on a large, fully 
sequenced substrate is described as a function of oligonucleotide 
composition, pH and temperature. Cooperative binding of 
oligonucleotides to abutting target sites on bacteriophage A DNA is 
demonstrated and the possible source of the cooperative interaction 
postulated. 
Chapter III describes the site specific cleavage of an engineered target 
site on chromosome III (340 kb) of yeast genomic DNA (14 Mb) by triple 
helix mediated affinity cleaving and Achilles heel cleavage techniques. 
Secondary cleavage sites are mapped on the chromosomal substrate, 
nonspecific oligonucleotides are used to target endogenous sequences, and 
the specificity of oligonucleotides containing base substitutions is 
demonstrated. A complete protocol is included for insertion of triplex 
target sites into yeast chromosome III. 
Chapter IV demonstrates triple helix mediated enzymatic cleavage 
of an endogenous target site near the tip of human chromosome IV. The 
3.6 Mb fragment liberated by cleavage contains the entire candidate region 
for the Huntington disease gene. Cleavage of the target site is achieved in 
80-90% yield. The chapter includes a review of the literature describing 
efforts to identify the HD mutation, and discusses the conflicting 
recombination data that places the mutation into either of two 
nonoverlapping regions. It also describes a number of protocols used to 
identify endogenous triple helix target sites that overlap methylation 
recognition sequences. 
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Chapter V suggests potential strategies using triple helix mediated 
cleavage that could assist in the search for the Huntington's disease 
mutation. Some preliminary experiments toward these goals are 
described. 
Appendix A contains a complete listing of the oligonucleotides used 
for experiments in this thesis, and a brief description of their designed 
application. 
Appendix B contains a manuscript prepared in collaboration with 
Tom Povsic, describing the quantitative site specific double strand cleavage 
of a yeast chromosome by alkylation. The paper analyzes the cleavage 
products from single base resolution on restriction fragments to the site 
specific cleavage of chromosomal DNA in yeast. The products are 
compatible with ligation into a restriction enzyme site with 
complementary ends. The cleavage specificity and yields of the chemical 
cleavage mechanism are comparable to that achieved by triple helix 
mediated enzymatic cleavage. The manuscript was submitted to the 
Journal of the American Chemical Society. 
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Chapter II 
Part I 
Site Specific Oeavage of Bacteriophage Lambda Genomic DNA 
The binding site size of oligonucleotide directed triple helix formation 
is sufficiently large to statistically define a single site in the human genome (1 , 
2). To achieve the goal of site specific cleavage of human genomic DNA, we 
examined triple helix formation on incrementally larger DNA substrates (3, 
4). A pyrimidine oligonucleotide equipped with the affinity cleaving agent 
EDTA-Fe(II) (5) was initially shown to cut at a single site within an 
oligonucleotide duplex (101 bp), a restriction fragment (102 bp), and a 
prokaryotic plasmid (103-104 bp) (3). Bacteriophage A DNA (48.5 kb) was 
chosen as a substrate in the 104-105 bp size range because it was fully 
sequenced and there were a number of potential endogenous target sites for 
affinity cleaving (6). Several issues were investigated using bacteriophage A as 
the DNA substrate. These included: (i) studying the specificity of triple helix 
mediated cleavage of small genomic DNA (4), Oi) determining the cleavage 
efficiency of DNA embedded in agarose (4), (iii) assaying the specificity of 
oligonucleotides with novel base modifications, (iv) studying techniques for 
improved cleavage efficiency with affinity cleaving, and (v) investigating 
cooperative binding of oligonucleotides in a triple helical complex (7). 
The site targeted in these studies was an 18 bp homopurine sequence 
located within the bacteriophage A origin of replication, 39,138 bp from the left 
terminus (6, 8, 9). The target sequence, S'-A4GA6GA4GA-3', is essential for 
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replication of the bacteriophage genome (8-11), and is the initial DNA 
segment to become single stranded preceding replication (12-15). The 
sequence is located within the A. 0 protein coding sequence, immediately 
adjacent to four 19-bp sequence repeats of hyphenated dyad symmetry that are 
bound by the A. 0 protein during the initial steps of replication (12, 13, 16, 17). 
A number of sequence and structural characteristics of this region are 
consistent with formation of a transient intramolecular triple helical 
structure (H-form DNA) (18-21): (i) the sequence contains a strong purine 
bias that is a short homopurine-homopyrimidine mirror repeat (22, 23), (ii) a 
structural transition is observed that is dependent upon negative supercoiling 
(10), and (iii) the structure is partially S1 nuclease sensitive (14). Although 
there is currently no direct data to demonstrate that the structure adopted is 
H-form DNA, it is noteworthy that the target site chosen for triple helix 
formation in bacteriophage A. DNA is a phenotypically important endogenous 
DNA sequence, potentially capable of forming an intramolecular three 
stranded structure in vivo. 
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The sequence·specific cleavage of double helical DNA by re-
striction endonucleases is essential for many techniques in mo--
lecular biology. including gene isolation, DNA sequencing. and 
recombinant DNA manipulations.I,l: With the advent of 
pulsed-field gel electrophoresis. the separation of large segments 
of DNA is now possible,l,4 However, tbe recognition sequences 
of naturaUy occurring restriction enzymes are in the range of 4-8 
base pairs, and hence their sequence specificites may be inadequate 
for isolating genes from large chromosomes (10' base pairs in size) 
or mapping genomic DNA.s 
Pyrimidine oligonucleotides bind duplex DNA sequence spe~ 
cifically at homopurine sites to form a triple helix structure.6•1 
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Fipn 3. (A) Site·specific double strand cleavage or bacteriophage" 
DNA. Autoradio8ram of IIp right (R) and leCt (L) end-labeled DNA. 
48.5 kbp in lenltb. on a 0.4% nondenaturinlaprose lei. Lane I. DNA 
size marlcen obtained by digcstion or L Cfld-labeled >. DNA with BamH 
I. Sma I. A~ I. SnaB I. and Xba I; dilestion of nlht end-labeled DNA 
with BamH I. Sma I. and Xho I: .. g.s (undilcstcd DNA): 24.5. 19 .... 
15.0.12..2.10.1. 8.6.6.7. and 5.5 kbp. Lane 2. L end·labeled intact >. 
DNA control. Lane J . L end-Iabded " DNA with 0 .8 JIM oligo-
nucleotide-EDTA·Fe. Lane 4. R end·labeled intact >. DNA control. 
Lane 5. Rend-labeled" DNA with 0.8 JIM oIiIOnuc!eotide-EDTA.Fe. 
(8) Site specific double strand c1eavale of bacteriophale " DNA in a 
1% LMP 2llatose maln... Autoradiogram of 12p R end· labeled DNA on 
a 0.4% nondenaturinl agarose gei. Lane I, R end·labeled intact A DNA 
control. Lane 2. R end-labeled A DNA with 0.8 "M oligonucleotide-
EDTA·Fe. Lane 3. DNA size markers as described above. Arrow on 
the right indicates 9.4 kbp cleavage fragment. 
pairing (Figure fFK~ We have shown that oligonucleotides 15 
bases in length. equipped with a cleaving function EDTA-Fe at 
tbe 5' end. cause sequence specific double strand breaks at one 
site in plasmid DNA which is 4.0 lrilobase pairs (kbp) in size.' 
Due to the length of the recognition site. in a fonnalscnse, this 
is 1(J4 times mor~ sequ~1fCe specific thun restriction enzym~sK~·· 
It is important to determine whether the full potential of this 
cleavage specificity can be realized in larger DNA. As an initial 
step beyond the cleavage of plasmid DNA. we report here the 
specificity and efficiency of double strand cleavage by an oligo-
nucleotid~baqA·ce probe targeted to a naturally occurring 18 
base pair" sequence. RD·A4d~dA4dA-PDK that occurs once within 
the 48 502 base pUn (48.5 kbp) of the bactcriopbap >. genome.,·lO 
The target sequence. located at base pair positions 39138·56 from 
tbe left (L) end. is an essential purine c1wter in ~Df origin of 
replication (ori) (Figure 2).11.12 Double strand dcavage at the 
18 base pair target site would afford two DNA fragments. 39.1 
and 9.4 lc.bp in size. 
(8) For backlfOund on triple belical potynllcleotldl:l _: (a) Fe\senCeld, 
G.; Daviel. D. R.; RIch, A. J . Am. ell"m. Soc. 19!7. 7P. 2021. (b) MicbelIoIl, 
A. M .; MUIOIlIi&. J.; Guaeblbauer. W. I'roK. Nw:/iI!lc Acids Ru. Mol. BWl. 
1"'.6.83. (e) Fellcnfeld, G.; Miles. H. T. AIIIIII. RIO. BlocM", . • "'. 36. 
-407. (d) LiJllClt, M. N. BI«"_. BloplfYJ. Ru. Co_ .. ,., 1963.11. 224. (e) 
UpKtt. M . N. J. Bioi. ell"",.l"". 23P. 1256. (0 Howard... F. 8.; Frazier. 
J.; Upactl, M. N.: Mik:I. H. T.; BlocMm. BIopIIYJ. Ru. GlMmIto'J. .964.17. 
91. (8) Miller. J. H.; SoboU. H. M. Proc. Nall. Acad. Sd. U.s.A. 1""- S'. 
1201 . (b) Morpll. A. R.; Wells, R. D. J. Mol. Blol. IHI. 11. 63. (i) I...cc, 
J. S ..; JOOtLJOll. D. A .; MOC"p.II. A. R. Nuel. Add.r Ru. I"'. 6. 1073. 
(9) Sal1act. F.; CoulKM, A. R.; HOItJ, G. F.; HiU. D. F.; ~tcneaK G. B. 
J. Mol. Bioi. 1911, 162. 729-773. 
(10) Strain e1857lndISam7 rrom New Enalalld Biolatll. 
(II) TbompiOn. K. D.: Moore, D. D.; Kru,er. K.. E.; Furtll. M. E.; 
Blattner. F. R. Scll_ (WQJllillJ1ol1, D. C.) 1m. 198. 1051-1056. 
(12) Furth. M. E .. Wickncr. S. H. In UmtbtJa Jl; Hcndlh, R. W.; Robctu, 
J. W.; Stabl. F. W.; Weubcr" R. A.. EWi.; Cold Sprinl Harbor. NY 1983: 
pp 145-173. 
Linearized bacteriophage>.. DNA was labeled with up indi-
vidually at the left (L) and right (R) ends ()' lill-in reaction) with 
AMV reverse transcriptase. An 18 base homopyrimidine oligo-
nuclectide. 5'-PTlCT6CT,CT-3'. with thymidine-EDTA (T*)ll 
at the 5' end. was synthesized by automated methods. The oli-
gonucleotide-EDTA (0.8 ~MF was mixed with Fe(NH')l(SO,h 
(1.0 .101M) and spermine (1.0 mM). The oligonucleotide-
EDTA·Fe(ll)j spcrmine was added to a solution of L (or R) IIp 
end-labeled A DNA (approximately 4,u.M in base pairs) in 100 
mM NaC! and 2S mM tris-acetate at pH 7.0.1' After 0.5 h 
incubation at 24 DC. 4 mM dithiothreitol was added to initiate 
strand cleavage. The reaction was allowed to continue for 6 h 
(24 DC). The double strand c1eange products were separated 
on a 0.4% vertical agarose gel whicb resolves DNA segments up 
to 25 kbp in size (Figure 3). Therefore, DNA uniquely labeled 
at the Rand L ends allows cleavage site analysis of the entire 48.5 
kbp of the>.. genome. 
No cleavage was observed for the first 25 kbp of the L end-
labeled DNA (Figure 3A. lane 3). However, a single major 
cleavage site 9.4 kbp from the right (R) end of the 48.5 kbp DNA 
was visualized on the autoradiogram (Figure 3A, Lane 5).1' This 
was quantitated by scintillation counting of the individual bands. 
The oligonudeotide--EDTA·Fe probe afforded double strand 
cleavage of >.. DNA at the target sequence, RD-AKd~dAKdA-P/K 
with an efficiency of 25% (Figure 3) .16 Within the limits of our 
detection. overexposure of the autoradiogram revealed no sec-
ondary cleavage sites. We estimate that all secondary site$; were 
cleaved at least 3a-rold less efficiently than the primary sequenceP 
In order to prevent random shearing of the DNA caused by 
pipetting or vortexinsY large DNA is routinely manipulated by 
embedding it in low melting point (LMP) agarose and diffusing 
reagents into the matrix. To test whether triple helix mediated 
site-specific cleavage can occur with oligonucleotide-EDTA·Fe 
within an agarose matrix, end-labeled >.. DNA was embedded in 
1% LMP agarose gel, and tbe cleavage reactions were perfonnc:d 
as described above (24 DC, pH 7.0, 6 h, initial incubation time 
was extended to I h to allow for complete diffusion into the matrix) 
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followed by electrophoresis. Primary site-specific double strand 
cleavage occurred in the aprose matrix with an efficiency or 25% 
(Figure 38. lane 2). 
In conclusion, this work has implications for human genetics. 
The way is now clear for t~e development or a triple helix strategy 
to isola~e large segments of genomic DNA for mapping and 
sequenclnl· 
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.... 
(1-4) ConomttatiOlll , iveD Ire final dilutioN. 
(15) The oomplemenr.ry fnlpncnt, 39.1 II:bp from the L terminus, wu noc 
resolved rrom tbe inr.ct X DNA bu.t ~ be riJualized in underexp!»ed au-
10000iosnmA u a .Itoakkr willi huc..;ty equJ to the 9.4 II:bp fn,ment. 
(16) 25.., efficiency mea .. that ono-quancr of all the DNA underwent 
double strand c1eavl,e at ono lite. 
(17) Altboulh lhe lbows conditions ue optimal for .IDJlc-tlite eleavl,e, 
reaction ~nmetmi CIlI be modifNd for tbc ~ of -rdliztt IarJc DNA 
for sequcnea of JHl'I/al homoIOI)' with tbe primary tarpt ,ite. For cumple. 
identical reaction conditiona performed It the rcdllCUl. lempcntua of 0 ·C 
for 2-4 h 1'C5u1tcc1 in three minor liu. of elea ..... e (2.s-fold lea efficient) ""hKi~ 
mlp to 22.4. 37.9. IDd 47.7 II:br, rrom tbe L terminus. Seque.nea partWly 
homolollou, ""hb the primary I Ie Ire fOllnd It each of the.c ~ition •. One 
site, Y-AACAAAAAAAAG-3'. contailll two milmatehl:S in the fint 12 nu-
deocide- fnxn the j ' end of the oIiJofIucleocidc-EDTA·Fe probe. Two otbct 
silea, 5'-AAAAGAAAAATGM-)' Ind Y-AAATGAATAMGAA-3'. 
contain one Ind two milmatebea in the fin! 14 base pain. Icspcaively. All 
other .sequCIICICI in X DNA witb I similar degree of sequence homo/OIY (two 
mismatc.hcs m 12) were not clcat'Od .-itbiD tile limitl of ourdctcdioo and haYe 
in common the milmllcb It Of adjacent to the 1"* wbich oonwns the 
EDTA.Fe(lJ) c\eavinl moiety. 
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Specificity of Triple Helix Formation. Although the reaction 
conditions described were optimized for single site cleavage (4), the specificity 
of triple helix formation could be modified by adjusting the reaction 
conditions (3). By reducing either the temperature or the pH, sites of near, but 
imperfect sequence identity with the target site were cleaved. Reactions 
performed at 0° C pH 6.6 instead of 24° C pH 7.0 revealed three other cleavage 
sites that mapped 22.4, 37.9, and 47.7 kb from the left terminus of the 
bacteriophage A. genome (Fig. 2.1). Reactions performed at pH 7.0 and 0° C 
produced only one secondary cleavage site at 37.9 kb. This suggests that the 
sequence at 37.9 kb is more extensively homologous with the target site than 
the other two sites detected under less stringent conditions. 
Sequences at the physical map positions of the observed cleavage 
products contained partial homology with the target site (6). A sequence 
containing only one mismatch within 14 contiguous base pairs (beginning 
with an A recognized by T* at the 5' end of the purine sequence) was 
identified at position 37.9 kb (Fig. 2.2). As predicted from the affinity cleaving 
data, no other sequences with 13 of 14 base pair homology were present in the 
bacteriophage A. genome. The sequences mapping to 22.4 and 47.7 kb were less 
homologous, containing two mismatches within 12 and 14 contiguous base 
pairs, respectively (Fig. 2.2). Unlike the 37.9 kb product, sequences with 
homology similar to the 22.4 and 47.7 sites were present, but none of these 
sites were cleaved within the limits of detection (>2% cleavage). Each of the 
partially homologous sequences not cut by the Oligonucleotide contained a 
mismatch at or adjacent to the base pair bound by T* (Fig. 2.2). Presumably, 
the mismatch near T* generates a local structural distortion that effects the 
cleavage efficiency of the EDTAoFe(II). A similar homology requirement was 
observed using oligonucleotides targeted to sites within adenovirus~O DNA. 
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Fig.2.1. Cleavage of secondary sites in bacteriophage A. DNA by 
oligonucleotide-EDTAeFe(II). Autoradiogram of 32p right (R) and left (L) end-
labeled DNA, 48.5 kb in length, reacted with oligonucleotide-EDTAeFe(II} at 
pH 6.6, 00 C. Reactions were performed on R or L end-labeled A DNA (4 IJM 
in base pairs), in 100 mM NaCI, 25 mM tris-HCI, 0.8 J.1M oligonucleotide-
EDTA, 1.0 J.1M Fe(NHt}z(S04}z, 1.0 mM sperminee4HCl. Oligonucleotide, 
Fe(NHt}z(S04}z'6H20 and spermine were preequilibrated together for 5 
minutes and then added to the buffered salt solution of DNA. Triple helix 
formation was allowed to proceed for 30 min. at 00 C after which DTT was 
added to a final concentration of 4 mM. The cleavage reaction was allowed to 
proceed for 24 hours. Cleavage products were resolved on a 0.4%, lxTBE 
agarose gel. The gel was dried under vacuum and an autoradiogram obtained 
with an intensifying screen at -700 C. 
Lane M, DNA markers of the size indicated. Lane 1, Lend-labeled 
intact A DNA control. Lane 2, L end-labeled A DNA with oligonucleotide-
EDT A e Fe(II}. Lane 3, R end-labeled intact A DNA control. Lane 4, R end-
labeled A DNA with oligonucJeotide-EDTAeFe(II). Cleavage products at R 9.4 
kb (base position 39.1), R 10.8 kb (base position 39.7), R 26.1 kb and L 22.4 kb 
(base position 22.4) are indicated by arrows. The sequences in the region of 
cleavage most homologous with the target site are also indicated. 
Mismatches between the target site and the sequence identified at this locus 
are marked by a shaded box. The intensity of the 22.4 kb product is unusually 
high. The intensity is typically equivalent to the complementary 26.1 kb 
product seen in lane 4. The secondary target sites were cut 3 to 10 fold less 
efficiently than the primary target site. 
Identical cleavage reactions also revealed a 0.8 kb product with R end-
labeled DNA (base position 47.7) when separated on a 0.8% agarose gel for 100 
V·hr (data not shown). The homologous sequence identified at this position 
was 5'-AAATGAA-TAAAGAA-3', where the mismatches are underlined. 
- -The cleavage efficiency was 3-fold less intense than the 9.4 kb major product. 
The 0.8 kb band had migrated off the bottom of the 0.4% gel shown here. 
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... 5'-AAAAGAAAAAI!3AA-3' 
_ ... 5'-AAAAGAAAAAAGAAAAGA-3' 
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39,138 S'-T AC AAAAG AAAAAAG AAAAG AT T A-3' 18/18 
B 37,867 S'- AAAAAAAG AAAAA TG AAC T TGG CT -3' 13/14 
47,736 S'- AC AAAA TG AA T AAAG AAC AATC TG-3' 12/14 
22,365 S'-AG AAAC AAAAAAAAG CCTG ATG CA-3' 10/12 
C 36,829 S'-CAACAAACAAAAAAGATGGGAATC-3' 11/13 
43,336 S'-TCGACAACAAAAAAGACCTGCTT A-3' 11/13 
36,946 S'-TGG TAAAGAGAAAAGTTTTTCCAT-3' 10/12 
30,664 S'-CGAAT AAT AAAAAAGGAGCCTGT A-3' 10/12 
Fig.2.2. Sequences of primary and secondary cleavage sites within 
bacteriophage A. genomic DNA. A. Sequence of the oligonucleotide used for triple 
helix mediated affinity cleaving, and its primary target site. B. Secondary cleavage 
sites recognized and cut by oligonucleotide at low efficiency. C. Other potential 
secondary cleavage sites within bacteriophage A. DNA that have comparable 
homology to the target sequence as those listed in B, but were not cut by 
oligonucleotide-EDT A • Fe(II). These sequences have in common a mismatch at or 
adjacent to T". 
The base position in the bacteriophage A. genome is indicated to the left. The 
homologous region is underlined. The degree of homology with the target site is 
listed to the right. Mismatched bases within the underlined region are shown in 
outline. All sequences represent the maximum alignment of the oligonucleotide-
EDTA.Fe(m within the region where cleavage is observed. 
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Specificity of Oligonucleotides Containing Mec and Bru substitutions. 
Povsic and Dervan reported that replacement of C with 5-methylcytosine 
(Mec) increased the affinity of the oligonucleotide for the target site and 
extended the pH range for binding (24). They also reported that substitution 
of T with 5-bromouracil (B'11) increased the binding affinity but did not 
change the pH profile of binding (24). Because the assay was performed on a 
plasmid with a limited number of partially homologous secondary binding 
sites, it was important to determine if these base substitutions affected the 
specificity of triple helix formation as assayed on larger DNA substrates. 
An oligonucleotide specific for the bacteriophage A. target site was 
synthesized with T* at the 5' terminus and Mec and B'11 substitutions for C 
and T, respectively. The specificity of this modified oligonucleotide was 
directly compared to the original CT oligomer (Fig. 2.3). At pH 7.0, 24° C 
several secondary cleavage sites were detected with the MecB'11 
oligonucleotide that were not seen with the CT oligomer under similar 
cleavage conditions. These included sites at 37.9 and 22.4 kb (measured from 
the left terminus) that had previously been observed only at 0° C and pH 6.6. 
Additionally, there was a new product at map position 36 kb E~1O kb 
fragment) and two other cleavage sites that mapped to positions between 20 
and 30 kb from the left terminus. None of these products had previously 
been detected with the CT oligonucleotide. Cleavage at the secondary 
cleavage sites was not detected at lower oligonucleotide concentrations «200 
nM), although the MecBru oligonucleotide consistently cleaved more 
efficiently at lower concentration than the CT oligomer (Fig. 2.3). 
Efforts to identify the new sequences recognized by the MecB'11 
oligonucleotide were unsuccessful. No Significant homology with the target 
site was detected at any of the new map positions, and no pattern could be 
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Fig. 2.3. Cleavage of bacteriophage:\. DNA with CT and MecBru 
oligonucleotides as a function of oligonucleotide concentration .. 
Autoradiogram of 32p right (R) end-labeled:\. DNA (4 ~M in base pairs) 
reacted in 100 mM NaCi, 25 mM tris-HCl, 1.0 mM spermine-4HCl, and 4 mM 
orr at pH 7.0, 24° C. CT and MecBru oligonucleotide-EDTA concentrations 
were varied between 200 nM and 1 ~M using one molar equivalent of 
Fe(NH!)z(S04)z. Oligonucleotide, Fe(NH!)z(S04)z·6H20 and spermine were 
preequilibrated together for 5 minutes and added to the buffered salt solution 
of DNA. The DNA was incubated with oligonucleotide-EDTA-Fe(II) for 30 
min. to facilitate triple helix formation after which orr was added to a final 
concentration of 4 mM. The cleavage reaction was allowed to proceed for 24 
hours. Cleavage products were resolved on a 0.4%, lxTBE agarose gel. The 
gel was dried under vacuum and an autoradiogram obtained with an 
intensifying screen at -700 C. 
Lane M, DNA markers of the size indicated. Lane 1, Rend-labeled 
intact :\. DNA control. Lanes 2-6, reactions with CT oligonucleotide-
EDTA-Fe(II) at 1000, 800, 600, 400, and 200 nM, respectively. Lane 7-11, 
reactions with MecBru oligonucleotide-EDTA-Fe(II) at 1000, 800, 600, 400, and 
200 nM, respectively. 
, 
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detected to explain why these sites were cleaved at the exclusion of other sites 
with similarly low homology. The data suggest that in addition to having 
higher affinity for the target and homologous secondary sites, the base 
substitutions produced altered specificity. Subsequent experiments on yeast 
genomic DNA demonstrated that the altered specificity was caused by BI'{] 
substitution and not from MeC (25). BI'{] is known to be mutagenic when 
incorporated into DNA, resulting in increased base misincorporation during 
replication and transcription (26-28). This could be caused by several 
mechanisms including Bru base ionization (29,30) or tautomerization of the 
base to the enol form (31, 32). At neutral pH, greater than 40-fold more of the 
BI'{] residues are calculated to be ionized than T (7.4% compared to 0.16%) (30), 
and the enol tautomer of BI'{] is ten times more favored than that of T (32). 
The resulting alteration in hydrogen bonding properties could contribute to 
the broader sequence tolerance of BI'{] oligonucleotides, though the actual 
specificity of BI'{] within the triple helix has not been determined. 
Improved Cleavage Efficiency. Although the target site in 
bacteriophage", was cut more efficiently than any other sequence targeted by 
oligonucleotide directed affinity cleaving, the cleavage efficiency reached a 
maximum at 25% (4). Longer incubation times, higher oligonucleotide 
concentrations, additional iron and more reducing agent failed to improve 
the cleavage efficiency. In most cases, additional reagents and reaction time 
only increased the nonspecific nicking of the DNA substrate. To increase the 
efficiency of double strand cleavage, we employed two strategies: (i) cutting 
with oligonucleotides containing multiple T* moieties, and (ii) cutting the 
target site several times by pH cycling and fresh reagent addition. 
Cleavage of Bacteriophage ;., with Oligonucleotides Containing 
Multiple T* Moieties. A number of possible explanations could be advanced 
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to explain the cleavage maxima observed with affinity cleaving using 
oligonucleotide directed triple helix formation. These include: (i) incomplete 
occupation of the target site by the oligonucleotide, (ii) rapid probe exchange 
at the target site, (iii) low cleavage efficiency of EDTAoFe(II) in the major 
groove, and/or (iv) autocleavage of the oligonucleotide. 
Saturation and oligonucleotide exchange at the target site are not 
significantly limiting factors for cleavage. Competition experiments between 
probes with and without "P residues demonstrated that there is little probe 
exchange at the target site within the time course of the reaction, suggestive of 
a slow oligonucleotide off rate (Fig. 2.4) Footprinting and enzyme inhibition 
studies demonstrated that under the reported conditions, nearly all the target 
sites are occupied (33, 34). Subsequent kinetic analysis of triple helix 
formation demonstrated that the oligonucleotide off rate is several hours (35). 
Quantitative cleavage of duplex DNA is observed with affinity cleaving 
agents that bind in the minor groove (1). Double strand oxidative cleavage is 
slowed, however, by low EDTAoFe(II) reactivity in the major groove of DNA 
(36,37). It is proposed that the oxidative species must migrate from their 
source in the major groove to reactive sites in the minor groove. Due to the 
increased lifetime of the reactive species required to access these minor 
groove sites, abstraction of hydrogen atoms from the bulk solvent becomes a 
significant competing side reaction (36, 37). 
The fundamental limitation to the efficiency of affinity cleaving by 
oligonucleotide-EDTAoFe(II) is autocleavage of the oligonucleotide (38,39). 
Griffin and Dervan reported significant degradation of T* oligonucleotides in 
solution during the course of a cleavage reaction when monitored by 
radiolabeling of the oligomer (38). Ts'o and coworkers also reported 
Significant degradation of oligonucleotides containing EDT A ° Fe(II) under 
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Fig. 2.4. Autoradiogram of a pulse chase competition reaction between 
oligonucleotides with and without the affinity cleaving agent EDTA·Fe(II). 
Oligonucleotide-EDTA (lJ-lM) was preequilibrated with Fe(NHi)z(S04)z·6H20 
(lJ-lM) and spermine (l mM) for five minutes. The metal complexed 
oligonucleotide was added to R end-labeled bacteriophage I.. DNA (4 J-lM in 
base pairs) in 100 mM NaCl, 25 mM tris-HCl pH 7.0, at 240 C. The DNA was 
incubated with the oligonucleotide for 30 minutes to facilitate triple helix 
formation. Fifty fold excess (50 J-lM) of a non-T* oligonucleotide [5'-
(T)4C(T)6C-(T)4CT-3'] identical in sequence to the T* oligomer was added to 
the triplex solution. DTT (4 mM) was added to the reaction at variable times 
after the addition of the non-T* oligomer and the cleavage reaction allowed 
to proceed for six hours. Cleavage products were resolved on a 0.4%, lxTBE 
agarose gel. The gel was dried under vacuum and an autoradiogram obtained 
with an intensifying screen at -700 C. 
Lane M, DNA markers of the size indicated. Lane 1, cleavage reaction 
on bacteriophage I.. DNA performed in the absence of competitive non-T* 
oligonucleotide. DTT was added at t = O. Lane 2-9, variable times of DTT 
addition after the addition of non-T* oligonucleotide. Times are t = 0, 10, 20, 
30,45,60,90, and 120 min. Lane 10, unreacted control containing all reagents 
except DTT. The higher cleavage efficiency observed in the absence of non-T* 
oligonucleotide (Lane 1) suggests that some oligonucleotide exchange might 
be occurring during the six hour cleavage incubation, or that the high 
oligonucleotide concentration in lanes 2-9 partially quenches the reaction. 
The high concentration of non-P oligonucleotide in the solution 
guarantees that if the T* oligomer dissociates from the target site prior to DTT 
addition, it would not be capable of rebinding. Despite the presence of non-T* 
oligonucleotide for at least 2 hours, the cleavage reaction still proceeds at high 
efficiency. This suggests that the oligonucleotide dissociation rate is on the 
time scale of hours, and that oligonucleotide exchange at the target site is 
quite slow. 
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oxidative conditions (39). Autocleavage of an oligonucleotide bound to the 
DNA duplex would result in a competitive inhibitor of the reaction. The 
degraded species would retain binding capacity, but would be unable to cleave 
the target site due to 1055 of the 5' terminus containing the EDTA-Pe(II) (38). 
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Pig. 2.5. Synthetic scheme for 5'-DMT, 3'-succinyl, thymidine-EDTA-
triethyl ester coupled to control pore glass (CPG). See Materials and Methods 
for detailed protocol. 
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If autocleavage is the limiting factor for efficient cleavage, one possible 
strategy to improve the yield is to construct oligonucleotides containing 
multiple cleaving moieties. This would place several EDTA-Fe(II) groups 
into a localized region and generate a high concentration of strand nicking at 
the oligonucleotide binding site. 
T* can be introduced at the 5' terminus and at any internal position by 
coupling T* phosphoramidite to the 5' end of a growing nucleotide chain 
during automated DNA synthesis (5, 40). Placement at the 3' terminus, 
however, required preparation of a T* solid support (41). Synthesis of 5'-
DMT, 3'-succinyl T* triethylester-control pore glass (CPG) (4) is shown in Fig. 
2.5. 5-DMT-T*-triethylester (1) was succinylated at the free 3'-hydroxyl to yield 
nucleoside 2. Activation of the succinylated T* derivative with p-
nitrophenol afforded nucleoside 3. The crude mixture containing the 
activated T* derivative (3) was added directly to long chain alkyl amine CPG 
beads to yield 4. Nucleoside loading was determined by DMT deprotection 
with acid. Free amines on the CPG were capped with acetic anhydride to 
prevent nonspecific coupling to the support during subsequent 
oligonucleotide synthesis. 
Oligonucleotides (1-6) specific for the homopurine sequence in the 
bacteriophage A. genome (Fig. 2.6) (4) containing one to four T* moieties at 5', 
3' and internal positions were synthesized. The high resolution cleavage 
pattern of oligonucleotides containing a 3'-T* was examined on a 7.4 kb EcoRI 
restriction fragment from the bacteriophage A. genome. This fragment 
contained the homopurine target site 18 bp from the radiolabeled terminus. 
Oligonucleotide 1 containing a 5'-T* demonstrated a 5' shifted cleavage 
pattern (Fig. 2.7-1) consistent with major groove binding similar to that 
reported for a restriction fragment (3). The pattern for the 3' T* 
Fig. 2.6. Enhanced cleavage efficiency using oligonucleotides containing multiple T* 
moieties. A. Sequence of oligonucleotides 1-6 specific for triple helix fonnation at a single 
homopurine target site in the bacteriophage I genome. B. (Left) Double strand cleavage of 
bacteriophage I DNA generates two fragments, 39.1 (L) and 9.4 kb (R) in size. (Center) Schematic 
model of triple helix fonnation between the Watson -Crick homopurine-homopyrimidine site on I 
DNA and the Hoogsteen hydrogen bonded pyrimidine oligonucleotide 3 with 5' and 3' EDTAoFe(II). 
1 
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TATTCGTCAGAGAA TT-3' 
'i-'r':'-;;;-:-'-:"":"';"";::-'-'-'-'-"-'-' AT A AGCA GT C T C T T AA-5' 
ltt 
ACACTATTAC'r<AAAGAAAAAAGAAAAG IrTAT TCGT CAGAGAATT-3' 
TGT GAT AAT GIrTTT CTTTTTT CTTTTC ~Aq AAGCAGTCTCTT AA-5' 
+11 t1 
ACACTATTAC 
TGTGATAATG 
H 
TATTCGT CAGAGAATT-3' 
ATAAGCAGTCTCTTAA-5' 1++' 
Fig. 2.7, Histogram of the high resolution DNA cleavage pattern on 
bacteriophage A DNA by oligonucleotides 1-3 as derived from densitometry 
of the autoradiogram. The arrow height represents the relative cleavage 
intensities at the indicated bases. The shaded bases indicate the base bound by 
T* in each triplex. 
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oligonucleotide was also 5' shifted, but the purine strand was cut significantly 
less efficiently (Fig. 2.7-2). The cleavage pattern of oligonucleotide 3 with "p" 
at both termini, was a composite of the single "P" oligonucleotides, although 
the intensity of cleavage at each base was slightly lower (Fig. 2.7-3). 
Differential single strand cleavage efficiency by T* placed at various 
positions within the Hoogsteen strand indicated structural features of the 
complex (1). The 5'-"P" displayed equal cleavage of the purine and pyrimidine 
strands. Reduced cleavage of the purine strand by the 3'-T* oligonucleotide 2 
is consistent with asymmetric self-footprinting of the DNA. The geometry of 
the 3'-"P" EDTA in the pyrimidine triple helix motif requires that the 
oxidative species diffuse over the oligonucleotide phosphate backbone to 
access the purine strand (Fig. 2.6). Thus, the 5' and 3' termini are not 
geometrically equivalent. Interestingly, Beal and Dervan showed that 3' T* in 
the purine motif shows a reversed pattern of access to the Watson-Crick 
strands, i.e., the purine strand is cut efficiently and the pyrimidine strand is 
footprinted (42). In this motif the third strand is bound in the reverse 
orientation, closer to the center of the major groove, and employs reverse 
Hoogsteen TAT triplets (43). 
Site specific double strand cleavage efficiencies of the A. genome by 
oligonucleotides 1-6 were also tested (Fig. 2.8). Oligonucleotide 1 was 
previously reported to yield 22±3% cleavage (Lane 1) (4). The double strand 
efficiency of the 3' T* oligonucleotide 2 was slightly lower (l7±3%) (Lane 2). 
Oligonucleotide 3 with T* at both 5' and 3' termini yielded 40±4% cleavage, 
approximately the sum of cleavage from oligonucleotides 1 and 2 (Lane 3). 
Oligonucleotide 4 also contained two T* residues but generated only 27±3% 
cleavage (Lane 4). This may result from lower binding affinity of the probe 
due to the close proximity of the two T* residues. Oligonucleotides 5 and 6 
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Fig. 2.8. Site-specific double strand cleavage of bacteriophage i.. DNA by 
oligonucleotides 1-6. The number above each lane indicates the 
oligonucleotide tested in the reaction. Right end-labeled i.. DNA (4 IlM in base 
pairs) was digested with 1.0 IlM of oligonucleotides 1-6 in one molar 
equivalent of Fe(NHth(S04)2 per EDTA, 1 mM spermine, 100 mM NaCl, 25 
mM tris-acetate pH 7.0, and 4 mM DTT at 240 C. Oligonucleotide, 
Fe(NH4h(S04h and spermine were preequilibrated together for 5 minutes, 
added to the DNA in buffered salt solution, and incubated an additional 30 
minutes to facilitate triple helix formation. DTT was added to a final 
concentration of 4 mM, and the cleavage reaction was allowed to proceed for 6 
hours. Cleavage products were resolved on a 0.4%, 1xTBE agarose gel. The 
gel was dried under vacuum and an autoradiogram obtained with an 
intensifying screen at -700 C. 
Lane M, DNA size markers of size indicated. Lane C, intact right end-
labeled i.. DNA control. Lanes 1-6, cleavage reactions using oligonucleotide 1-
6, respectively. Arrow on the right indicates the 9.4 kb cleavage fragment. 
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(with three and four T* residues, respectively) failed to cut efficiently «5%) 
(Lanes 5 and 6). Cleavage by oligonucleotides 5 and 6 was enhanced under 
more permissive binding conditions, but the effect was small, and cleavage 
remained lower than that obtained with either single or double T* 
oligonucleotides. This suggests that the oligonucleotides did not bind the 
target site, and indicates that binding affinity was reduced by multiple T* 
substituents. Decreased cleavage may reflect triplex destabilization due to 
unfavorable steric interactions in the major groove involving bulky EDTA 
substitutions of thymidine at C5. It further suggests that a critical number of 
base triplets were necessary to stabilize each T* residue in the probe (38). 
Mathematical Model of Autacleavage. In spite of oligonucleotide 
saturation of the target site and the introduction of multiple cleaving 
functionalities into a single oligonucleotide, the efficiency of affinity cleaving 
remains fundamentally limited by oligonucleotide self cleavage. Statistically, 
double strand cleavage efficiency is limited by the probability of cleaving both 
duplex DNA strands before suicide inactivation of the probe. A simple 
mathematical model expressing the efficiency of double strand cleavage (E) is 
the summation: 
E = LPy(i-t).pu + pu(i-l).py 
i = 2 
(Eq.2.1) 
where detectable oxidative events, i, are defined as those resulting in cleavage 
of the purine, pyrimidine, or Hoogsteen strands. The corresponding 
probabilities per event are pu, py, and H, respectively. For each detectable 
oxidative event, pu + py + H = 1. An analysis using this model was applied to 
oligonucleotide 1 containing the 5' T*. For this oligonucleotide, the observed 
pulpy ratio was 1.0 (Fig. 2.4), and the double strand cleavage efficiency (E) was 
25%. Iteration using the above equation to solve for the cleavage probabilities 
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yielded values of 0.29, 0.29, and 0.42 for pu, py, and H, respectively. This 
suggests that for each oxidative event, autocleavage is 1.4 times more probable 
than cleavage of either the purine or pyrimidine strands. 
In the case of oligonucleotide 2 with a 3'-T*, the pulpy ratio was 
reduced to 0.3, while the double strand cleavage efficiency was 17%. The 
corresponding values for pu, py, and H were 0.13, 0.46, and 0.41, respectively. 
Thus, pyrimidine and Hoogsteen strands were cleaved with approximately 
equal probability, while the purine strand was cut less efficiently due to 
protection by the bound strand. Partial protection of the purine strand results 
in a lower probability of double strand cleavage before the oligonucleotide 
was inactivated. Therefore, the difference between the values obtained for 
oligonucleotides 1 and 2 reflect the distinct steric environments at the 5' and 
3' termini. This simple model allows quantitative estimation of the 
significance of autocleavage as a limitation to double strand cleavage 
efficiency . . 
In addition to providing a simple mechanism to improve the efficiency 
of double strand cleavage, the coupling of T* to the CPG solid support offers a 
number of synthetic advantages. T* phosphoramidite coupling to the nascent 
nucleotide chain typically proceeds with only moderate coupling efficiencies 
(50-75%), because the reaction is extremely sensitive to the trace impurities 
typically present in the phosphoramidite. Such impurities significantly 
reduce shelf life of the T* phosphoramidite making it necessary to freshly 
prepare the material for each synthesis. Coupling to the 5' end of the nascent 
oligonucleotide chain is also inherently wasteful due to the need for 20-fold 
excess nucleoside for efficient cOupling. Conversely, the T*-CPG consistently 
couples to high efficiency, does not require phosphitylation for activation, 
and can produce ten fold more couplings per gram than in the T* 
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phosphoramidite form. T"-CPG support is stable at 4° C for at least two years, 
and 1.0 g of protected T" coupled to T"-CPG support is sufficient to make 
several hundred oligonucleotides. 
Enhanced cleavage of bacteriophage}.. DNA by pH cycling. Despite the 
improved cleavage efficiency produced by chemical modification of the 
oligonucleotide, binding affinity and autocleavage still limit the overall 
cleavage efficiency. A second method to improve the cleavage yield was by 
performing multiple rounds of cleavage. Because the majority of the binding 
site remained occupied despite autocleavage of the oligonucleotide, and the 
inactivated autocleavage product of autocleavage could readily bind to the 
target site after denaturation, it was necessary to physically remove the third 
strand from the substrate DNA between each round of reagent addition. 
Several attempts to use increased temperature to remove the third strand 
proved unsuccessful as the elevated temperature promoted strand nicking by 
oxidative reagents in the solution, and no overall cleavage enhancement was 
observed at the target site. Ethanol coprecipitated the 48.5 kb substrate and the 
18 base oligomer. Triple helix formation in the pyrimidine motif is highly 
pH sensitive, and providing a nondestructive mechanism for triple helix 
disruption (3, 4, 24, 44-47). Separation could be achieved by embedding the 
DNA substrate in agarose and diffusing the oligomer into and out of the 
matrix as a function of pH (4). The size differential between the 
oligonucleotide and genomic substrate would facilitate efficient separation. 
Three cleavage cycles were performed on bacteriophage)" DNA using 
high pH washes between cleavage cycles to remove the oligonucleotide. 
Increased efficiency was observed after each round of cleavage (Fig. 2.9) 
Although DNA embedded in agarose was generally cut slightly less efficiently 
than in solution, pH cycling resulted in improved cleavage yields. Using 
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oligonucleotide 1, the efficiency improved from 18% after one pH cycle, to 
29% after two, and 37% cleavage after three cycles (Fig. 2.9). The yields using 
oligonucleotide 2 also improved with cycling, but they were not significantly 
better than observed in solution with a single round of cleavage. The values 
were 19% after one cycle, and 37% after two cycles. 
Although theoretically, the cleavage rounds could be continued until 
the substrate DNA was cut quantitatively, incomplete removal of reagents 
from the previous cycles resulted in gradually lower efficiency in later 
cleavage rounds. Additionally, the nonspecific oxidative nicking became 
significant after the first two cycles. Despite the preference of performing the 
reactions in solution for both ease and reduced levels of random DNA 
degradation, pH cycling was a useful method for improving the efficiency of 
cutting large chromosomal DNA that must be manipulated in agarose (see 
Chapter 3) (48). 
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Fig. 2.9. Improved cleavage efficiency of bacteriophage A. DNA by pH 
cycling. p32 right end-labeled A. DNA embedded in 0.8% low melting point 
agarose E~1MM !J.L total plug volume) was equilibrated in 1.0 mls of triplex 
buffer (NTS: 100 mM NaCl, 25 mM tris-HCl pH 7.0, and 1.0 mM 
spermine-HC!) for 15 minutes, decanted and overlaid with 120!J.L of NTS. 
2!J.L of 100 !J.M oligonucleotide 1 was preequilibrated with an equal volume of 
Fe(NH4)z(S04)z·6H20 and 3!J.L of the resulting solution added to the plug. 
The mixture was incubated for 3.0 hours at 24° C to facilitate diffusion of the 
oligonucleotide into the agarose and to promote triple helix formation. The 
NTS was then decanted and a fresh 120 !J.L aliquot of NTS added to the plug. 
3 !J.L of 0.2 M OTT was added and the reaction incubated an additional 7 
hours. The reaction was stopped by the addition of 1.0 ml of 100 mM tris-HCl 
pH 8.5 to disrupt the triplex. The oligonucleotide was removed from the 
solution by three 1.0 ml washes (15 min. to overnight) with 100 mM tris-HCl 
pH 8.5. The plugs were then reequilibrated in NTS buffer and the reaction 
repeated as described. After 1, 2, or 3 rounds of cleavage were complete, the 
plugs were equilibrated in 10 mM tris-HC!, 1 mM EDTA pH 8.0 and loaded 
onto a 0.5% agarose gel for resolution of the cleavage products. The gel was 
dried under vacuum and an autoradiogram obtained with an intensifying 
screen overnight at -700 C. 
Lane C, No treatment control of intact right end-labeled A. DNA. Lanes 
1-3, cleavage reactions using oligonucleotide 1 with 1, 2 and 3 pH cycles, 
respectively. The 9.4 kb cleavage product is indicated with an arrow to the 
right. 
b L 
# of Cycles o 1 2 3 
--- 9.4kb 
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Part II 
Cooperative Site Specific Binding of Oligonucleotides to Duplex DNA 
Cooperative binding to DNA has been observed in many natural 
systems (for reviews see references 49-51). Cooperative interactions between 
DNA binding proteins result in greater sequence specificity and improved 
sensitivity to changes in concentration. The activity of a number of DNA 
binding proteins is affected by cooperative interactions with homologous or 
heterologous proteins bound at neighboring recognition sites (52-60). The 
cooperative interaction is typically through protein-protein contacts between 
domains distinct from those for DNA binding (52-60). 
Cooperativity has also been implicated in binding of small molecules 
to DNA (49). The interaction is either between the DNA binding molecules 
or through a cooperative allosteric change in the DNA (49). Examples of the 
first are the heterodimeric binding of distamycin and 2-imidazole-netropsin 
in the minor groove of DNA (61), and the cooperative intercalation of 
acridine (62). In the second cooperative model, the molecules interact 
indirectly by altering the conformational state of the nucleic acid. Examples of 
this include ethidium (63), daunomycin (64), actinomine (65), or actinomycin 
D (65) cooperatively binding to left-handed Z DNA producing a local 
conformational change to a right-handed helix. 
Cooperative binding of single stranded oligonucleotides to single 
stranded templates has also been examined. Studies on the binding of 
oligoinosine I(pI)S-lO to a polycytidine template found that the oligomer 
cooperatively bound in clusters (66). Cooperativity was also detected for the 
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binding of sequence specific oligonucleotides to adjacent target sites on single 
stranded RNA or DNA templates (39,67,68). 
To define the degree of cooperative interaction between two 
heterologous ligands, it is necessary to determine binding isotherms for one 
ligand in the presence and in the absence of the second ligand (56). A 
qualitative estimate can be made, however, by observing differential cleavage 
efficiencies by affinity cleaving. This analysis was used to examine 
cooperative interactions between heterologous oligonucleotides bound to 
adjacent sites on double stranded DNA by triple helix formation (7). 
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Cooperative interactions between DNA binding ligands arc 
critical to their specificity. affinity, and biological activity. H 
Triple helix formation by oligonucleotides is the most powerful 
chem.ical approach to date ror the sequence.specific recognition 
of double helical DNA.H Hoogsteen hydrogen bonded base 
triplets, TAT and C+OC. result from pyrimkline ~igonuclootidcs 
binding site specifically to purine duplelt sequences. [n the triple 
helical model, a binding site size of 18 purine base pairs affords 
36 disc::rete sequence-specific hydrogen bonds (or recognition o( 
DNA in the major groove. As a possible mechanism for improving 
the specificity o( triple helill formation. we tested whether oli-
gonucleotides could cooperativdy bind to a double-strandcd DNA 
template. 
We report that two different pyrimidine oligonucleotides, which 
are nine bases in length. cooperaliw/y bind to an 18 base-pair 
homopurine site in bacteriophage" genomic DNA by triple helix 
formation. The purine target sequence 5' -~dAfg~dA-PD occurs 
once in " DNA 10 (48.S kilobase pain) aDd can be considered as 
two amtiguous unique half-sites., pD-~dAK-PD and S'-A1GA.GA-3'. 
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F1pft I. Upper: pyrimidine oligonucleotidcs dcsi,ned to bind adjacent 
half-!ites of the target sequence. A-and B* contain an EDT A cleavinS 
function at their 3' and 5' termini, respectively. Lower: double !trand 
cleavase of;\ DNA affords two fraaments. 39.1 and 9.4 kbp in size. 
Simplined modeb or tbe triple helix compka between adjacent Wat-
son-Cric:k homopurine-homopyrimidine ball·sites and the Hoossteen 
pyrimidine oligonucleotides A- and 8- bound bead-ta-tail. 
Two pyrimidine oligonucleotides. specific (or the adjacent half 
sites, were tcsted for cooperative binding interaction by the affinity 
cleaving method.i,II,II 
Oligonucleotides A *. B. and B* were synthesized by automated 
methods (Figure I). A modified nucleoside for cleaving DNA. 
thymidine-EDTA (T*),l] was placed at the 3' end of 5'-
T]CT4CT*-3'. (A *).Il OIiJOnucleotides 5' -T4CT4-3' were syn-
thesized with and without a T* moiety at the 5' end (B- and O. 
respectively). X DNAI2 was labeled with up at the right end (R) 
with AMY reverse transcripwe. ... SpecifIC double stnnd oxidative 
cleavage at the target site by an oliaonucleotidc-EDT A·Fe affords 
a 9.4 kbp fragment (Figure 2).'b The intensity of the 9.4 kbp 
fragment indicates the extent of oligonucleotide binding. 
Combinations of oligonucleotides A-. O. and O· at 5 ~M 
conce'?'trations were incubated at 24°C with Fe(NH4h<S04h. 
spemunc (1.0 mM). X DNA (approximately 4 #M in base pairs), 
100 mM NaO. and. 25 mM tris-acetatc at pH 6.6. Dithlothreitol 
(4 mM) was added after 0.5 h to initiate strand cleavage. The 
(II) DervaD, P. B. pcg~II" ''''. 212. 464. 
(12) Dreyer, O. B.; Derv .... P. 8. hoc. Nad. kad. Sci. U.s.A. 1915,82 • 
.... 
(13) TlI)'1nidilIooEDTA (T-)U ..... pCaocd at the Y temimuI or oUp 
nucleotide A- by co.plinl 5' DMT-thymidjnc EDTA·triethyl eater to a QOatrol 
pore llua IUppon. Eilbtccn base olilonlK:leotida with T- at tbe 3' end .re 
... pa.bIe of ,meratin, double ttrand elca"a,e in 17'it yield uoder previoualy 
described c:ooditioot." Strobel, S. A.; Dervall, P. B .• . unpubfubed wort. 
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cl~c·lpCcificKKdouble .. urand cl .... vale of bacteriophage A DNA. 
Autoradiogram of up right end·labeled ;\ DNA, 48.5 kbp in size. on an 
0.5% 'I'rose leI. Lane M, DNA size markers obtained by rcslriction 
enzyme digestion of left end·labeled DNA witb BamHI. Ape. I. and Sma 
I; digestion of right end·labeled DNA with SamHI, Sma I, and Xho I: 
48.5 (undiscsted DNA), 19.4. U .O. 10.1 .8.6.6.7. and 5.5 kbp. Lane I. 
right end-labeled intact ;\ DNA control. Lane 2. riSht end-labeled ;\ 
DNA with 5.0 ",M A- and 5 ",M Fe(Il). Lane 3.;\ DNA with 5.0 ",M 
A-. 5.0 ",M B. and 5.0 ",M Fe(lI). Lane 4.;\ DNA with 5.0 ",M B- and 
5.0 ",M Fe(II). Lane 5,). DNA with 5.0 ",M A-. 5.0 ",M B-. and 10 
",M Fe(II). Arrow on the right indicates 9.4 kbp cleavasc fragment . 
reactions proceeded (or 6 h (24 *C) and were stopped by ethanol 
precipitation. Double strand cleavage producu were separated 
by agarosc gel electrophoresis and visualized by autoradiography 
(Figure 2). Cleavage efficiency was quantitated by scintillation 
counting of the individual bands. 
A-incubated in the absence of B generated a marginally de-
tectable level of cleavage. 1.3 (:*:0.2)% (Figure 2. lane 2). A 
similar rC5ult 1.7 (±O.2)% was observed for B- incubated alone. 
(lane 4). This suggests that these nine base pyrimidine oligo-
nucleotides have low binding affinity for their target sites under 
the conditions chosen (24°C. pH 6.6), consistent with previous 
observations.ja In contrast, when A-was incubated in the presence 
of O. the cleavage efficiency improved to 4.4 (:*:0.5)% (lane 3). 
This 3.5-fold improvement in double strand cleavage indicates a 
positive binding interaction between contiguous oligonucleotides 
A* and. B. aligned head-Io-tail in the major groove of duplex DNA. 
Double strand cleavage can be further increased to to.5 (%1.1)% 
when both oligonucleotides were equipped with EDT A (A * in the 
presence of 0*. lane 5). 
Cooperative binding could arise from two different interactions: 
base stacking of the termina.l thymine bases of the Hoogsteen 
strand in the major groove and/ or an induced conformational 
change at contiguous DNA sites. There is literature precedent 
for both types of interactions. although in significantly different 
systems. l -4 If base stacking between the terminal bases of con· 
tiguous oligonucleotides in the triple helical complex is important 
for cooperative binding.l ] then disruption of this interaction could 
be utilized to make seqUence-SpecifiC recognition highly sensitive 
to single base mismatches. Design of structural motifs that en-
hance the cooperative interaction of adjacent sequence-specific 
binding oIigonuclcotidCI on duplex DNA is in progress. 
Aekno"WfDNL This work was supported in part by the 
National Institutes of Healtb (GM-35124) and the Caltecb 
Consortium in Chemistry and Chemical Engineering (Founding 
membcn: E. 1. du Pont de Nemours &: Co .• Inc., Eastman Kodak 
Comp8ny. Minnesota Mining and Manufacturing Company. and 
Shell Oil Company Foundation). 
(14) Strain e l8j7 Ittdl Sam? (rom New Enaland Btolabl. 
(15) (a) Solie, T. N.; Scbellman, J. A. J. Mol. Bioi. 1!J6I, 11. 61. (b) 
Haran. T. E.; 8crtorich·Yellin, z.; Sbatkcd, z. J. BJomo/. Strwt. Dyn. 1'" 
1,397. 
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Nature of the Cooperative Interaction . We originally proposed two 
possible mechanisms to explain the cooperative effect observed with these 
oligonucleotides: (i) base stacking of the terminal thymine bases of the 
Hoogsteen strand in the major groove, and/or (ii) an induced allosteric 
change in the DNA at contiguous binding sites (7). While we can not rule out 
either of these explanations, recent data demonstrates the importance of base 
stacking for cooperativity. Horne and Dervan incorporated an abasic 
deoxyribose residue into a full length oligonucleotide and observed a 
significant reduction in binding affinity (69). Distefano and Dervan did not 
observe cooperative binding if the ends of the oligonucleotides were 
separated by one base (70). Povsic and Dervan failed to detect end-to-end 
cooperativity if the oligonucleotides were abutting, but on opposite faces of 
the major groove (33). This configuration would eliminate base stacking 
while retaining contiguous binding. In a similar study, Beal and Dervan 
failed to detect cooperativity between two oligonucleotides that bound 
adjacent sites in the pyrimidine and purine motifs, respectively (42). This 
configuration also minimized base stacking while retaining contiguous 
binding. Together these data suggest that cooperativity is primarily through 
base stacking between the terminal bases, or possibly hydrogen bonding 
between the terminal deoxyribose sugars (71, 72). 
In 1989 we reported a 3.5 fold cooperative enhancement. Subsequent to 
this analysis cooperative binding isotherms were studied by a restriction 
enzyme assay (34) in a system more compatible with analysis of cooperativity. 
Ratios as high as ten to one were obtained at optimal concentrations on the 
binding isotherm (73). Povsic and Dervan also assayed end-to-end 
cooperativity by alkylation and observed similar values (33). 
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Artificial Motifs for Cooperative Triple Helix Formation . Other 
cooperative systems involving oligonucleotide directed triple helix formation 
have now been demonstrated. Povsic and Dervan observed cooperative 
binding to yeast genomic DNA (33). Distefano and Dervan observed greater 
than a 40-fold increase in binding affinity due to cooperativity between two 
oligonucleotides capable of forming a Watson-Crick duplex dimerization 
domain perpendicular to the triple helix (70, 74). Gates and Dervan observed 
a modest cooperative effect of 3.7 using a metalloregulated domain for 
dimerization (75). In this system, oligonucleotides equipped with 1, 10 
phenanthroline at their 5' terminus bound cooperatively to a duplex DNA 
template only upon the addition of cobalt, cadmium or zinc. 
Conclusion. Bacteriophage A. genomic DNA served as a valuable 
substrate for the study of triple helix formation in the critical size range 
between plasmid DNA and the complex genomes of yeast and human 
(Chapters 3-4). Cleavage efficiencies as high as 45% were detected at a single 
target site with low background. Efficient cleavage of DNA embedded in 
agarose (37%) was also demonstrated. The stringency of triple helix 
formation was examined as a function of pH, temperature, and 
oligonucleotide base composition. Cooperative binding of oligonucleotides to 
duplex DNA via triple helix formation was also demonstrated. 
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Material and Methods 
IH nuclear magnetic resonance (NMR) spectra were recorded on a Jeol 
JNM-GX400 Ff 400 MHz spectrometer and are reported in parts per million 
(ppm) from tetramethylsilane. Ultraviolet-visible (UV-Vis) spectra were 
recorded on a Perkin-Elmer Lambda 4C UV /Vis spectrophotometer. Flash 
chromatography was carried out under positive air pressure using EM Science 
Kieselgel 60 (230-400 Mesh). Thin-layer chromatography (TLC) was 
performed with precoated 0.25 mm silica gel 60 F-254 TLC plates (EM 
Reagents, Darmstadt F. R. G.). Long chain alkyl amine control pore glass 
beads (CPG) were obtained from Sigma. T* and T* diisopropyl amino 13-
cyanoethyl phosphoramidites were synthesized as described (5). 
Oligonucleotide synthesis was performed on a Beckman System 1 Plus DNA 
Synthesizer using standard j3-cyanoethyl phosphoramidite chemistry and 
reagents purchased from Beckman (41). 5-methylcytosine and 5-bromouracil 
j3-cyanoethyl phosphoramidites were purchased from Cruachem. Aqueous 
5'-[a32PldA TP, 5'-[a-32PldGTP and 5'-[y_32PldATP (3000 Ci/mmol; 1 Ci = 37 
GBq) were purchased from Amersham. Radioactivity was measured with a 
Beckman LS 3801 liquid scintillation counter. Unlabeled 
deoxynucleotriphosphates were purchased from Boehringer Mannheim. 
Bacteriophage A. DNA (cI857ind1Sam7) and all enzymes were obtained from 
New England Biolabs except AMV reverse transcriptase and calf intestinal 
alkaline phosphatase, which were purchased from United States Biolabs and 
Boehringer Mannheim, respectively. Solutions of ceEk~hEpM4h·SeOMI and 
dithiothreitol (DTT) were freshly prepared. 
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Synthesis of 5' -DMT, 3' -succinyl T* triethyl ester control pore glass: 
Nucleoside 2. Succinic anhydride (150 mg, 1.5 mmoI) was slowly added to a 
solution of 5'-DMT-T* triethylester (1) (1.007 g, 1.0 mmoI) and 4-
dimethylaminopyridine (DMAP) (60 mg, 0.5 mmoI) in dry pyridine (4 mls) 
and stirred under argon for six hours. A second portion of DMAP (60 mg, 0.5 
mmoI) and succinic anhydride (100 mg, 1.0 mmoI) was added and complete 
conversion to nucleoside 2 was obtained after 12 hours. The solution was 
reduced to a gum by rotary evaporation and the residual solvent removed by 
coevaporation with dry toluene. The crude mixture was dissolved in CH2Cl2 
(5 mls), washed with 10% cold sodium citrate (2x 5 mls) and H20 (2x5 mls), 
dried over anhydrous Na2S04, and reconcentrated. The residue was 
redissolved in CH2CI2 (5 mls), precipitated in stirring hexane (250 mls), 
decanted, and dried under vacuum to give nucleoside 2 (1.023 g, 0.93 mmol, 
92% yield). IH NMR (CDCI3): d 9.67 (1H, bs), 8.46 (1H, m), 7.48 (1H, s, H6), 7.39 
(2H, d), 7.32-7.22 (7H), 6.88 (1H, m), 6.84 (4H, d), 6.24 (IH, t, Hr), 5.35 (1H, m, 
H3'), 4.15 (6H, m, OCH2CH3), 4.11 (1H, m, ~IFI 3.78 (6H, s, OCH3), 3.53 (4H, s), 
3.41-3.27 (8H), 2.96 (2H, s), 2.78 (4H, m), 2.76 (4H, m), 2.31-2.18 (7H), 1.24 (9H, t, 
OCH2CH3). TLC (5% MeOH in CH2CI2): Rr-O.lO. 
Nucleoside 4. A solution of nucleoside 2 (1.023 g, 0.93 mmoi) in 
anhydrous dioxane (4 mls) and pyridine (0.2 mls) was stirred with p-
nitrophenol (140 mg, 1 mmol) and dicyclohexylcarbodiimide (515 mg, 2.5 
mmol) for 2 hours to yield nucleoside 3. (Rf=0.75 in 10% MeOH, CHCI3). The 
crude mixture was filtered through a fritted funnel, washed with 
dimethylformamide (DMF) (5 mls) and added to CPG beads (5.0 g). 
Triethylamine was added and the slurry was swirled periodically for 8 hours. 
The solution was decanted, an additional portion of CPG added (2.5 g), and 
the coupling reaction allowed to proceed for 12 hours. The derivatived CPG 
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was washed successively with DMF, followed by MeOH, and finally with 
ether. The T*-CPG was dried under vacuum. Nucleotide' loading was 
determined to be 29 j.lmoles of nucleoside per gram of support by a DMT 
deprotection assay (41). The uncoupled amine groups on the CPG support (7.5 
g) were capped in pyridine (30 mls) with acetic anhydride (2 mls) and DMAP 
(100 mg, 0.8 mmol) for 30 minutes. The support was then refiltered, washed, 
and dried as above. T* derivatized CPG (25 mg) was loaded into 1.0 IJIDole 
fritted columns for automated oligonucleotide synthesis. 
Oligonucleotide Synthesis . Oligonucleotides were synthesized by 
standard automated methods using l3-cyanoethyl phosphoramidites. 
Oligonucleotides with a 3' T* were synthesized using T* derivatived CPG 
support. T* nucleotides at other locations were introduced as activated 13-
cyanoethyl phosphoramidites as described (5). Oligonucleotides were 
deprotected with 0.1 N NaOH (1 .5 mls) for 24 hours at 55° C. The oligomers 
were purified on a 20% denaturing polyacrylamide slab gel (19:1 bisacrylamide 
crosslinked) containing 45% urea. The products were visualized by UV 
shadowing, excised from the gel, extracted with 100 mM NaCI, 1 mM EDTA 
for 40 hours, and dialyzed against distilled water at 4°C for 3-4 days. The water 
was changed every 6-10 hours. Oligonucleotide concentration was 
determined by UV absorption at 260 nm. The extinction coefficient for each 
oligonucleotide was calculated using the following nucleotide extinction 
coefficients: T, T*=9000 M-l, C=8000 M-l, B'1]=4600 M-l, and Mec=5700 M-l. 
The MecB'1] oligonucleotides were slightly shifted towards the visible with a 
AMAX of 277 nm compared to a AMAX for the CT oligonucleotide of 267 nm. 
Preparation of End Labeled DNA for High Resolution Analysis. 
Bacteriophage A DNA was digested to completion with EcoR! to produce 21.2, 
7.4, 5.8, 5.6, 4.9, and 3.5 kb products. The ends of alI fragments were 5' or 3' 
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end labeled. The digest was 3'-end labeled with [a._32PldATP by Klenow 
fragment of DNA polymerase. 5'-End labeling was performed by alkaline 
phosphatase treatment to remove the 5' terminal phosphates, followed by 
phosphoryl transfer with [y_32PldATP and polynucleotide kinase. 
Unincorporated mononucleotides were removed by G-50 Sephadex spin 
column chromatography in water. The 3' or 5' end labeled 7.4 kb fragment 
containing the homopurine target site was isolated on a 0.5% agarose gel, 
extracted by electroelution, ethanol precipitated, and dissolved in 250 mM 
NaCI and 62 mM tris-acetate pH 7.0. 
Preparation of End Labeled DNA for Low Resolution Analysis. 
Bacteriophage A. DNA was uniquely labeled at the right or left terminus by 
filling in the single stranded cos ends. This was done by providing the 
polymerase with only the appropriate mononucleotides for partially filling in 
one end. In the absence of all four nucleotides, many polymerases have 
extensive 3' exonuclease activity that remove nucleotides from the 3' 
terminus and subsequently fills in with the radioactive nucleotides provided. 
This results in both ends becoming equally labeled. To achieve unique end-
labeling it was necessary to select an enzyme lacking exonuclease activity. For 
this reason, end-labeling reactions were performed with AMV reverse 
transcriptase. 
Linear bacteriophage A DNA (7.5 Ilg) was incubated in 100 mM tris-HCl, 
pH 8.3, 140 mM KCl, 10 mM MgCI2, 28 mM ~-mercapthoethanolI and 5 units 
of AMV reverse transcriptase. For unique labeling of the right end, 0.6 mM 
dCTP and 2.5 III of [a-32PldGTP were added to the 50 III final reaction volume 
(Fig. 2.10). For left end labeling, 2.5 III of [a-32PldATP was added. The 
unincorporated mononuc1eotides were removed by G-50 Sephadex spin 
column chromatography preequilibrated in H20. Radioactive incorporation 
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was quantitated by scintillation counting and the DNA diluted to 5000 cpm 
per microliter. The quality of the DNA was improved and the shelf-life 
extended if the DNA was stored in a buffered solution (250 mM NaCl, 62 mM 
tris-acetate, pH 6.6-7.4). 
Cleavage Reactions. Affinity cleaving reaction conditions are described 
in the figure legends. Cleavage efficiencies were determined either by laser 
densitometry of the autoradiograms or radioactive scintillation counting of 
the excised bands. Efficiencies were expressed as a ratio of radioactive 
emissions in the product band to the sum of emissions in the product and 
uncut substrate bands. 
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Chapter III 
Site Specific Oeavage of Yeast Genomic DNA 
Mediated by Triple Helix Formation 
Site specific cleavage of bacteriophage A DNA (104 bp) demonstrated the 
utility of using oligonucleotide directed triple helix formation for genomic 
cleavage (1). The next incremental step toward site specific cleavage of a 
human chromosome (109 bp) was to demonstrate that an oligonucleotide was 
capable of mediating target site cleavage within yeast genomic DNA (107 bp). 
The Saccharomyces cerevisiae genome contains more than 14 megabase pairs 
(Mb) of DNA divided among 16 autonomously segregating chromosomes (2). 
The chromosomes range in size from 220 kb to 2.5 Mb and are readily 
resolvable by pulsed-field gel electrophoresis (3-8). Chromosome III, one of 
the smallest yeast chromosomes (340 kb), was chosen as a target because of its 
ease of manipulation and resolution. Yeast is an ideal organism for genetic 
manipulations, and many genes and sequences have been mapped to specific 
chromosomal locations (2,9) . One such gene is LEU2 which maps to the 
short arm of chromosome III (3p) near the centromere (9), and encodes for 13-
isopropylmalate dehydrogenase, an enzyme that catalyzes the third step in 
leucine biosynthesis (10-12). LEU2 can be used to specifically insert a triple 
helix target sequence by homologous recombination at a defined position in a 
yeast chromosome and select for the insertion by screening cells for the ability 
to synthesize leucine. 
This chapter describes the site specific cleavage of yeast chromosome III 
by oligonucleotide directed triple helix formation. It is divided into two 
sections based on the method of cleavage. The first describes the site specific 
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cleavage of yeast chromosome III by oligonucleotides containing the affinity 
cleaving agent EDTAoPe(II) (P) (13). It includes the use of specific, base 
modified, and nonspecific oligonucleotides to cut yeast chromosome III by 
affinity cleaving, and an analysis of the specificity of triple helix formation as 
a function of pH and oligonucleotide composition. The major findings of 
this work were published in Science 249,73-75 (1990) (14). The second section 
describes single site cleavage of the yeast genome by a modification of the 
Achilles heel technique for enzymatic cleavage, and analyzes the effects of 
oligonucleotide composition and pH on cleavage specificity by this technique. 
The results were reported in two publications. The report in Nature 350, 172-
174 (1991) emphasized the experimental result (15), while the paper to appear 
in Methods in Enzymology (in press) provides a detailed description of the 
protocol (16). This chapter also contains a methods section that provides a 
complete description of plasmid construction, chromosomal recombination, 
and polymerase chain reaction (peR) protocols used to generate and verify 
the yeast strains used as genomic substrates in these reactions. 
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Site-Specific Cleavage of a Yeast Chromosome by 
Oligonucleotide-Directed Triple-Helix Fonnation 
SCOTT A . STROBEL AND PETER. B. DERVAN* 
Oligonucleotides ~quippcdK with EDTA'Pc can bind specifically to duplex DNA by 
triplc:·hdix formation and produce double-strand cleavage at binding sites greater than 
12 base pain in size. To demonstrate that oligonucleotide-directed. triplc:-hdix 
fonnatiOD is a viable chemical approach for the site-specific cleavage of large genomic 
DNA, an oligonucleotide with EDTA'Pc at the S' and 3' ends was targeted to a 20-
base pair sequence in the 34O-kilobase pair chromosome m of Saultilrtlmycu 
Iu~"riaeK Double-strand cleavage products of the correct size and location were 
observed, indicating that the oligonucleotide bound and cleaved the target site among 
almon 14 mcgabase pairs of DNA. Because oligonuclcotide-directed triple-helix 
fonnation has the potential to be a general solution for DNA recognition, this result 
has implications for physical mapping of chromo.somes. 
T ECHNIQt1ES FOa. THE SITE-SPECIFIC cleavage of double·suanded DNA are vital to chromosomaJ mapping.. 
gene isolation, and DNA sequencing (I, 2). 
Restriction endonuclcaso with 4-- to 6-
base pair (bp) binding sites ckavc roo ftt-
quendy for many chromosomal DNA ma-
nipulacions (J). Rare-cutting restriction en-
zymes with 8·bp specificities have found 
widespread we in generic mapping; howey· 
er, m($(: enzymes are few in nwnber. are 
/.irnjted to the recognition of CpG-rich sc· 
quences, and cleave at sites that tend to be 
h..ighly clustered (4) . Combinations of mc:th· 
ylases and restriction enzymes that require 
methylared sequences can produce cleavage 
specificities of 8 to 12 bp (5). Transient 
methylase protection can be induced by 
ONA binding proteins that recognize se· 
quences with overlapping restriction·meth-
ylation sites; restriction enzyme digestion 
then produces specific cleavage at the pr0-
tein binding site (6). Recendy, endonucle-
ases encoded by group I introns have been 
discovered that might have greater than 12 
bp s~city (7). Unfortunately, none of 
th($(: strategies can be generalized to recog-
nize and cleave at any of the large nwnber of 
unique sequences contained in hwnan 
DNA. 
Pyrimidine oligonuclrotides bind specifi-
cally to purine sequences in duplex DNA to 
fonn a local triple-helix structure (8-12). 
The oligonucleotide binds in the major 
groove parallel to the WatsOn-Crick purine 
strand by Hoogstec:n hydrogen bonding (8-
12). Triple-helli: specificity is derived from 
thymine (T) binding [0 adenine-thymine 
base pairs (T-AT base triplet) and protonat-
ed cyrosinc (C+) binding to guanlne-cyto-
Arnold and Mabel BecknwJ LabonlDries of O\cmica.l 
SyndIQU. DiviNon of ~ and 0\emiaI Engi. 
~O~ lnninIa: of c:rl!ncHogy. fD~ 
"-0 whom. ~ W!oukt be adWascd. 
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sine base pairs (C + GC bue triplet) (8-15). 
Guanine recognition of thymilK-idenine 
base: pairs (G'TA base: triplet) within the 
pyrimidine: aiplc-helix rnorif (9) and rccog-
nic:ion of (purinc) .. (pyrimidine)". type se-
quences by alternate stnnd triple-helix for-
mac:ion (to) have extended recognition of 
duplex DNA ro a wide dus of mixed pu-
rine-pyrimidine sequences (16). Oligonucle-
otides 15 to 20 bases in length equipped 
with an EOTA·Fe moiety produce se-
quencc-specific double-strand breaks with 
efficiencies ranging from 5 to 25% at their 
target sites within genomes as large as that 
of bacteriophage). (48.5 kbp) (8-10). In 
order to detennme if this specificity can be 
achieved in chromosomal DNA, a aiple-
helix target site, RD·AO~dAOdAldAj-PDI 
was inserted proximal ro the LEV2 gene on 
the short ann of me 340-kb duomosome III 
of StJcc/uJromyctS ctTtllisitJt (17-25) by ho-
mologous teoombinaoon (Fig. 1). The ge-
I \ 
pUCLEU2B 
Pili 
FIg, 1. Schema.cic diagram of pUCLEU2B con-
5ttueted by insertion of the Pst J-Xma I 4.0-kb 
LEU2 fragment from YEpl3 into pUC19 by 
sandard procedures (19). Complc:mcnwy oligo-
nuclcoridcs conWning a homopurine sequence 
were ligated into the unique Xho I site, upsttt:am 
of the LEU2 gene. 
netic map location of the LEV2 locus indi-
cates that double-strand cleavage .at the 20-
bp target 5ite should produce twO frag-
ments, approximately 110 ~ 10 and 230 = 
10 kb in siu: (26) (Fig. 2). We report the 
sitc-specific cleavage at this genetically engi-
neered sequence on chromosome III by an 
0Iigonucleotide-(EOTA'Fe)2' 
A 20-basc pyrimidine oligonucleotide. 5'-
T*TCT"CT2CT3CT"T*-3', with thymidine 
EOTA (T*) (27) .at the 5' and 3' termini, 
was 5)'Ilthcsiz.ed by .au[Qm.ated methods be-
ginning with 5'-Q-DMT-mymidinc:-EDTA· 
aicthylesttr 3' -succinyl connol pon: glass as 
the solid support (DMT, 4,4' ·dimethoxytri-
tyl). C1c:avage reactions were performed on 
yeast transfonnants SEY6210 (- target 
site) and SEY6210B ( + target site) (28) . 
Ouomosomal DNA embedded in an agar· 
osc plug was equilibnted with o ligonuclc:o-
tide-(EOTA'Feh to hcilitate dilfu.sion into 
the agarosc and aiplc-heJjx fonnaoon (pH 
7.2. 220C). The cleavage reaction was initi-
ated by addition of dithiochreitol (OTT). 
To improve the cleav.agc yield, a second 
cleavage cycle was performed by disrupting 
the aiplex at conditions of h..igh pH (8.5 ). 
rccquilibrating the plug in a triplex-compat-
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Fig. 2. (Left) Genetic nup of S. cmvuillf: srrain 
SEY6210B (+ target site) chromosome llI. The 
locations of HIS4-, PGKI, LEU210ci (boxes). me 
centromere (circle), and me aiplc-helix ruga site 
are indkatcd. The sizes of the deavage productS 
(based upon genetic map disrances and expcri-
mana! results) :an: shown. (Right) Schematic 
diagram of the aiple-helix complex. The pyrimi-
dine: oligonucleoc:ide with EOTA'Fe at the S· and 
3' tamini is bound in the major groove parallel to 
the purine scrand. 
ible buffer, and repearing the reaction with 
fresh reagents. The chromosomes were sepa-
rated. by pulsed-field gel eleCtrOphoresis and 
detected by ethidium bromide staining (Fig. 
3, A and B). Cleavage products were deteCt-
ed by DNA blotting with chromosome IU-
specific probes (Fig. 3, C and D). 
The HIS4 (29) and PCKl (30) genes arc 
located on the short and long anTIS of chr0-
mosome III, respectively (Fig. 2). DNA 
hybridization of the resolved cleavage prod-
UCts (Fig. 3A) with a radiolabeled. HIS4 
probe revealed a 110 ± 10 kb fragment 
present only in the yeast strain containing 
the engineered target site (SEY6210B) (Fig. 
3C, lanes 3 and 4). Hybridization with a 
radiolabc:lcd PCKI probe revea1ed a second 
Wlique fragment 230 ± 10 kb in Slzc (Fig. 
3D, lanes 3 and 4). The extent of double-
strand cleavage 3.[ the target site was estimat-
ed at 6% by densitometry. The observed 
fragment sizes are consistent with those 
estimated from the genetic map (26). Thw, 
after searching through almost 14 megabase 
pairs of yeast DNA, the oligonucleotide 
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bound and cleaved specifically at the 20-bp 
target site while leaving the o ther chromo-
somcs largely intact (Fig. 3B). 
The sequence specificity of pyrimidine 
o ligonucleotides for local aiple-helix fonna-
tion on duplex DNA is dependent upon pH, 
tempenuurc, and organic cosoJvenu (S). 
Under conditions of lower pH, lower tem-
perature, or added ethanol., oligonucleotides 
have been observed to bind to sites that arc 
in significant but not perfect match with the 
target-site sequence (8). Becawc the com-
plete sequence of the yeast genome is not yet: 
available. the location and number of sc=c-
omwy binding sites on chromosome lIT 
could not be predicted a priori. Imercsring-
Iy, one major (300::!: 10 ~F and thrtt 
mino r (190, 210, and 240 ::!: 10kb)sccond-
ary cleavage fragments were dcrccted on 
chromosome ill at pH 7.2 (Fig. 3, C and D, 
lanes 3 and 4 ) {31}. The 2ppcaranCe of the 
three minor fragments (190, 210, and 240 
kb) upon hybridization with the Banking 
markers HIS4 and PCKI indiC2tes that the 
minor secondary cleavage sites arc found on 
the long arm of chromosome III, dista1 to 
the engin~rcd ru-gct sire. The major sec-
ondary clClllvage site (300 kb) was not 
flanked by the markers, but must map to 
within 40 kb of a du"Omosome III telomere. 
The extent of sc=quence similarity of the 
secondary sites to the target Site can be 
escim2ted by examining the cleavage pattern 
as a function of increasing pH. The cleavage 
products were examined OVer the pH range 
7.2 to 7.8 (Fig. 3E). The 190- and 210-kb 
bands were not observed above pH 7.4 
Ag, 3. Site-spcc:ific cleavage of yeast chromo-
somes. Lana 1 :md 2 (all geb): SEY6210 (- tar-
get $ite) and SEY6210B (+ target site) chromo-
somal DNA unrcacrcd controls, respectively. 
Lanes 3 and 4 (all gels): SEY6210 and 
SEY6210B chromosomal DNA, ~pcctivdyI af-
ter reaction with oLigonuclcoride·(EDTA·Feh . 
(A) Separation of yca.5t chromosomes less than 
400 kb in size by pulsed-field gel electrOphoresis 
on a Bio-R..td CHEF system. Pul.sc rimes were 
ramped from 10 to 20 5 during a 24-hour period 
( H OC and 200 V). Chromosomal DNA Wil5 
detected by cthidium bromide staining. Fngmcnt 
sizes were estimated by comparison to bacteri-
ophage "' concatcmet"S. (8 ) Separation of all yeast 
chromosoma with tent;ltive assignments. A 6O-s 
pul.sc rime for 16 hours w:u followed by 90-05 
pulsc.s for 8 houn (14GC, 200 V) . Sizes were 
estimated by comparison to YNN295 chromo-
somal DNA (24). (C) DNA blot hybridWtion of 
reactions shown in (Al with a 250·bp HIS4 
fragment labeled with lp by random priming 
( 19). The DNA blot transfer and hybridization 
were pcrfonncd by standard procedures ( 19). Thc 
cleavage products were visua.l.izcd by autoradiog-
raphy and quantitated by laser densitometry. (D) 
DNA blot hybridization as in (C) except a l.3-kb 
marker from the promoter region of PCKl was 
used for hybridization (E). pH profile: of cleavage 
produCts hybridized with PGKl marker. 
(lanes 7 to 10), whereas raising the pH 
above 7.6 eliminated the 240-kb fragment 
(lanes 9 and 10). The 300-kb band and the 
fragment corresponding to the designed tar-
get sire were still o bserved at pH 7.8 (lanes 9 
and 10) though at lower cle2vage efficien-
cies. Utis suggests that the order of se-
quence similarity of the differen[ sites with 
the target site arc 300 > 240 > 210, 190 
kb. 
A chemical approach for the site-specific 
cleavage of intact chromosomes at 12- to 
20-bp sequences might assist the large effort 
being directed toward mapping genomic 
DNA. Fat 2n unambiguous test of site-
spec.i.fic cleavage on chromosoma1 DNA by 
oligonucleotide-directed triple-helix fonna-
non, a urger site of known sequence 2nd 
approxim2te physica.l location was chosen 
for this experiment. H owever, the ability of 
oligonucleotide-directed triple-helix forma-
rion m recognize a wide variety of purine 
and mixed purine-pyrimidine sequences (16) 
could allow the o rchestrated cleavage of 
large genomic DNA at any genetic marker 
for which some sequence infonnation is 
kno~K 
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Comments to Site-Specific Cleavage of a Yeast Chromosome by 
Oligonucleotide-Directed Triple Helix Formation . Although a number of 
endogenous triple helix target sites could be identified within the yeast 
genome, including at least one within the LEU2 gene itself (12), it was 
advantageous to engineer target sites into yeast chromosome III for a number 
of reasons: (i) a site of optimal length and A vs. G content could be targeted 
for initial studies on the larger DNA substrate, (ii) it provided a positive and 
a negative control for specific cleavage of a large DNA substrate that had not 
been fully mapped or sequenced, (iii) it enabled construction of chromosomes 
containing target sites compatible with triplex mediated enzymatic OS), 
alkylation (17, 18), and affinity cleaving techniques for cutting 0, 14, 19), and 
(iv) yeast constructs containing specific target sites from human DNA 
sequences were used to optimize conditions for cleaving the human genome 
(20). 
The yields from affinity cleaving of yeast were significantly lower than 
observed with bacteriophage A 0). One possible explanation stems from the 
use of high EDTA concentrations (0.5 M) in preparing the yeast chromosomes 
(21,22). Unless all the EDTA was removed, the exogenous EDTA could 
compete for the Fe2+, reducing the concentration of oligonucleotide-
EDT A • Fe(II) complexes. A second possibility is that the bacteriophage A yields 
were uncharacteristically high for this type of reaction. No other substrate has 
been cut with efficiencies comparable to A phage. Plasmid DNA containing 
the yeast target site was cut at less than 15% cleavage, suggesting that the low 
efficiency was not inherent to the cleavage of megabase genomic DNA. A 
third possibility is that the target site was not saturated, however subsequent 
enzyme inhibition experiments proceeded almost quantitatively, arguing 
strongly against this possibility OS). Modest yields are more likely due to a 
Oligonucleotide CT T' 
3q 
t 
§,s;. 
'" .. 
..... 0 
~g 
6 
<1j 
..... 
0 
.... 
N 
~ 
~ 
6 ~ 
-N 
-
..... ..... 
0 0 
- '" Cl. C 
t t 
88 
6 
'" N ..... 
0 
-
-
~ 
~t ~ 3p t ~ s .... 
'" 
V) 
t.:l 
'" 
lJ Q., ...., ~pK 8", 
'" .. 
.....0 
~~ 
~ 
Fig. 3.1. Map of primary and secondary cleavage sites recognized by 
oligonucleotide CTT" on chromosome III at pH 7.0. The centromere (circle), 
PGK1, LEU2, and HIS4 loci are shown as rectangles along chromosome III 
(dark line). The sites shown with arrows above the chromosome have 
defined map locations, while the site below the line could map to either 3p or 
3q (both possible sites are shown). The pair of numbers next to each arrow 
correspond to the product sizes observed with HIS4 and PGKl hybridizations, 
respecti vel y. 
combination of a target site less susceptible to triple helix mediated affinity 
cleaving and exogenous EDT A in the reaction competing for the metal 
cofactor. 
In addition to the primary target site near the LEU2 gene, the CTT" 
oligonucleotide was reported to cut at four secondary sites on chromosome 
III. Hybridization of the reaction products with HIS4 (23, 24) and PGKl (25, 
26) identified the location of the secondary cleavage sites (Fig. 3.1) . The 300 kb 
product was not flanked by either of the markers and could not be definitively 
mapped to either end of chromosome III. 
Cleavage of Yeast Chromosome III with Mec and BTU Modified 
Oligonucleotides. Oligonucleotides CTT", MeCTT' and MeCBruT" were 
synthesized specifically for the target site on yeast chromosome III with T' at 
the 5' and 3' ends and Mec and Bru base modifications (27). Reactions were 
performed as a function of pH between 7.0 and 7.6 to examine the relative 
89 
specificity of the oligonucleotides (Fig. 3.2 A). Ethidium bromide staining of 
the cleavage products showed little chromosomal degradation by CTT" at any 
pH. MeCTT" showed significant degradation of all chromosomes at pH 7.0, 
and modest degradation at pH 7.2 and above. MecB'1JT" extensively degraded 
the DNA, leaving no visibly intact chromosomal bands except at pH 7.6, 
where secondary cleavage remained extensive. 
DNA hybridization with the LEU2 (12,28,29) gene confirmed the 
general observations evident by ethidium bromide (Fig. 3.2 B). The 
oligonucleotide with the greatest specificity under the conditions tested was 
CTT". At pH 7.6 only the 110 and 230 kb products were detected in significant 
yield (Strain SEY6210B (30) has a duplication of the LEU2 locus that flanks the 
engineered target site resulting in detection of both the 230 and 110 kb 
cleavage products upon hybridization with LEU2). Oligonucleotide-MeCTT" 
showed slightly less specificity, and generally higher overall background, 
particularly at lower pH. The specificity was partially restored at pH 7.6, 
though the secondary cleavage sites were cut more extensively than with 
CTT" at the same pH. MeCB'1JT" was very nonspecific under these reaction 
conditions resulting in a broad smear in which all the chromosome III 
molecules had been cut at least once at pH 7.0. At pH 7.6, the specificity 
slightly improved, and specific bands became visible above the high 
background. 
The relative specificities of the oligonucleotides was similar to that 
observed with bacteriophage:\. cleavage (1) (Chapter 2). It suggests that both 
pH and oligonucleotide composition can be used to adjust the specificity of 
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Fig. 3.2 Triple helix mediated affinity cleaving of yeast chromosomal 
DNA prepared from strain SEY6210B as a function of oligonucleotide 
composition and pH. 
A. Ethidium bromide stained gel of total yeast chromosomal DNA 
reacted with oligonucleotides CTT", MeCTT", and MeCB'1JT" at pH 7.0 to 7.6 
(conditions in each lane listed in legend above gel). Chromosomal DNA 
embedded in 0.6% lncert LMP agarose was washed extensively to remove 
exogenous EDTA and equilibrated fro 12 hours in 100 mM NaCl, 25 mM tris-
acetate, pH 7.0 to 7.6, and 1.0 mM spermine o 4HCl (NTS buffer). The agarose 
blocks E~UM Ill) were transferred to 2.0-ml flat bottom eppendorf tubes and 
overlaid with 120 III of NTS buffer. 2.5 III of 100 11M oligonucleotide (CTT", 
MeCTp, or MeCB'1JT") was equilibrated with 2.5 III of 100 11M 
Fe(NHi)z(S04)z°6H20 (freshly prepared) for 5 minutes, and 4 III of the 
resulting solution added to the DNA. The solution was incubated for 3 hours 
to promote triple helix formation, and the affinity cleaving reaction was 
initiated by the addition of 4 III of 200 mM DTT (freshly prepared). The 
cleavage reaction was allowed to proceed for 8 hours. The DNA was digested 
a second time with fresh reagents by washing agarose plugs with 1.0 ml 
aliquots of 100 mM tris-HCl (pH 8.5) for 30 min. three times, and 
reequilibrating the plugs in NTS buffer. The plugs were then incubated with 
a second aliquot of oligonucleotide, Fe(NHi)z(S04l206H20 and DTT. 
Reactions were performed at room temperature (22° C). After two reaction 
cycles, the chromosomal plugs were washed in 1 ml of 10 mM tris-HCI (pH 
7.5), 1 mM EDTA, and loaded on a 1 % agarose (O.5xTBE) gel at 6.0 V / em, 120° 
switch angle, 15-30 sec. ramped switch times for 25 hours at 14° C. The DNA 
stained with ethidium bromide and visualized by UV irradiation. 
B. DNA hybridization of gel shown in A, hybridized with the PCR 
product of the LEU2 subcloned plasmid pUCKE400 (see methods for plasmid 
construction and hybridization protocol). A duplication of the LEU2 gene in 
construct SEY6210B resulted in the detection of both the 110 and 230 kb 
products upon hybridization with LEU2. Other secondary cleavage sites are 
also evident as a function of pH and oligonucleotide composition. 
A 
Oligonucleotide 
pH 
1 2 3 4 5 6 7 8 9 101112 
-- IX430kb 
-- ll340kb 
-- VI 260 kb 
-- I 230kb 
B 
CTT* MecBrUT* Oligonucleotide 
a N ~ ~ a N ~ ~ a N ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ pH 
1 2 3 4 5 6 7 8 9 10 11 12 
--340 kb 
I --300kb 
-- 230kb 
--110kb 
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triple helix formation. This observation was useful for the identification of 
endogenous target sites in unsequenced human DNA (20) (Chapter 4). 
Cleavage of Yeast Chromosomal DNA with Nonspecific 
Oligonucleotides. The observation that an oligonucleotide was capable of 
cleaving sites for which it was not specifically designed and not completely 
homologous (14), suggested that it should be possible to use nonspecific 
oligonucleotides to cut yeast chromosomal DNA. To test this, 
oligonucleotides specific for sites in bacteriophage J.. (oligonucleotides 1 and 2) 
and adenovirus (oligonucleotides 3 and 4) genomes were used to cut yeast 
chromosome III (Fig. 3. 3A). No degradation was apparent by ethidium 
bromide staining for reactions with oligonucleotides 1,2, and 3. 
Oligonucleotide 4, containing a long T sequence, produced a faint smear 
consistent with a large number inefficiently cut sites. This oligonucleotide is 
specific for poly-A runs frequently found in genomic DNA. 
DNA hybridization with chromosome III specific markers PGKl and 
HIS4 revealed a discrete set of cleavage products generated by the 
oligonucleotides (Fig. 3.3 B). Oligonucleotides 1 and 2, differing only in the 
number of T* moieties, produced identical products with different 
efficiencies. Oligonucleotide 2 cut less efficiently, suggesting that the second 
T* was destabilizing for these target sites. Oligonucleotide 3, containing a 
high C content, inefficiently cut only two sites suggesting low oligonucleotide 
affinity and minimal sequence similarity. In contrast, the poly-T 
oligonucleotide 4 produced six discrete cleavage products in good yield. 
Comparison of PGKl and HIS4 hybridizations allowed most of the sites 
to be mapped to a specific position on chromosome III (Fig. 3.4). 
Oligonucleotides 1,2 and 4 bound a sequence at or near the engineered target 
site producing 110 (HIS4) and 230 (PGK1) kb cleavage products. It is 
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Fig. 3.3. Cleavage of yeast chromosomal DNA with nonspecific 
oligonucleotides by affinity cleaving. Top. Oligonucleotide-EDT A sequences 
specific for target sites in other substrates. Oligonucleotides 1 and 2 were 
designed to cut bacteriophage A DNA at the origin of replication. These 
oligonucleotides were originally given the title AS' and A5'3', respectively. 
Oligonucleotides 3 and 4 were designed for target sites in adenovirus-2 
genomic DNA. They were originally titled Ad-l and Ad-2, respectively. 
Middle. Ethidium bromide staining of cleavage reactions using 
oligonucleotides 1-4 (indicated above gel) to cut chromosomal DNA prepared 
from SEY6210B. Cleavage reactions and pulsed-field gel electrophoresis were 
performed as described in Fig. 3.2 except only one cleavage cycle was 
completed. Bottom. DNA hybridization of gel shown above with DNA 
markers HIS4 and PGK1. DNA transfer, immobilization, and hybridization 
were performed as described in the methods section of this chapter. Cleavage 
products were detected by autoradiography, and size estimates made by 
comparison to a bacteriophage A DNA ladder. 
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Fig. 3.4. Map of primary and secondary cleavage sites recognized by 
oligonucleotides 1-4 on chromosome III at pH 7.0. The centromere (circle), PGKl, 
LEU2, and HIS4 (rectangles) loci are shown along chromosome III (dark line). The 
sites shown with arrows above the chromosome have defined map locations, while 
sites below the line could map to either 3p or 3q (both possible sites are shown). The 
pair of numbers next to each arrow correspond to the product sizes observed with 
HIS4 and PGKI hybridizations, respectively. 
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noteworthy that there is a long poly-A run about 300 bp 5' of the target site 
that could be recognized by the oligonucleotides (12). All of the sites 
recognized by oligonucleotides 1 and 2 were cut more efficiently by 
oligonucleotide 4, suggesting that the sites bound were predominated by A 
rich sequences. This is indirectly supported by the observation that sites 
recognized by oligonucleotide 3, a sequence with high-C content, were not 
detected by any of the other oligonucleotides. 
The cleavage pattern demonstrates that T· oligonucleotides are useful 
for generating a partial DNA digest whose products depend upon the 
sequence of the oligonucleotide, without requiring prior knowledge of 
sequence information. Affinity cleaving mediated by nonspecific 
oligonucleotides is similar to restriction enzyme mapping by partial digestion. 
This could potentially be useful if affinity cleaving oligonucleotides designed 
for conserved sequence elements within protein coding regions could be used 
to map the location and frequency of such sequences within the genome. 
Conclusions. This work demonstrated the feaSibility of targeting 
specific sites within megabase genomic DNA by triple helix formation with 
small oligonucleotides. Oligonucleotide binding was assayed by affinity 
cleaving of yeast chromosome III. In addition to the target site, affinity 
cleaving detected four secondary binding sites on yeast chromosome III and 
DNA hybridization facilitated the identification of their map position. The 
specificity of oligonucleotide directed triple helix formation could be 
regulated by adjusting the pH and the base composition of the 
oligonucleotides. Although the low efficiency of cutting by this method 
makes generating large quantities of cleaved genomic material impractical, 
affinity cleaving demonstrated the specificity of triple helix formation on 
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large DNA, and could be useful for mapping the frequency and location of 
conserved sequence elements within chromosomes. 
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Part II 
Single Site Enzymatic Oeavage of Yeast Genomic DNA 
Mediated by Triple Helix Formation 
While affinity cleaving was useful for demonstrating triple helix 
formation at specific sites within large genomic DNA, it was limited by low 
cleavage efficiency and cutting at secondary sites (1, 14). Because affinity 
cleaving cut al1 sites bound by the T* end of the oligonucleotide, it 
demonstrated the gap between the theoretical frequency of the target site (one 
site in 1011 bp) (31) compared to the actual ability of the oligonucleotide to 
differentiate between several similar but imperfectly matched binding sites 
(approximately one site in lOS bp). Thus, despite the size of the recognition 
site, affinity cleaving mediated by oligonucleotide directed triple helix 
formation was insufficient to define a single site in megabase DNA. 
Single site cleavage of megabase DNA was achieved by two techniques 
that coupled the specificity of triple helix formation with a sequence specific 
cleaving function (15-18). Triple helix mediated alkylation combined triple 
helix formation with the requirement for a G (alkylation at N7) two bases to 
the 5' end of the oligonucleotide (Appendix B) (17). Work done in 
col1aboration with Povsic demonstrated that double strand cleavage was only 
observed if the sequence met the fol1owing criterion: (i) there must be two 
oligonucleotide binding sites, (ii) the oligonucleotide binding sites must be on 
opposite strands, (iii) there must be a G two bp to the 5' side of each binding 
site, and (iv) the binding sites must be within approximately 20 bp of each 
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other to facilitate strand separation (32). Such a rigidly defined class of 
sequences occurs sufficiently infrequently to specify a single site in megabase 
DNA. Alkylation was highly efficient, producing double strand cleavage 
yields approaching 90% (Appendix B). 
A second strategy for generating quantitative single site cleavage 
combined triple helix formation with the specificity of methylases and 
restriction enzymes (15,33,34). In this approach, a triple helix site partially 
overlapping the recognition site of a sequence specific methylase blocked the 
methylase activity only at the site bound by the oligonucleotide. All other 
methylation sites were modified by the enzyme. Subsequent methylase 
inactivation, triple helix disruption, and digestion by the cognate restriction 
enzyme produced cleavage only at the unmodified site previously bound by 
the oligonucleotide. In this approach, cleavage is only observed if the 
oligonucleotide binding site partially overlaps the methylation site. If there is 
no overlap, or if the site bound is not adjacent to a methylation site, no 
cleavage is observed. This section describes the application of this technique 
to the cleavage of yeast chromosome III at a single site. 
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Site Specific Cleavage of Plasmid DNA Containing a Triple Helix 
Target Site. Koob and Szybalski originally demonstrated that protein 
mediated methylase inhibition could be used to modify the effective 
specificity of a restriction enzyme on plasmid and yeast genomic substrates 
(15, 33, 34). They entitled the procedure Achilles' heel cleavage because of its 
similarity to the story of Achilles from Greek mythology. Maher, Wold, and 
Dervan demonstrated the feasibility of triple helix mediated methylase 
inhibition on plasmid DNA using the cognate enzymes TaqI methylase and 
TaqI endonuclease (35, 36). Although this conceptually verified that triple 
helix mediated Achilles' heel cleavage was also possible, it utilized the 
unique thermostability of the restriction enzyme to remove the 
oligonucleotide. Therefore, it was necessary to optimize triple helix and 
enzyme conditions for thermolabile enzyme pairs. The temperatures used to 
destabilize the triplex were incompatible with large DNA as the LMP agarose 
used to retain chromosomal integrity would melt at 65° C. To optimize low 
temperature reaction conditions, the plasmid used for homologous 
recombination with chromosome III, pUCLEU2A, was used as a cleavage 
reaction subs trate. 
Plasmid pUCLEU2A was generated by inserting a homopurine 
sequence overlapping an EcoRI methylase/endonuclease site into the unique 
XhoI site of pUCLEU2 (Fig. 3.5) (see methods). The plasmid contained a total 
of three EcoR! sites, as well as a unique HindIII site immediately opposite the 
EcoR! target site. Thus, if the DNA was linearized with HindIII and cut only 
at the desired EcoR! site, the linear 6.6 kb plasmid would be cut into two 3.3 kb 
products. The ratio of the 6.6 to the 3.3 kb band detected by ethidium bromide 
staining would define the cleavage efficiency. 
EeoRI 
EcoRI 
101 
Ir 
(XhoI) 
pUCLEU2A 
(6.6 kb) 
Hindill 
Fig. 3.5. Map of pUCLEU2A showing the triple helix target site. The 
target EcoRI site is shown in a shaded box within the duplex sequence 
inserted into the XhoI site (top). The triple helix binding site is shown as a 
dark line within the duplex. Also shown are the restriction sites used in this 
study, the LEU2 gene, the pUC19 vector, and the size of the plasmid. 
It was initially important to define a strategy for the removal of the 
oligonucleotide from the target site. LMP agarose has an upper temperature 
limit of 55° C, a temperature too low for complete triple helix disruption. 
Triple helix formation was shown to be polycation sensitive suggesting that 
removal of the spermine from the solution should be sufficient to destabilize 
the triplex (19). This approach was problematic because the restriction 
enzyme buffer contains magnesium, a dication capable of triplex stabilization. 
If oligonucleotide was still present upon addition of endonuclease buffer, the 
oligonucleotide could reform the triplex, block the restriction enzyme, and 
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reduce. the cleavage efficiency. Several studies demonstrated that triple helix 
formation is highly pH sensitive (19, 27, 37). By raising the pH of the 
restriction enzyme digestion buffer to between 8.5 - 9.5, the oligonucleotide 
was removed from the target site, without effecting the fidelity of the 
restriction enzyme. 
Reactions performed as a function of methylation time and pH are 
shown in Fig. 3.6. No cleavage was observed in the absence of 
oligonucleotide indicating that the methylase had reacted to completion 
(lanes 5, 10, 15). Complete digestion of plasmid DNA was observed in the 
absence of methylase despite the addition of oligonucleotide (lanes 4, 9, 14). 
This indicates that the high pH workup conditions were sufficient to remove 
the oligonucleotide from the duplex target site, that the specificity of the 
restriction enzyme was not Significantly affected by the high pH buffer, and 
that EcoRI was cutting the DNA to completion. Plasmid DNA methylated in 
the presence of the oligonucleotide was cut by EcoRI endonuclease only at the 
triplex target site to generate the desired 3.3 kb products in 92 ± 3% yield (lanes 
1-3,6-8, and 11-13). After longer methylation times, the cleavage efficiency 
was gradually reduced, suggestive of a slow oligonucleotide off rate (38) 
(compare lanes 1 &3,6 & 8, and 11 &13). The cleavage efficiency was slightly 
better at pH 6.6 than at pH 7.4 indicative of triple helix stabilization at low pH. 
However, at lower pH the methylase required a slightly longer incubation 
time to achieve complete methylation (lane 1). While the techniques used at 
the plasmid level could not be immediately transferred to yeast chromosomal 
DNA, i.e., the reactions were phenol extracted and ethanol precipitated, two 
procedures incompatible with agarose embedded chromosomal DNA, they 
demonstrated that an oligonucleotide was capable of site specific protection 
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Fig. 3.6. Enzymatic cleavage of plasmid pUCLEU2A DNA mediated by 
triple helix formation. Reagents, methylation times, and pH were as 
indicated above the figure. pUCLEU2A plasmid DNA (2 jlg) was incubated 
for 2.5 hours with 1 jlM MecBru A oligonucleotide in methylation buffer 
containing 100 mM NaCl, 100 mM tris-HCl, 100 jlg/ml BSA, 2 mM spermine, 
10 mM EDTA, pH 6.6, 7.0, or 7.4 at 22° C. Following triple helix formation 160 
jlM S-adenosyl methionine (SAM) and 120 units of EcoRI methylase were 
added resulting in a final volume of 20 jll. The DNA was methylated for 2,4, 
or 7 hours at 22° C after which the methylase was stopped by phenol 
extraction. The DNA was recovered by ethanol precipitation, 70% ethanol 
washing, and drying. The DNA was resuspended in EcoRI restriction enzyme 
buffer containing 10 units EcoRI, 100 jlg/ml BSA, 100 mM tris-HCl, pH 9.5, 50 
mM NaCl, 5 mM MgCl2 and digested to completion at 37° C for 45 min. The 
products were loaded directly on a 0.8% agarose gel containing lxTAE and 
ethidium bromide. Products were visualized by UV illumination. 
1U4 
pH 6.6 7.0 7.4 
• • r v "\ r 
Methylation Time (hrs) 2 4 7 0 2 2 4 7 0 2 2 4 7 0 2 
EeoR! Endonuclease + + + + + + + + + + + + + + + 
EeoR! Methylase + + + - + + + + - + + + + - + 
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..... 0.4 
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against ,EcoRI methylation resulting in highly efficient cleavage upon EcoR! 
restriction enzyme digestion. 
Comparable experiments were performed on plasmid DNA using 
enzymes HpaII, Haem, MspI, dam/MboI, AluI, TaqI, AluI-Me/Sstl, and 
HindIIl. Nonoptimized cleavage efficiencies ranging from 50-98% were 
observed. In each system it was necessary to reduce the pH of the 
manufacture's recommended buffer to near pH 7.0, add spermine to promote 
triple helix formation, and add at least 50 mM NaCI to prevent DNA 
precipitation by the spermine. 
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Chemical reagents and biological methods that infrequently 
cleave double helical DNA are being developed for genomic 
mapping l - 12 • Recently. Szybalski and coworkers reponed an 
'Achilles heel cleavage' technique that limits restriction enzyme 
cleavage to an overlapping I4c repressor-endonuclease sitel1.l 1 . 
Protein-mediated Achilles heel cleavage may, however. not be 
readily generalized to unique cleavage at selected genetic 
markers owing to the paucity of applicable DNA.binding pro. 
teins relative to the number of sites in megabase genomic DNA. 
To achieve orchestrated cleavage at selected genetic markers in 
human DNA by this approach may require the protein.binding 
sequence to be artificially inserted into the chromosome at 
precise locations. A more general method for recognition of 
endogenous DNA sequences might be a chemical approach 
based on oligonucleotide-directed triple helix formation l . 
Pyrimidine oligonucleotides bind specifically to purine sequen-
ces in duplex DNA to form a local triple-helix structure l • S•ll•I ... 
The generalizable code for triple-helix specificity is derived from 
thymine (T) binding to adenine-thymine base pairs (T·AT base 
triplel)" and NJ protonated cytosine (C+) bindin, to 8uanine-
cytosine base pairs (C+GC base triplet)16.17. Higher affinity 
oligonucleotides can be obtai.ned by substituting 5-bromouracil 
for thymine and 5-methylcytosine for cytosine". Moreover, the 
number of potential target sequences amenable to recognition 
by the triple helix motif can be extended to some mixed purine-
pyrimidine sequences I9•20• By replacing the lac repressor protein 
in the Achilles heel technique with triple-helix-mediated protec-
tion. one combines the strengths of the two approaches; a general 
chemical method for recognition of DNA sequences in the range 
of 15-20 base pairs (bp) with the cleavage efficiency of restriction 
enzymes (Fig. -1). 
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AG. 1 General scheme for sil\&le-site enzymatiC Cle8llace of genomiC DNA 
by oIigooucteotide-directed triple helil{ fonnation. Chromosomal ONA is 
equilibrated with an Oligonucleotide In a methylase compatible buffer contain. 
ing poIycation. EcoRI methylase which methylates the central adenines of 
the sequence 5'-GAATTC·3· and renders the sequence reSistant to cleavage 
by EcoRI restriction endonuclease. is aoaeo and allowed to proceed to 
completion. The methylase is inactivated and the triple helix is disrupted at 
55"C in a high_pH buffer containing oetergent. After waShing extensively. 
the chromosomal DNA Is re-equilibrated in restriction enzyme buffer and 
cut to completion with EcoRI restrictiOn endonuClease. The Cleavage products 
are separated by pulsed·fleld gel electrophoreSIs and efficiencies quantitated 
by Southern bkJtting. 
To demonstrate single-site enzymatic cleavage of the yeast 
genome by this technique, a sequence containing an overlapping 
24-bp purine tract and 6-bp EcoRJ site was inserted proximal 
to the LE U2 (ref. 21) gene on the short arm of chromosome 
III (Fig. 2) (ref 3). Oligonucleotides designed to form triple 
helix complexes that overlap half of the EcoRI recognition site 
were synthesized with CT, MeCT or MeC··U nucleotides" . The 
genetic map of yeast chromosome III (refs 22,23) and affinity 
cleaving datal indicate that cleava.e at the target site should 
produce two fragments 110% 10 and 230% 10 kilobases (kb) in 
size (Fig. 2) . 
Resolution of total yeast chromosomal DNA by pulsed· field 
gel electrophoresis24•n revealed that chromosome III was cut 
exclusively at the target site when a MeeT oligonucleotide was 
used for triple helix formation at pH 7.6 (Fig. 3, lane I) . No 
cleavage was detected on any other chromosomes under these 
conditions nor was cleavage observed in the absence of oligonu-
cleotide (lane 2) or in a yeast strain lacking the target sequence 
(lane 3). The expected 1I0-kb product was visualized with 
ethidium bromide staining and confirmed by Southern blotting 
with a HIS4 (ref. 26) marker (Fig. 3e). The 230-kb product 
comigrated with chromosome I. but was detected by Southem 
blouing with a LEU2 (ref. 24) marker (Fig. 3b). The cleavage 
efficiency was 94 ± 2%. Similar efficiencies were seen with a CT 
oligonucleotide up to pH 7.4 and MeCT and MeCB·U oligonucleo~ 
tides past pH 7.8 (Fig. 4). The cleavage efficiency with all 
oligonucleotides was gradually reduced with longer methylation 
times, sug.esting that the oligonucleotide dissociation rate might 
be the limiting factor for efficiency in this system 27• 
The specificity of triple helix fonnation has been shown to 
be pH.depe:ndent l - 1 . By lowerin. the pH, sequences of near but 
imperfect similarity can be bound and cleaved l - 1. In agreement 
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FIG. 2 left genetic map of S. cerellisiae Chromosome III. The locations of 
the H1S4 ana L£J.J2 loci (boxes). the centromere (circte), and the triple 
t'ie4ix-£coRl target site are indicatea. The expected sizes of the cleavage 
products are shOwn. Right. schematic diagram of the triple helix complex 
overlapping the EcoRI restriction-methylation Site. The pyrimidine oligonu-
cleotide is bound in the major groove parallel to the purine strand of the 
DNA duplex, and covers half the EcoRI site. 
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FIG. 3 Single-site enzymatic cleavage of yeast genomic DNA with reagents 
indicated above figure. 1. Yeast chromosomel DNA. embeOded in low-melting-
point agarose (-SO j.l.1) was waShed twice in 1.0 ml of 100 mMNaCl.l00 mt..1 
Tris-HCf, 10mM fOTA, 2m.\1 spermine. pH 7.6 for 10 min. decanted. and 
overlayed with 150 j.l.1 of the same buffer. Oligonucleotide was added to 
1 JIM final concentration and incubated 8 h at 22 "C. 2. Bovine serum albumin 
(100 J.I.i ml - 1 ), S-adenosylmethionine (160 jJ.M) and EeaRI methylase (80 
units) were added to the overlay and incubated with shaking for 3 h. 3, The 
triple helix was destabitized and the methylase was simultaneously inacti-
vated at 55 -C in 1 .0 ml of 1% lauryl sarcosyl, 100 mM Tris-HCI pH 9.5. 
10 mM EDT A for 30 min . . The oligonucleotide and deterlent were then 
removed with 4 x 10 min washes (1 .0 ml) with 10 mM Tris.HC1 pH 9.5,10 mM 
tfi' I!Onuc!eoL,dC' 
l"arg .. l 5lL .. 
~telhylae 
t:ndonud~Ke 
3-1 0 kbllIl I _ 
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EDT A. . 4. The agarose plug was washed twice WIth 1.0 ml 2 x potaSSium 
glutamate restrict ion enzyme buffer i200 roM potassium glutamate. 50 roM 
Tris- acetate. pH 7.6 . 20 mM magnesium acetate, 100 ~g ml - 1 BSA, 1 mM 
:2-mercaptoethanol). decanted, overlayed with 150 ~f ot buffer and the DNA 
digested to completion with 20 U feaRI restriction endonuclease for 6 h at 
22 '"C. After digestion the enzyme was heat-inactivateo at 55 "'C for 10 min 
and the ONA loaoeO onto a 1% agarose. 0 .5 x TBE pulseO.field gel at 14 "C. 
200 V. Switch times were ramped from 10-40 s for 18 h followed by ramping 
from 60-90 5 fOf 6 h. Products were visualized by ethidlum bromiae staining 
i a) and Southern blotting with LBJ2 (b ) and HfS4 (c) chromosome mari<ers. 
Cleavage efficiencies were measured using storage phosphO imaging plates 
with a Molecular DynamiCS 400S Phospholmager. 
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~K 4 Triple-helill_mediated enzymatic deavage of the yeast genome as a 
function of OIigonucll!OtiCJe composition and pH. Lanes 1-12. reactions on 
a yeast strain containing the triple helix target site with OligonucleotideS 
iCT, -CT and ""-C--U) and pH values (6.6, 7.0, 7.4 and 7.8) as indicated 
above figure. Methylation time was 4.5 h. 110-kb and 6SO-kb (unresolved) 
secondary cleevage products were Observed with both -C substituted 
oligonucleotides at Of below pH 7 .4 . The cle .... age site can be assigned to 
dYomosome II (820 kb) by two-dimenSional pulsed-field lei eleetrophoresis 
in which the DNA was triple ~ill-mfotected and methytated before the first 
dimension and restriction enzyme-digested befOfe the second dimension 
(data not Shown). Additional secondary Cleavage sites were observed with 
the -cB'"u oligonucleotide at pH 6.6 (lane 9). The 180- and 480-kb products 
were assigned to chromosome XI (660 kb), and the 330 and 780 kb (unresol-
ved) products were assigned to the VII/XV do!.tIlet (1.100 kb) by the same 
methOd (data not Shown). 
with this observation. secondary cleavage sites were revealed as 
a function of oligonucleotide composition and pH (Fig. 4) . 
Cleavage at the secondary site was preferentially reduced by 
longer methylation times, suggesting differential oligonucleotide 
dissociation rates between the primary and secondary target 
sites. Cleavage at all secondary siees could be eliminated at a 
threshold pH for each oligonucleotide. 
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Whereas affinity cleaving using oligonucleotide-EDTA'Fe 
identifies all sites of oligonucleotide binding!-), triple-helix-
mediated endonuclease cleavage exposes only those sequences 
that also partially overlap a restriction site·". The sequence 
requirement of a methylation-restriction site increases the 
cleavage specificity but reduces the number of available sites. 
To panially overcome this limitation, other commercially .vail-
able methylation and restriction enzyme pairs with homopurine 
half sites were tested on plasmid DNA. In addition to Taql 
(ref. 4) and EcoRl (ref. S), single-site protection of plasmid 
DNA was possible with Mspl, Hpall and AlwI methylases. 
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Bam HI, HOf'lIl and dam methylases could potentially be used, 
but remain untested. 
The generalizability of triple helix-mediated enzymatic 
cleavage affords high specificity that can, in principle, be custom.-
ized to unique genetic markers without artificial insenion of a 
target sequence. The use of degenerace olilonucleocides in this 
technique to rapidly screen genetic markers for overlappinl 
triple-helix methylation-restriction sites could make it possible 
to cut chromosomal DNA uniquely and efficiently at 
endogenous sites with minimal sequence information (S.A.S. 
and P.B.D., unpublished observations). 0 
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Oligonucleotide directed triple helix formation is a generalizable chemical 
approach for the recognition and cleavage of a single target site within several 
megabase pairs of duplex genomic DNA (1-4). Pyrimidine 
oligodeoxyribonucleotides 15 to 25 bases in length form a highly specific triple helix 
structure with purine tracts in double stranded DNA of high complexity (1-4). The 
pyrimidine oligonucleotide binds by Hoogsteen hydrogen bonding in the major 
groove of the DNA duplex parallel to the Watson-Crick purine strand (1). The 
recognition motif is generalizable to homopurine target sites utilizing thymine 
binding to adenine-thymine base pairs (ToA-T triplet) (5) and N3 protonated 
cytOSine binding to guanine-cytosine base pairs (C+G-C triplet) (6-8). 5-bromouracil 
(BrU) and 5-methy1cytosine (MoC) can be substituted in the third strand for T and C 
respectively, to generate oligonucleotides with higher binding affinities at slightly 
basic pH's (9). The triple helix motif is partially extended to mixed 
purine-pyrimidine sequences utilizing guanine binding to thymine-adenine base 
pairs (GoT-A triplet) (10) and alternate strand triple helix formation (11). More 
recently, a G-rich oligodeoxyribonucleotide third strand has been shown to bind 
antiparallel to the Watson-Crick purine strand via GoG-C, AoA-T, and ToA-T base 
triplets (12). The binding site size of triple helix recognition is sufficiently large to 
statistically identify a unique site in the human genome (>16 bp) (13, 14). 
Koob et. aI. demonstrated the feasability of using a DNA binding protein to 
uniquely block the action of a methylase at a single overlapping recobo.ition site 
while methylating all other sites (15, 16). Using this Achilles' heel cleavage 
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procedure, they demonstrated single site cleavage of yeast and E. coli genomes upon 
digE'stion with a restriction enzyme able to cut only at unmethylated sites (16) . 
Protein-mediated Achilles heel cleavage may not, however, be readily generalizable 
to unique cleavage at selected genetic markers without artificial insertion of the 
target sequence due to the paucity of applicable DNA-binding proteins. A more 
general approach for recognition of endogenous DNA sequences might be a 
chemical approach based on oligonucleotide directed triple helix formation. This 
strategy offers a generalizable DNA binding motif that is capable of locally protecting 
the DNA from methylation at an overlapping target site while not affecting the 
activity of the methylase at its other recognition sites (17, 18). Triplex formation, 
global methylation and triple helix disruption results in DNA that is resistant to 
endonuclease digestion at all sites except the one previously bound by the 
oligonucleotide (17, 18) (Fig. 1). Subsequent restriction enzyme digestion produces 
nearly quantitative single site cleavage of large genomic DNA at endogenous 
sequences (4) . In this chapter we fully describe the procedure for triple helix 
mediated enzymatic cleavage of the Saccharomyces cerevisiae genome at a single 
predetermined site on chromosome III (340 kb) using a 24 base oligonucleotide and 
EcoRI methylation and restriction enzymes. 
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Materials and Methods 
Media, Solutions, and Reagents 
YPO media: 1% (w/v) bactoyeast extract, 2% (w/v) bactopeptone, 2% (w/v) glucose. 
Autoclave yeast extract and peptone for 20 minutes, cool and add 1/25th 
volume of sterile 50% (w/v) glucose. 
Spheroplasting Solution: 0.9 M sorbitol, 20 mM Tris pH 7.5, 50 mM EOTA pH 8.0, 
7.5% l3-mercaptoethanol, and 20 Ilg/rnl zymolyase lOOT (lCN). Zymolyase is 
prepared as a stock solution at 2 mg/ml in 10 mM phosphate buffer pH 7.0 
and 50% (w Iv) glycerol. 
Sucrose Solution: Same as above without zymolyase. 
NOS Solution: 0.5 M EDTA pH 8.0,10 mM Tris pH 7.5,1% (w/v) lauryl sarcosyl, 1.0 
or 0.5 mg/ml proteinase K (BRL). 
Triple Helix/EcoR! Methylase Solution (THEM): 100 mM NaCl, 100 mM Tris-HCl, 
10 mM EDTA, 2 mM spermineo 4HCI (Nuclease free grade from Sigma). 
Adjust final solution to pH 6.6, 7.0, 7.4, or 7.8. 
Inactivation Buffer: 1% lauryl sarcosyl, 100 mM Tris-HCl, 10 mM EOTA. Adjust 
final solution to pH 9.0. 
Wash Buffer: 10 mM Tris-HCl, 10 mM EDTA at final pH 9.0. 
2xKGB Buffer: 200 mM potassium glutamate, 50 mM Tris-acetate, 20 mM 
magnesium acetate. Adjust to pH 7.6 with acetic acid or potassium hydroxide. 
Add BSA and ~-mercaptoethanol to final concentration of 100 I1g/ml and 1 
mM, respectively. 
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Preparation of Yeast Chromosomal DNA 
1. Add 50 ",I of saturated overnight cultures of haploid yeast strain SEY6210 or 
recombinant derivatives (3,4) to 100 mls of YPD media. Grow overnight to 00600 
between 4-6. 
2. Harvest the cells by centrifugation at 5,000 rpm for 5 min. at 5° C. Discard the 
supernatant and wash with 20 mls 50 mM EDTA pH 8.0. Harvest and drain the 
pellet well. 
3. Resuspend the yeast in 6-8 mls of spheroplasting solution and incubate at 37" C 
for 60 min. Gently swirl the solution every 15 min. to resuspend the cells. After 
spheroplasting is complete, centrifuge the cells as before, decant, and resuspend 
in 6-8 mls of sucrose solution. Add an equal volume of liquified 1.4% LMP Incert 
(FMC) agarose in sucrose solution preheated to 42° C, mix and cast in 6x6xl00 
mm molds. Solidify the agarose on ice to prevent leakage. 
4. Carefully remove the plugs from the molds and transfer two plugs (=3.5 
mis/plug) to 25 mls of NOS solution in a 50 ml conical centrifuge tube. Incubate 
with gentle shaking at 50° C for 24 hours. The plugs which were originally pale 
white become transparent upon lysis. Decant and add a second 25 ml aliquot of 
NOS solution with 0.5 mg/ml proteinase K and incubate at 50° C for an 
additional 3 hours. 
5. Wash the plugs 3x30 mls for 20-30 min. with gentle shaking using 0.5 M EDTA 
8.0. Repeat the 3x30 ml washes with 10 mM EDTA. Add 1/100 volume of 100 
mM PMSF dissolved in 100% ethanol and incubate on shaker for at least 1 hour 
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to inactivate any residual proteinase K. Complete five 20-30 min. washes with 30 
mls of 10 mM EDTA and store the plugs at 4° C until use. 
Comments: DNA prepared from SEY6210 was more susceptible to degradation 
during preparation than other yeast strains tested. For this reason the standard 
procedure for DNA preparation from s. cerevisiae (19) was modified to maximize 
chromosomal integrity. In addition to the preparation in agarose blocks described 
above, DNA was prepared in agarose beads (16). tittle difference was found in 
either the quality of the DNA or its reactivity in subsequent enzymatic treatments. 
Preparation of Oligonucleotides 
1. Synthesize oligonucleotides on a 1 Ilmole scale using commercially available 
N,N diisopropyl ~-cyanoethyl phosphoramidites (BrU and MeC phosphoramidites 
are available through Cruachem). Deprotect oligonucleotides in concentrated 
ammonium hydroxide at 55° C overnight and rotovap to dryness. 
2. Purify oligonucleotides by 15% polyacrylamide gel electrophoresis in 1xTBE. 
Briefly visualize bands under a hand-held short-UV lamp and cut 
oligonucleotides from gel. Care should be taken with oligonucleotides 
containing BrU due to UV induced strand scission. Crush the polyacrylamide 
slice to powder and extract the oligonucleotide in 8.0 mls of 200 mM NaCi, 1 mM 
EDTA pH 8.0 at 37" C overnight. Pass extracted oligonucleotides through a 0.45 
I!ID cellulose acetate centrex filter (Schleicher and Schueli) to remove 
polyacrylamide fragments . 
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3. Desalt the oligonucleotides by slowly loading eluent on diposable CIS reverse 
phase column (Waters). Remove salt by washing extensively with 20 mls of 
distilled water, and eluting in 2.0 mls of 40% acetonitrile in water. Determine 
concentration by OD260 absorbance. Transfer oligonucleotides to eppendorf tubes 
in 20 nmole aliquots and dry on speedvac. Store at -200 C in the dark until use. 
Triple Helix Mediated Enzymatic Cleavage 
1. Cut 1.5 mm slices of yeast plugs (=50 ~ volume) and transfer to 1.8 ml flat bottom 
microcentrifuge tubes. Wash 2 x 1.0 ml with THEM buffer for 15 minutes. Decant 
and overlay the plug with 120 ~f of THEM buffer. 
2. Add 2 ~f of 100 ~M oligonucleotide to the overlay and incubate at room 
temperature on shaker (150 rpm) for 8 hours to facilitate oligonucleotide 
diffusion and triple helix formation. 
3. Add 1 ~ of 20 mg/ml acylated BSA (nuclease free grade from Sigma), 1 ~ of 32 
mM S-adenosyl-methionine in 5 mM H2S04, 10% ethanol, and 2 ~ of 40 units/~f 
EcoRI methylase (New England Biolabs). Incubate an additional 3-5 hours at 
room temperature with shaking. 
4. Simultaneously disrupt the triplex and inactivate the methylase by removing the 
supernatant above the plug and adding 1.0 mls of inactivation buffer. Heat plugs 
to 550 C for 30 min. Place tubes on ice following inactivation to harden the 
agarose plug before decanting. 
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5. Remove lauryl sarcosyl, oligonucleotide and methylase from plug by washing 4 x 
15 min. with 1.0 ml of wash buffer. 
6. Equilibrate the DNA in restriction enzyme buffer by washing 2 x 15 min. with 1.0 
ml of 2xKGB. Decant and overlay with 120 ~l of buffer. Add 1 ~ of 20 units/~l 
EcoRI restriction enzyme (New England Biolabs) and digest DNA for 6 hours at 
room temperature on shaker. 
7. Decant plugs and add 1.0 ml of o.5x TBE. Disrupt any DNA protein interactions 
by heating to 55° C for 10 min. and cooling quickly on ice. 
8. Resolve cleavage products by pulsed field gel electrophoresis (20, 21) using a 0.5x 
TBE, 1 % agarose gel at 14° C, 200 V on a CHEF II system (BioRad). Ramp switch 
times from 10-40 sec. for 18 hrs. and 60-90 sec. for 6 hrs. Visualize products by 
ethidiurn bromide staining (500 ng/ml) and Southern blotting with 0.45 ~ 
Nytran membranes according to manufactures proticols (Schleicher and Schuell). 
Comments: The incubation time necessary for complete methylation is dependent 
upon the pH of the buffer. The pH optimum is 8.0 for EcoRI methylase, but triple 
helix formation is more effective at neutral pH. Methylation is complete within 
three hours at pH 7.4, but 4.5 hours are necessary at pH 6.6. Thus, the methylation 
time must be optimized for the conditions chosen. 
Commercial preparations of EcoRI methylase contain endonuclease impurities 
that are active in the presence of magnesium. Fortunately, methylases do not 
require a metal cofactor for activity. To prevent nonspecific degradation of the 
chromosomal DNA, the methylation reactions were performed without 
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magnesium in the presence of the metal chelator EDTA. After methylation is 
complete, the methylase impurities must be inactivated in warm detergent before 
addition of the restriction enzyme buffer. 
Because triple helix formation can specifically block the activity of both 
methylases and restriction enzymes (17, 18) it is necessary to remove the 
oligonucleotide from the target site. Utilizing the observation that triple helix 
formation is temperature, polycation and pH dependent (1, 3) the complex can be 
readily disrupted in the absence of spermine at moderate temperatures and high pH. 
After triplex disruption and before the addition of magnesium (a dication necessary 
for the restriction enzyme that also stabilizes triple helix formation) the plug must 
be thoroughly washed to remove the oligonucleotide. 
Two Dimensional Pulsed Field Gel Electrophoresis 
1. Follow steps 1-3 as described above. After complete methylation of the DNA but 
before restriction enzyme digestion, separate the yeast chromosomes by pulsed 
field gel electrophoresis in a O.5x TBE, 0.8% Incert LMP agarose gel at 14° C and 
200 V. Set switch times at 60 sec. for 18 hours and 90 sec. for 6 hours to fully 
resolve all the yeast chromosomes. Include an untreated control lane to serve as 
a size standard. 
2. Cut the size standard from the gel and stain with ethidium bromide. Do not 
stain the methylated DNA. Based upon the location of the chromosomal bands 
in the standard lane, carefully cut a full length strip of methylated DNA and 
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place it in a 15 ml centrifuge tube containing 4 mls of 2x KGB buffer. Equilibrate 
for 10 min. at room temperature: 
3. Decant and add 4 mls of 2x KGB buffer and 10 IJ-i of EcoR! restriction enzyme (200 
units). Digest at RT with shaking (60 rpm) for 6 hrs. 
4. Load strip onto a second 1 % agarose pulsed field gel containing O.5x TBE at 14° C 
and 200 V. Set switch times as in step 1. Visualize products by ethidium bromide 
staining. 
Results and Discussion 
Studies with plasmid DNA demonstrate that oligonucleotide directed triple helix 
formation in combination with appropriate methylases and restriction enzymes can 
limit the operational specificity of restriction enzymes to endonuclease recognition 
sequences that overlap oligonucleotide binding sites (17, 18). To demonstrate the 
feasibility of single site enzymatiC cleavage of genomic DNA by triple helix mediated 
Achilles' heel cleavage, a sequence containing an overlapping 24 bp purine tract and 
6 bp EcoR! site was inserted proximal to the LEU2 gene (22) on the short arm of 
chromosome III (340 kb) by homologous recombination (Fig. 2) (3). Oligonucleotides 
designed to form triple helix complexes that overlap half of the EcoR! recognition 
site were synthesized with CT, MeCT, MeCBrU nucleotides (Fig. 2) (9). The genetic 
map of yeast chromosome III (23, 24) and affinity cleaving data (3) indicate that 
cleavage at the target site should produce two fragments 110 ± 10 and 230 ± 10 kb in 
size (Fig. 2). 
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Use of the MeCT oligonucleotide for triple helix formation at pH 7.4 followed by 
EcoR! methylase and endonuclease treatments, resulted in exclusive cleavage of 
chromosome ill at the target site (Fig. 3, lane 1). No cleavage was detected on any 
other chromosomes under these conditions. Cleavage was neither observed in the 
absence of oligonucleotide (Lane 2) nor in a yeast strain lacking the target sequence 
(Lane 3). The expected 110 kb product was visualized with ethidium bromide 
staining and confirmed by Southern blotting with a HIS4 marker (Fig. 3C) (25). The 
230 kb product comigrated with chromosome I, but was detected by Southern 
blotting with a LEU2 marker (Fig. 38) (22). The cleavage efficiency was 94 ± 2% with 
a three hour methylase incubation. Longer methylation times resulted in a gradual 
reduction in the observed cleavage efficiency, suggesting that the oligonucleotide 
dissociation rate might be the limiting factor for efficiency in this system (26). 
The specificity of triple helix formation has been shown to be pH dependent (1, 2, 
3). At lower pH, sequences of near but imperfect similarity can be bound and 
subsequently cleaved. In agreement with this observation, secondary cleavage sites 
were revealed as a function of oligonucleotide composition and pH (Fig. 4). Using 
either the MeCT or MeCBrU oligonucleotides at or below pH 7.4, 170 and 650 kb 
secondary cleavage products were observed (Fig. 4, lanes 5 and 9). The cleavage site 
can be assigned to chromosome II (820 kb) by two-dimensional pulsed-field gel 
electrophoresis (Fig. 5). Additional secondary cleavage sites were observed with the 
MeCBrU oligonucleotide at pH 6.6 (Fig. 4, lane 9). The 180 and 480 kb products were 
assigned to chromosome XI (660 kb), and the 330 and 780 kb products were assigned 
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to the VII/ XV doublet (1100 kb) (Fig. 5). Cleavage at all secondary sites could be 
eliminated at a threshold pH for each oligomlcleotide (Fig. 4, lanes 2, 8, and 12). 
Because of the greater triple helix stability at pH's optimal for the methylase (pH 8.0), 
MeC substituted oligonucleotides are preferred over C substitutions in this assay. 
BrU substitutions offered little additional pH stability and increased the number of 
secondary cleavage sites observed. This property of BrU substituted 
oligonucleotides is useful in searching for endogenous homopurine-methylase sites 
in unsequenced DNA by using degenerate oligonucleotides containing MeC and BrU. 
Many methylases, including Alul and dam, exhibit optimal activity in low salt 
buffers. Unfortunately, spermine rapidly precipitates DNA at low sodium chloride 
concentrations. To prevent precipitation during triple helix formation and 
methylation reactions, the salt concentration must be adjusted to 25-50 mM. The 
enzyme activity retained under these conditions is sufficient to yield complete 
methylation of genomic DNA if adequate time and enzyme concentration are 
employed. 
Not all methylases are compatible with this technique. BamHI methylase is 
significantly inhibited by spermine. HaeIII restriction enzyme can cut 
hemimethylated sites, making it much more difficult to achieve complete 
methylation (27). An additional concern when working with genomic DNA, 
particularly with enzymes sensitive to CpG methylation such as Hpall and Hhal, is 
the prior methylation state of the target DNA. A large yet variable percentage of 
CpG sequences in mammalian cells are methylated in vivo (28, 29). Achilles heel 
121 Methods in Enzymology (In Press) 
cleavage at these sites would not be possible unless methylation free DNA could be 
prepared. 
Affinity cleaving using oligonucleotide-EDT A • Fe, a technique that generates 
cleavage at all sites of oligonucleotide binding but in low yield, demonstrated that 
triplex formation is occurring at several positions on the yeast chromosomes besides 
the single target site (3). Triple helix mediated Achilles heel cleavage exposes only 
those sites that are tightly bound and partially overlap a complete 
methylase/ endonuclease site (4, 17, 18). The probability of finding an endogenous 
homopurine sequence that overlaps a EcoRI methylase site is quite low, possibly one 
every 500 kb or less (3). The frequency of targetable sequences is increased, however, 
when other methylase/endonuclease pairs are considered. In addition to TaqI and 
EcoRI (4, 17, 18), single site protection of plasmid DNA has been achieved with MspI, 
Hpall, and AluI methylase/endonucleases pairs. Several other methylases could be 
used, but remain untested. To date, complete methylation of yeast genomic DNA 
under conditions compatible with triple helix formation has been achieved with 
EcoRI, AluI and dam methylases. The list will expand as target sites of interest are 
identified. Although all enzyme sets tested might not be effective, the use of several 
different methylase/endonuclease combinations could increase the frequency of 
cleavable sites in endogenous sequences to as high as one every 10-30 kb (3, 27). 
The generalizability of triple-helix mediated enzymatic cleavage affords high 
specificity that can be readily customized to unique genetic markers without 
artificial insertion of a target sequence. Extensive sequencing to identify target sites 
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could be avoided by using degenerate oligonucleotides to screen genetic markers for 
overlapping triple helix/endonuclease sites. The potential generalizability of triple 
helix mediated Achilles heel cleavage, a technique capable of near quantitative 
cleavage at a single site in at least 14 megabase pairs of DNA, could assist in physical 
mapping of chromosomal DNA and expedite isolation of DNA segments linked to 
disease. 
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Fig. 1 General scheme for single-site enzymatic cleavage of genomic DNA by 
oligonucleotide-directed triple helix formation (4) . Chromosomal DNA is 
equilibrated with an oligodeoxyribonucleotide in a methylase compatible buffer 
containing polycation. EcoRI methylase, which methylates the central adenines of 
the sequence 5'-GAAITC-3' and renders the sequence resistant to cleavage by EcoRI 
restriction endonuclease, is added and allowed to methylate to completion. The 
methylase is inactivated and the triple helix is disrupted at 55° C in a high pH buffer 
containing detergent. After washing extensively, the chromosomal DNA is 
reequilibrated in restriction enzyme buffer and cut to completion with EcoRI 
restriction endonuclease. The cleavage products are separated by pulsed-field gel 
electrophoresis and efficiencies quantitated by Southern blotting (From ref. 4). 
Fig. 2 (Left) Genetic map of S. cerevisiae chromosome III. The location of the HIS4 
and LE U2 loci (boxes), the centromere (circle), and the triple helix-EcoRI target site 
are indicated. The expected sizes of the cleavage products are shown. (Right) 
Schematic diagram of the triple helix complex overlapping the EcoRI 
methylase-endonuclease site. The pyrimidine oligonucleotide is bound in the 
major groove parallel to the purine strand of the DNA duplex, and covers half of 
the EcoRI site (From ref. 4). 
Fig. 3 Single site enzymatic cleavage of yeast genomic DNA with reagents indicated 
above figure. Products were visualized by ethidium bromide staining (A) and 
Southern blotting with LEU2 (B) and HIS4 (C) chromosome markers (From ref. 4). 
Fig. 4 Triple helix mediated enzymatic cleavage of the yeast genome as a function oi 
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oligonucleotide composition and pH. (A) Lane 1-12: Reaction on a yeast strain 
containing the triple helix target site with oligonucleotides (CT, MeCT, and MeCBrU) 
and pH (6.6, 7.0, 7.4, and 7.8) as indicated above figure (From ref. 4). 
Fig. 5 Two dimensional pulsed field gel analysis of MeCBrU oligonucleotide 
incubated at pH 6.6. Intact chromosomes form a diagonal with cleavage products 
located immediately to the left of the chromosome of origin. 
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Conclusion . Single site cleavage of the yeast genome was achieved 
enzymatically by oligonucleotide directed triple helix formation. Triple helix 
specificity alone was insufficient to define one site on a single yeast 
chromosome even under optimized conditions. By coupling the specificities . 
of triple helix formation and enzymatic methylation/digestion, a single 
cleavage site was detected within plasmid and yeast genomic DNA. The 
sequence requirement of a triplex binding site overlapping a complete 
methylation site was sufficient to define a single site within 14 Mb of DNA 
and cut it at efficiencies exceeding 94%. Secondary target sites within the yeast 
genome could be detected with this cleavage technique through the use of 
modified oligonucleotides at low pH. The number of cleaved sites were 
surprisingly few considering the extent of degradation observed with MecBru 
oligonucleotides by affinity cleaving. The chromosomal identification and 
sizes of the products genera ted by cleavage at the less stringent triple helix 
condition were determined by two-dimensional pulsed-field gel 
electrophoresis. 
Materials and Methods. 
Materials Restriction enzymes were obtained from New England 
BioLabs, Boehringer Mannheim, and Gibco BRL (SstI only). All methylases 
were obtained from New England Biolabs and used without further 
purification. T4 DNA ligase and the Klenow fragment of E. coli DNA 
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polymerase were obtained from New England Biolabs. Sequenase 2.0 dideoxy 
sequencing kits were purchased from Unites States Biolabs. Taq DNA 
polymerase and PCR buffers were obtained from Perkin Elmer Cetus. PCR 
reactions were performed on a Perkin Elmer Cetus therrnocycler. Prep-a-
Gene DNA purification matrix and buffers were obtained from Bio-Rad. 
Large scale plasmid purification was performed using maxi-plasmid 
purification kits from Qiagen according to manufacture suggested protocols. 
Radioactive nucleotides 32p-Ct-dCTP and 32p-Ct-dATP were obtained from 
Amersham [10 mCi/ml, 3000 Ci/mmol). Unlabeled mononucleotides were 
purchased from Pharmacia, mixed at 2.5 mM in each nucleotide, and stored 
in small aliquots for PCR reactions. Sephadex G-I0 and G-50 matrices, 
spermine e4HCl (nuclease free), ampicillin, lauryl sarcosyl, isopropyl 13-0-
thiogalactopyranoside (IPTG), 10 mg/ml salmon sperm DNA (fragmented 
and phenol extracted), and bovine serum albumin (20 mg/ml nuclease free) 
were obtained from Sigma. 5-Brom0-4-chloro-3-indolyl f3-o-galactopyranoside 
(X-gal) and proteinase K were purchased from Boehringer Mannheim. 
Zymolyase was obtained from ICN Biochemicals. Fe(NI--4l2(S04l2e6H20 and 
ultrapure dithiothreitol were obtained from Baker Chemical and Gibco BRL, 
respectively. YNN295 yeast chromosomal size standards were a gift from Dr. 
Bruce Birren. The concatenated A. DNA size standard and Incert low melting 
point (LMP) agarose was purchased from FMC Bioproducts. Electrophoresis 
gradeagarose and LMP agarose were purchased from Gibco BRL. 
Plasmid pUC19 was obtained from Pharmacia. Plasmid YEp13 (28) and 
the haploid yeast strain SEY6210 (30) were gifts from the laboratory of 
Professor Scott Emr. Plasmid YCp503 was a gift from Professor Randy 
Scheckman (24). Plasmid pMA91 was the gift of Professor Judy Campbell (25). 
135 
Chromosomes and cleavage products were resolved on a CHEF-DRlI 
Pulsed-field gel electrophoresis chamber from Bio-Rad. DNA blotting was 
accomplished using a Stratagene Pressure Blotter. 0.45 Micron Nytran 
membrane was obtained from Schleicher and Schuell. DNA nicking was 
accomplished with a UV Products short UV TS-20 transilluminator. The 
DNA was immobilized by UV irradiation with a Stratagene Stratalinker. 
Radioactive emissions were detected on a Beckman LS 3801 liquid 
scintillation counter. DNA hybridization (Southern blotting) was 
accomplished in a Robins Scientific rotating hybridization incubator, Model 
310. Autoradiography was performed using Kodak X-Omat AR film with an 
intensifying screen at -700 C and developed on a Kodak M35 A X-OMAT film 
processor. Densitometric traces were recorded on an LKB Bromma Ultrascan 
XL Laser Densitometer. 
Media and Buffers. YPD media was prepared by mixing 10 g yeast 
extract, 20 g bactopeptone, 20 g bactoagar (if for plates), 960 mls of water and 
autoclaving for 20 min. 40 mls of sterile 50% w/v glucose was added to bring 
the volume to 1.0 L. 
Minimal media plates (leu-) were prepared by mixing 6.7 g yeast 
nitrogen base, and 25 g bactoagar in 860 mls of water and autoclaving for 20 
min. Sterile 50% w /v glucose (50 mls) and sterile lOx amino acid mix (200 
mg uracil, 200 mg histidine, 200 mg adenine, 300 mg lysine, 200 mg 
tryptophan, 200 mg methionine, 300 mg tyrosine in 1000 ml sterilized for 20 
min. in autoclave) (100 mls) were added, mixed, and poured into plates. 
LB media and TYE plates were prepared as previously described (39). 
Stock solutions for DNA electrophoresis and hybridization were as follows: 
-lxTAE, 40 mM tris-acetate, 1 mM EDTA, pH adjusted to 8.0 with glacial 
acetic acid. 
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-lxTBE, 45 mM tris-base, 45 mM boric acid, 2 mM EDTA, pH 8.0. 
-20xSSPE, 3.6 M NaCl, 0.2 M NaP04, 20 mM EDTA, pH 7.7. 
-20xSSC, 3.0 M NaCi, 0.3 M NaCitrate pH 7.0. 
-50xDenhardt's Reagent, 1 % w Iv ficoll, 1 % w Iv polyvinylpyrrolidone, 
1 % bovine serum albumin. 
Oligonucleotide Synthesis and Purification. Oligonucleotides for triple 
helix formation and affinity cleaving were synthesized, deprotected, and 
purified as described in Chapter 2. Oligonucleotides for use in plasmid 
construction, PCR, or as sequencing primers were synthesized on an Applied 
Biosystems 380 B DNA synthesizer and deprotected in concentrated Nli40H 
at 550 C for 12 to 24 hours in screw cap eppendorf tubes. Following 
deprotection the ammonia was removed with argon for 30-60 min. The 
oligonucleotides were dried by lyophilization, redissolved in 1.0 ml water, 
desalted through a Sephadex G-I0 size exclusion spin column, and the 
oligonucleotide concentration determined by A 260 absorbance. 
Plasmid Construction. Target site insertion into yeast chromosome III 
was achieved by homologous recombination with a LEU2 fragment 
containing the target sequence. The I,.EU2 fragment was derived from the 
plasmid YEp13, which contained the gene on a Pst! fragment inserted into the 
shuttle vector CV4, a pBR322 derivative containing the small EcoRI fragment 
from the 2Jl circle (12, 28, 29). Although YEp13 contained a unique XhoI site 
for target site insertion, it also contained two undesirable features: (i) it was a 
large low copy number plasmid, difficult to prepare in good yield, and (ii) it 
contained a 2Jl circle replication origin that facilitated extrachromosomal 
expression of the LEU2 phenotype. Because this could potentially reduce the 
recombination frequency of the target site into chromosome III, a high copy 
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Fig. 3.7. Construction of plasmid pUCLEU2 and its derivatives from 
parent plasmid YEp13. Top. The PstI/XmaI fragment of YEp13 was ligated 
into the polylinker region of pUC19 by a three piece ligation. The resulting 
plasmid, pUCLEU2, contained a unique XhoI site upstream of the LEU2 gene 
into which oligonucleotide duplexes A, B, C, D, E, H, and P were inserted. 
The plasmid also contained a unique HindIII site, opposite the XhoI site, that 
was frequently used for plasmid linearization in cleavage reactions. Bottom. 
The plasmid names, duplex sequences, and restriction enzyme sites inserted 
into the parent plasmid pUCLEU2. An additional plasmid containing two 
inserts of the A duplex was also constructed (pUCLEU2A2). Constructs E, H, 
and P are from sequences in human chromosome 4 (see Chapter 4). The 
sequence in plasmid P was changed slightly from the endogenous sequence to 
generate a BamHI site. The endogenous sequence reads GGA TCT instead of 
GGATCC. Both sites are recognized by the dam methylase sensitive enzyme 
MflI. 
PLASMID 
pUCLEU2A 
pUCLEU2B 
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YEp13 
(-11 kb) 
b~~f pUCl9 
(2.7 kb) 
XmaJ/PsII CuI 
XmaI/PsU CUj' L------------' 
Ligate 
Insert Oligonucleotide 
• Duplex 00 ., XholSile 
DUPLEX INSERT (X) 
Target Site 
5'· TCGACCAA TTCT T TTTCTTTCTTCTTTTCTTCCAG-3' 
3'·GCTT AAGAAAAACAAAGAAGAAAACAAGCTCAGCT-S' EroRI 
S'·TCGACGGATCCT TTTTCTTTCTTCTTTTCTTCCCGG-3' dam/MbaI 
3'·GCCT AG:;AAAAAGAAACAACAAAAGAACCCCCAGCT-S' BamHI 
TaqI 
Mspl 
Hpan 
S'- TCGAC T T TTCTTTCC T T T TeTTTT Ae TACT AAAAGAAAAGCAAAGAAAAG-3' 
pUCLEU2C 3'. GA AAAGAAAGGAAAAGAAAA TGATCATTTTCTTTTCCTTTCTTTTCAGC r-5' Alkylation 
pUCLEU2D 
pUCLEU2E 
pUCLEU2H 
pUCLEU2P 
S'·TeGACT ACT AAAGAAAAAGCTTTCTTCTT ACT AG-3' 
3'-GA TCA TTTCTTTTTCGAAAGAAGAA TCA TeAGeT-S' 
S'-TCGACTCCCT AA TCGAAACAGACAGAGACCTCACG TG-3' 
3'·GAGCGATT ACCTTTCTCTCf CTCTCGAGTGCACAGCT-5' 
S'·TCGACACAGAAGGAT AT AAAGAAAGCTTT Ad~D 
3'-CTGTCTTCCT AT ATTTCTTT CGAAA TCAGCT·S' 
5'· TCCACAT ACGCG ACAGGCAGGCCATCCGTG-3' 
3'·GT ATCCCCTCTCCCTCCCCT AGGCACAGCT·S' 
Alkylation 
Alul 
Sotl 
AluI 
Hlndm 
dam/Mho! 
Mm 
BamHr' 
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number plasmid, pUCLEU2, lacking the 2 ).l. circle was constructed (Fig. 3.7). 
Restriction maps of YEp13 showed the LEU2 insert to be on a single Pst! 
fragment with an Xmal site immediately adjacent to one end. YEp13 DNA 
was cut with Pstl and Xmal and ligated into Pstl/Xmal linearized pUC19 DNA 
(Fig. 3.7). DNA was transformed into XL-1 blue competent cells and 
transformants selected by a-complementation on TYE plates with ampicillin, 
IPTG, and X-gal. Few white colonies were detected if the YEp13 fragment was 
gel purified, and many plasmids with small Xmal/Pst! inserts were detected if 
the DNA from YEp13 was not purified after digestion. This suggested that 
there might be a second Pst! site internal to the Xmal site, and that the desired 
product required a three piece ligation. Plasmid DNA isolated from several 
clones was screened by restriction enzyme digestion (Pst!, Xhol, EcoR!, Sail, 
Xmal, and HindIII) to identify a single colony with the proper construction. 
Sequencing of this plasmid revealed a Pst! site approximately 60 bp from the 
Xmal site indicating that it was the product of a three piece ligation. Despite 
the difficulty of constructing the desired product because of an error in the 
restriction map, Pst! digestion of this plasmid, pUCLEU2, generated a single 
fragment complementary to the defective leu2 locus on yeast chromosome III 
of SEY6210. 
pUCLEU2 contained a single Xhol site upstream of the LEU2 gene into 
which oligonucleotide duplexes with homopurine target sites were ligated 
(Fig. 3.7). A number of duplexes with target sites for affinity cleaving (A and 
B), alkylation (C and D), and enzymatic cleavage (A, B, E, H, and P) were 
ligated into the Xhol site of pUCLEU2 (Fig. 3.7). The duplexes were designed 
to contain ends compatible with ligation into a Xhol site, and an internal C to 
destroy the Xhol site upon duplex insertion. In this way, the desired plasmid 
could be selected prior to transformation by performing a second XhoI digest 
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after ligation, relinearizing only those plasmids lacking an insert. The 
internal C also generated a Sail site if multiple duplexes were inserted, 
facilitating rapid clone identification by Sail digestion following 
transformation and colony selection. In this way, plasmid pUCLEU2A2 was 
selected containing two tandem inserts of the A duplex. 
Molecular cloning was performed using techniques previously 
described (39). pUCLEU2/duplex ligations were performed with 1 unit T4 
DNA ligase using a 2a-fold molar ratio of unphosphorylated duplex (=5 x 10-
12 moles) to plasmid (=2.5 x 10-13 moles or 1 I!g) in 20 I!l. Ligations were 
performed in lxKGB buffer (100 mM potassium glutamate, 25 mM tris-
acetate, 10 mM magnesium-acetate, 50 I!g/ml BSA, 0.5 mM ~-mercaptho­
ethanol, pH 7.6) and 0.5 mM ATP at 16° C for 2-4 hours, after which XhoI (20 
units) was added directly to the reaction mixture and incubated at 37° C for an 
additional hour. Transformation, selection, restriction enzyme digestion, and 
plasmid isolation were performed as described. Transformants were 
characterized by restriction enzyme digestion of purified plasmid DNA. The 
orientation and sequence of the inserts was directly determined by dideoxy 
sequencing with Sequenase 2.0. Large scale plasmid preparation was 
performed by double cesium chloride banding (pUCLEU2, A, A2 and B) or ion 
exchange chromatography (pUCLEU2C, D, E, H, and Pl. For reasons that are 
not clear, control ligations lacking the duplex generated significantly more 
transformants than ligations with the duplex, despite digesting both with 
XhoI. In spite of this troubling observation, roughly half of the resulting 
colonies contained the desired insert. 
Homologous Recombination of Yeast Chromosome III. Competent 
yeast were transformed with the Pst! fragment from pUCLEU2 and its 
derivatives to homologously recombine the triple helix target site into 
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chromosome III (40-43). Haploid yeast strain SEY6210 (MATa leu2-3, 112 . 
ura3-S2 his3-L1200 trp-L1901 lys2-BOI suc2-,19 GAL) was grown in 100 mls YPD 
at 30° C to A600 = 0.6 to 0.8 (00 readings taken on 10 fold dilutions from the 
concentrated culture). Cells were harvested by centrifugation at 5000 rpm for 
5 min. at 5° C, decanted, washed in sterile water, reharvested, and decanted. 
The cells were then resuspended in 20 mls 0.1 M lithium-acetate, 5 mM tris-
HCl pH 8.0,0.1 mM EDTA and incubated at 30° C for 30 min. The cells were 
harvested, resuspended in 1 rnl of lithium-acetate solution, and 50 III 
transferred to 1.8 ml eppendorf tubes for transformation. 
Plasmid DNA (5 Ilg) was digested to completion with PstI, added to the 
competent yeast cells, and the mixture incubated at 30° C for 30 min. Freshly 
sterilized 40% pOlyethylene glycol-4000 (0.6 ml) was added, mixed and 
incubated an additional hour at 30° C. Cells were heat shocked at 37° C for 5 
min., collected by quickly spinning in a microcentrifuge, decanted, 
resuspended in 125 ILL water, and plated on leucine deficient minimal media. 
Transformants were incubated for 48 hours at 30° C, after which several very 
small colonies and 10-25 large colonies were visible. Replating the small 
colonies on minimal media showed they were defective for growth, while the 
large colonies showed significant growth after 2 additional days at 30° C. Four 
of the large colonies were picked for storage and one of them screened for 
proper insertion of the target site. 
Confirmation of the Target Site in Yeast Chromosome III. Two 
procedures were used to demonstrate the target site had been inserted at the 
desired location within the yeast genome: (i) DNA hybridization with the 
LEU2 gene (39,44), and (ii) PCR amplification of the target site region 
followed by product digestion with informative restriction enzymes (45-48). If 
the target site was properly inserted, only one copy of the LEU2 gene would be 
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present and hybridization would show its location on chromosome III. If 
recombination had occurred at a second nonhomologous site, the 
hybridization would detect two chromosomes containing the LEU2 gene, the 
parental chromosome III and a second chromosome that had undergone 
recombination. 
Chromosomal DNA was prepared in Incert LMP agarose from 
recombinant yeast strains as described (14, 16,22). The chromosomes were 
resolved by pulsed field gel electrophoresis using a 1 % agarose, O.5xTBE gel, 
6.0 V / em, 120° switch angle, 60 sec. switch times for 16 hours, followed by 90 
sec. switch times for 8 hours at 14° C (3-8). The DNA was stained with 
ethidium bromide, photographed, nicked on a short UV light box for 30 sec. 
each side, and denatured by incubating the gel in 300 mls of 0.4 M NaOH/0.6 
M NaCI twice for 30 min. The DNA was transferred to a 0.45 11m Nytran 
membrane by pressure blotting (75 torr) in the alkaline solution for 1-4 hours. 
The membrane was neutralized in 2xSSPE and the DNA photocrosslinked. 
The membrane was incubated for 1-24 hours in 5 mls of 6xSSPE or SSC, 
10xDenhardt's reagent, 0.5% sodium dodecyl sulfate (SDS), and 50-200 I1g/mi 
fragmented and denatured salmon sperm DNA at 42° C. 
Southern Blot Hybridization. The location of the LEU2 gene within 
the yeast genome was determined by hybridization with the Kpnl/EcoRl 
fragment from pUCLEU2 (12, 28). This fragment was subcloned into pUC19 
(KpnI/EcoRl cut) to generate plasmid pUC-KE400. Large quantities of vector 
free fragment were prepared using the PCR (protocol below) with universal 
primers UP1200 and UP1201 (Appendix A) and 10 ng of pUC-KE400 DNA 
template. The PCR fragment (20-100 ng) was random primer radiolabeled 
with fully degenerate hexanucleotides, a32P-dCTP, and the Klenow fragment 
of DNA polymerase (39,49). Unincorporated mononucleotides were 
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eliminated by size exclusion Sephadex G-50 spin chromatography. 
Radioactive yields between 15 and 50 million cpm were typically obtained. 
The DNA was denatured by the addition of 0.1 volumes of 1 N NaOH with 
incubation at room temperature for 15 min. 
Following prehybridization, the solution was decanted from the 
membrane and incubated 4-24 hours at 42° C with 4 mls hybridization 
solution containing 6 x SSPE or sse, 0.5% SDS, 40% formamide, 50-200 Ilg/ml 
fragmented and denatured salmon sperm DNA, and the radiolabeled and 
denatured PCR fragment from pUC-KE400. After hybridization, the solution 
was decanted, and the membrane washed twice with 6xSSPE, 0.5% SDS for 10 
min. at room temperature, and twice in lxSSPE, 0.5% SDS for 15 min. at 42° C. 
The membrane was placed between two pieces of plastic wrap and the 
radioactive signal detected by autoradiography. 
peR Amplification and Product Digestion. PCR analysis was also used 
to confirm the presence of the triple helix target site by amplifying all the loci 
in the genome that were upstream of a LEU2 gene. If a wild type sequence 
was present, the peR product would be sensitive to digestion with XhoI and 
insensitive to the enzyme characteristic of the desired construct. If the wild 
type sequence had been replaced by recombination, the reverse pattern would 
be observed. If both wild type and altered sequences were present, peR 
products would be partially cut by both enzymes. By selecting for the LEU2 
phenotype, screening recombinants by LEU2 hybridization, and confirming 
the presence of the target site by the PeR, several chromosome In constructs 
containing triple helix target sites were generated. 
peR primers were developed to amplify the region surrounding the 
XhoI site upstream of the LEU2 gene. The sequence of the XhoI/Sali fragment 
(Fig. 3.7) containing the LEU2 gene had been fully determined, but the 
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Xmal 
CCCGGGCAGCCTGCTCTGCCTGTGTTTTCTTTAATTGAGCAGTAGACCATTTAGCAGTTGCATGA65 
Pstl 
ATAGCTGCAGATGCAGGGGTGAGTTATGTTGTTGCTTTACTTTTTAGCTTGCTTGCTGGAACTAC130 
ATTAGGTATTTGGGGT ATTGCT ATTGTTACAGGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT 195 
UP-MID 
I I I I I I I I AAAGGCTT ACTT ACTGAT AGTAGATCAACGATCAGT ATAATT AAGTCT ACAAATGAA 260 
.. 
GAGAAATTTAGAAACAGAI I I I I IGGCACAAAGGCAAATGAGACTTAGAGATGAAGTATCAGGTA 325 
ATAATTTATACGTATACTACATCGAGACCAAGAAGAACATTGCTGATGTGATGACAAAACCTCTT390 
• CCGATAAAAACATTTAAACTATTAACTAACAAATGGATTCATTAGATCTATTACATTATGGGTGG455 
---A-MID Xho+250 
TATGTTGGAATAAAAATCAACTATCATCTACTAACTAGTATTTACGTTACTAGTATATTATCATA 520 
.. 
TACGGTGTTAGAAGATGACGAAAATGATGAGAAATAGTCA TCT AAA TT AGTGGAAGCTGAAACGC 585 
AAGGATTGATAATGTAATAGGATCAATGAATATTAACATATAAAATGATGATAATAATATTTATA 650 
Xhol 
GAA TTGTGT AGAA TTGCAGATTCCCTTTT ATGGA TTCCTAAATCCTCGACTCGAGGAGAACTTCT 715 
LEU2-Saquanca 
K AdqAqAqCCACAqACCqAAqAqq~_K~A~qq~d~C~C~f~fA~qq~A~A~A~A~A~q~d~dAAqCCCAACAAqqACAqCAAAAqTUM 
CCACATTCTCTTCAAAATCAATTGTCCTGTACTTCCTTGTTCA TGTGTGTTCAAAAACGTT AT AT 845 
qqAqAddAqAAqqAqACqCqAqqqCqCAACAAdqAAqqddqqdqqqddCCdAdCddqCqAAdd~91M 
Xho-235 
CCTGATTCAAGAAATATCTTGACC 934 
Fig. 3.8. Sequence of pUCLEU2 from the Xho-235 hybridization site to the Xmal 
ligation site in the pUC19 vector. Oligonucleotides used for sequencing primers or 
PCR amplification are indicated as arrows within the sequence. The arrowhead 
indicates the 3' end of the oligonucleotide. Restriction enzyme sites Xmal, Pst!, and 
Xhol are also indicated. 
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sequence from XhoI to the XmaI ligation site was unknown. This sequence 
was obtained by dideoxy sequencing of pUCLEU2 using sequencing primers 
UP1200, LEU2-Sequence, A-MID, UP-MID, and Xho+250 (Fig. 3.8) (Appendix 
A). The region contained approximately 700 bp of sequence including the 
small XmaI/Pst! fragment that is unlikely to be contiguous on chromosome 
III. 
PCR amplification using primers Xho+250 and Xho-235 (1 f.1M each) 
was conducted on 1.0 III of yeast chromosomal DNA embedded in agarose, or 
5 III of yeast cells lysed by vortexing in a 10 mM EDTA solution containing 
glass beads. Buffer conditions were 10 mM tris-HCl, pH 8.3 (at 25° C), 50 mM 
KCl, 1.5 mM MgCI2, 0.001% (w/v) gelatin, 200 IlM of each dNTP, and 2.5 units 
of Taq DNA polymerase in 100 III total volume. Temperatures and times 
were 94° C, 1 min.; 55° C, 1 min.; and 72° C, 1 min. for 30 cycles. Reactions 
were performed under light mineral oil to prevent evaporation. The PCR 
product (10 Ill) was digested with either XhoI or a construct specific restriction 
enzyme (A: EcoRI; B: BamHI; C: SpeI; D: HindIII; E: Sst!; H: HindIII; P: BamHI) 
to confirm the presence of the target site in the yeast genome. Products were 
resolved on a 1.0% agarose gel in lxTAE and ethidium bromide and 
visualized by UV illumination. 
Yeast constructs SEY6210, A, A2, B, C, D, and E were prepared and 
confirmed by this method. In the case of SEY6210B, the hybridization signal 
on chromosome III was twice as intense as the wild type, and the PCR 
reactions showed a product partially cut by both XhoI and BamHI. This 
suggested that there was a duplication of the LEU2 gene on chromosome III. 
Subsequent cleavage experiments demonstrated that the duplication flanked 
the target site resulting in detection of both cleavage products. In the case of 
SEY621OE, very few transformants were observed and the one which was 
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subsequently characterized contained an insertion of the target site into yeast 
chromosome Xl. A chromosome III insertion for SEY6210E was not critical, 
and therefore a second clone was not characterized. Although homologous 
recombination proceeds with good fidelity, the overall error rate for these 
constructs likely increased due to the presence of a Tyl repetitive element 
upstream of the LEU2 gene (12, 28). 
Affinity Cleaving Reactions. Reactions were performed as described 
above in footnote 28 (14) and in figure legends. 
Enzymatic Cleavage Reactions. Reactions were performed as described 
above in figure legends 3 and 4 (15) or more completely in the methods 
section of the Methods in Enzymology manuscript (16). 
Southern Blotting of Cleavage Products. The 110 and 230 kb cleavage 
products were detected by hybridization with radiolabeled fragments from 
HIS4 (23, 24) and PGKl (25,26), respectively. HIS4 hybridization was 
performed with a 250 bp Sall/EcoRI fragment derived from the HIS4-SUC2 
fusion plasmid YCp503 (24). The Sall/EcoR! HIS4 fragment was ligated into 
pUC19 to generate pUCHIS4-SE250. DNA for hybridization was prepared by 
the PCR using universal primers UP1200 and UP1201 specific for the pUC19 
vector arms. PCR conditions were performed as described above except 10 ng 
of pUCHIS4-SE250 were used as template. The DNA was radiolabeled and 
hybridized as described above. 
DNA for PGKl hybridization was amplified by the PCR directly from 
pMA91, a plasmid containing the LEU2 gene, the 2).1 circle, and the PGKl gene 
promoter inserted into pBR322 (25). PCR primers were designed for the 
amplification of a 1.3 kb fragment from the 5' promoter of PGK1. The first 
primer, PGKPCR1, was derived from the sequence between the EcoR! and 
HindIII sites in pBR322. The second primer, PGKPCR2, was designed to 
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hybridi;z:e to the promoter region of pMA91 immediately upstream of the 
transcription initiation site (Appendix A). PGKPCR2 was designed to avoid 
amplification of conserved sequences in the promoter to minimize possible 
cross-hybridization to other loci in the yeast genome. PCR amplification was · 
as described above using 10 ng of pMA91 as template. The PCR product was 
radiolabeled and hybridized as described above. 
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Chapter IV 
Site Specific Oeavage of Human Chromosomal DNA 
Mediated by Triple Helix Formation 
Triple helix experiments on plasmid, bacteriophage A, and yeast 
chromosomal DNA demonstrated the feasibility of cutting genomic DNA at a 
single site within DNA of high complexity (1-4). The specificity and efficiency 
were sufficient to suggest that triple helix formation could find application in 
the site specific cleavage of human chromosomal DNA (4). The human 
haplOid genome contains approximately three billion base pairs of duplex 
DNA (109 bp) divided into 23 chromosomes ranging in size from 25-300 Mb. 
Complete sequence determination of the human genome is a major goal of 
the human genome initiative (5). A preliminary goal is the identification of 
genetic markers at approximately 5 centimorgan intervals, or approximately 
every 5 megabases (Mb) along the length of each chromosome (5, 6). This goal 
has been reached in some regions of the genome (5-7). In light of this effort, it 
is desirable to develop a cleavage strategy capable of cutting uniquely at each 
genetic marker to liberate the intervening megabase fragment for subsequent 
analysis and subcloning. As an initial demonstration of the site specific 
cleavage of a human chromosome mediated by oligonucleotide directed triple 
helix formation, we targeted the tip of human chromosome 4 in a region 
known to contain the Huntington disease (HD) gene. 
Huntington Disease: Review of the Mapping Literature. HD is an 
autosomal disorder characterized by progressive neurodegeneration 
(reviewed in 8). Outward characteristics of the disease include involuntary 
movements by all parts of the body, cognitive deterioration, and often severe 
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emotional disturbance. The degree of emotional disturbance is variable, but 
usually includes depression, irritability, apathy, and occasionally violent 
outbursts, hallucinations and delusions. Patients often develop dysarthria 
which impairs their speech to the point that they become mute. Patients lose 
short term memory and organizational abilities, but retain awareness of time, 
place, and recognition of their own identities and that of family and friends. 
They are often keenly aware of their intellectual failures. 
The biochemical basis of HD is not known, but the disease is 
characterized physiologically by genetically programmed cell death of specific 
neuron classes in the caudate nucleus and the basal ganglia (9, 10). Cell loss 
also occurs in the cortex, globus pallid us, hypothalamus, and cerebellum (8). 
Average age of onset is approximately 39 years, but cases of early (ages 2 
to 20) and late (ages greater than 60) onset are not uncommon (8). The disease 
manifests itself at a slow rate, showing symptoms for a period of 3 to 10 years 
before HD can be definitively diagnosed. The disease has an average duration 
of approximately 19 years before the death of the patient. Although 
invariably fatal, HD is the underlying rather than the immediate cause of 
death. The primary causes of death are aspiration-induced pneumonia, 
choking, heart failure, hematomas, or suicide. 
HD shows a classical pattern of autosomal dominant inheritance at a 
single locus, but also shows many unusual genetic characteristics. HD has a 
very low mutation rate. No cases of a new mutation have been documented, 
suggesting that the mutation arose only once in history and is possibly of 
European origin (8). A second unusual feature of HD is its inheritance as a 
autosomal dominant trait that exhibits full penetrance (11). Phenotypic 
characterization of a number of individuals likely to be homozygous for the 
mutation demonstrated no increase in the severity of the symptoms or age of 
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onset compared to heterozygotes for the disease (11, 12). This represents the 
first human disease that displays complete phenotypic dominance and is 
suggestive of a gain of function allele (11). 
An alternative hypothesis suggests that the HD gene is subject to 
dominant position-effect variegation (13). In this model a gene located close 
to a highly condensed heterochromatic region of the chromosome, such as 
the telomere, may become inactivated by the heterochomatic DNA due to 
chromosomal rearrangement, insertion, deletion or local region inactivation. 
The dominant effect comes from trans inactivation of the wild type allele. 
This pattern of inheritance has been demonstrated in the dominant 
Drosophilia mutation brown+ (14, 15). 
A third unusual feature of HD inheritance is the pattern of early onset. 
Individuals that display early onset typically inherit the HD mutation from 
the father rather than the mother (16), suggesting that the gene is subject to 
chromosomal imprinting (17, 18), possibly by an altered methylation state of 
the inherited DNA (19). It is not clear why paternal inheritance does not 
always lead to early onset, or why early onset is observed from maternal 
inheritance. 
Efforts to clone the HD gene have relied upon knowledge of its 
chromosomal location, because the nature of the gene responsible for HD is 
not known (Reviewed in 20-23). The first major breakthrough in the 
identification of the chromosomal location for HD came in 1983 (24). Gusella 
et al. identified a restriction length polymorphism (RFLP) in a single copy 
DNA clone (G8 or D4510) that showed significant linkage to HD. The clone 
mapped to chromosome 4 by blotting to a panel of human-mouse somatic cell 
hybrids. It was the first example of gene localization by RFLP mapping and 
suggested that the mutation would quickly be identified. 
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Linkage analysis with additional families confirmed the genetic 
proximity of D4510 and HD (25, 26). The maximum recombination frequency 
between D4510 and HD was determined by two and three point linkage 
analysis to be 0.04 (4 eM) (27). As a result of this low, but measurable rate of 
recombination no linkage disequilibrium was detected between HD and 
D4510 (27). Analysis also detected no evidence for locus heterogeneity, an 
indication that HD is most likely caused by a mutation within a single gene 
(27). 
The location of HD was narrowed further by analyzing chromosomes 
from patients with Wolf-Hirschhorn syndrome (WH5), a congenital 
abnormality involving heterozygous deletion of the short arm of 
chromosome 4 (28). DNA from several of these individuals was assayed for 
heterozygosity at any of the D4510 polymorphisms. All of the WH5 patients 
examined displayed homozygosity for each of the RFLP's in D4510, 
demonstrating that one copy of D4510 had been deleted. Analysis of the 
deletions in these patients placed the HD gene to the terminal band of the 
short arm of chromosome 4 (4pI6) (28). This assignment was confirmed by in 
situ hybridization (29,30). Multipoint linkage analysis with RFLP markers 
centromeric to D4510 demonstrated that the candidate region for the gene was 
confined to a small segment of DNA «5 Mb) flanked by D4510 and the 
telomere (31, 32). Unfortunately, several years of additional effort has failed 
to definitively localize HD to a single candidate region within this interval 
(23). 
Extensive effort was invested in isolating genetic markers in the 
candidate interval between D4510 and the telomere (33-49). These markers 
were used to create detailed physical (50) and genetic maps (51) (Fig. 4.1). In an 
effort to refine the candidate region for HD, RFLP linkage analysis was 
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performed using several of these markers (51). The design of this work was to 
identify cross over events between a flanking marker and HD so that the 
interval could be reduced. It was soon discovered that most of the families 
that showed recombination between D4S10 and HD failed to narrow the 
candidate region due to a hot spot for recombination immediately distal to 
D4S10 (52). 
1000 kb 
045113/114 045115 04590 
04510 045125 04595 04543 04598 045168 045111 045142/169 
4p Telomere 
Linkage Oisequilibrium 
Fig. 4.1. Physical map of interval from D4S10 to 4pter. The genetic 
markers are indicated along the map by D4S numbers. The thick black lines 
indicate the two candidate regions for the HD gene based upon genetic linkage 
analysis. Linkage disequilibrium has been reported between D4S95 and D4S98 
and HD, though it was not detected with D4S43. The scale of the map is 
indicated. 
Four recombination events outside the hot spot suggested conflicting 
locations for HD (51,53) (Fig. 4.2 and 4.3). In three recombinants, HD 
segregated with the marker alleles expected for the normal chromosome at 
D4S10 and at all informative distal markers (Fig. 4.2). The most telomeric 
informative marker for families 1 and 2 was D4S111, which maps 1100 kb 
from the telomere of 4p (50) (Fig. 4.2 A, B). Family 3 was also informative for 
D4S90 which maps to within 300 kb of the telomere (50) (Fig. 4.2 C). 
Interpretation of these families as single recombinants within the candidate 
interval placed the HD mutation telomeric to D4590, within a 300 kb interval 
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Fig. 4.2. Recombination events predicting a distal location for the HD gene (Taken 
from references 51 and 53). A. Family 1. Filled shapes represented HD affected 
individuals. The boxed alleles represent the chromosomes carrying the HD gene. The 
genotype (indicated in brackets) of the affected parent was reconstructed from the progeny 
shown, and several additional unaffected sibs. Progeny II-3, indicated by an asterisk, 
reveals a recombination event in which all four marker loci segregate from the HD gene. B. 
Family 2. Graphical representation as in A Individual m-3, marked by an asterisk, does 
not possess alleles for any of the marker loci characteristic of the HD chromosome, 
indicating recombination between the defect and all four DNA loci. Since neither of the 
children of m·3 are symptomatic, it is not possible to establish which chromosome now 
carries the HD gene. The presumed recombination event could potentially have occurred 
during meiosis in individuals 1·1, II·t, or II-3. C. Graphical representation as in A HD 
haplotype in this family is BBA. Affected individual m-l is a recombinant between the loci 
04510, D4595, and possibily between O4S90 and the HD gene. 
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Fig. 4.3. Recombination events predicting an internal location for the 
HD gene (Taken from references 47, 51 and 61). A. Family 4. Affected 
individuals in the family are depicted as black shapes. Alleles for all 
informative markers are shown for each chromosome. The solid bar 
indicates marker alleles characteristic of the HD chromosome in this pedigree. 
Individual II-2 (marked by an asterisk) reveals a recombination event 
between D45113 and D45115 in which the distal markers segregate from the 
genetic defect. B. Family 5. HD family displaying recombination event 
between D45115 and D45168. The haplotype traveling consistently with HD is 
boxed. The recombination event occurred during meiosis in individual II-3 
and has been passed to affected individuals III-4, IV-5, IV-6, and IV-7. 
Additional high risk individuals are not yet symptomatic. The telomeric 
markers segregated from HD in this recombination. 
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D4510 D4S43 D45114 D45111 
Family 1 I 
04510 O4S43 D45113 045111 
Family 2 I 
D4510 D4595 D4590 
Family 3 
D45168 D4590 
D4510 D4595D4S43 D45113 1 D45115 D45111 I D45142 
Family 4 I I 
, I 
I 
D4510 D45125 D45168 D45115 D45111 
II 
Family 5 
Fig. 4.4. Possible locations for HD based upon five families displaying 
recombination events informative for this region. Predictions are based on a 
single recombination event for each recombinant. Hatched boxes correspond to 
regions whose genotype is unknown. Gray boxes represent regions known or 
thought to originate from the HD chromosome. Interpretation of each family 
as a single recombination event predicts two nonoverlapping candidate 
regions. The conflicting candidate locations could be the result of a double 
crossover or gene conversion event in a subset of the families. 
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(Fig. 4.4). However, in family 4, HD segregated with the HD allele at D4510, 
and with wild type alleles at telomeric markers D45111 and D4590 (51). The 
most proximal informative marker inherited with the wild type allele was 
D45168, which restricts the point of recombination to a 150 kb interval 
between D45168 and D45113 (47) (Pig. 4.3 A). If interpreted as a single 
recombination event, this family places HD in an interval more than 1 Mb 
internal from the telomere (50) (Fig. 4.4). This family could be brought into 
agreement with the other three by postulation of a highly telomeric second 
recombination event. Using this interpretation of the data, efforts were made 
to clone the 4p telomere (54, 55). 
The telomeric location of the gene was placed in serious doubt when 
yeast artificial chromosomes containing DNA spanning the region from 
D4590 were analyzed (54, 55). The region contained very few genes and no 
detectable rearrangements associated with the disease. The telomere did not 
differ in size or structure between HD and normal individuals. Analysis of a 
polymorphism within 100 kb of the telomere failed to detect recombination 
in the first three families, and the postulated second recombination event in 
family 4 was not observed (54). A telomeric location became increasingly 
doubtful when human chromosomes were shown to contain homologous 
telomeric sequences which were polymorphic in length, suggestive of 
telomeric exchange (56). A highly telomeric location might be susceptible to 
chromosomal exchange, a phenomena inconsistent with tight linkage to 
4p16. The final argument against a telomeric location was the observation of 
linkage disequilibrium between two markers (D4595 and D4598) located in 
the internal candidate region (57-59). Linkage disequilibrium was not 
observed be~een HD and the telomeric marker D4590. This suggests that the 
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normal haplotypes associated with HD in the first three families might have 
resulted from a narrow double crossover or gene conversion. 
The internal candidate region was further characterized to define the 
maximum candidate interval for HD (47, 60). Family 4 defined the distal 
boundary as being between 045113 and D45168 (47). Only a single family had 
been reported to carry a recombination event between D4510 and HD that was 
distal to D4595 but proximal to D4590 (44). 5uch a recombinant would define 
the lower boundary for the internal candidate region. Unfortunately, the 
recombinant had been originally mistyped for D4595 and the recombination 
was actually in the D4510 recombination hot spot. An additional 
recombination event was recently identified that supports, but does not 
narrow, the assignment of HD to the internal candidate region (61) (Fig. 4.3 B, 
Fig. 4.4). Thus, the boundaries for the internal HD candidate region remain 
D4510 and D45168, a 2.5 Mb interval containing no known recombinants (60). 
A complete analysis of linkage disequilibrium in the candidate region 
demonstrated the intractability of the HD mapping problem (61). Whereas 
cloning of the cystic fibrosis gene was assisted by identification of significant 
linkage disequilibrium (62), no continuous increase in linkage disequilibrium 
was detected across the HD candidate region, nor was a region of extreme 
disequilibrium identified (61). While disequilibrium was detected at D4598 
and D4595 using a subset of RFLP's, disequilibrium was not consistently 
observed with closely spaced RFLP's in these loci (61). 
The diversity of HD haplotypes suggest that simple recombination 
following a single original HD mutation cannot readily explain the modern 
pool of HD chromosomes (61). Possible explanations for the complex pattern 
of disequilibrium in the candidate region are: (i) none of the markers are 
sufficiently close to HD to display extreme disequilibrium, (ii) two or more 
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original and independent HD mutations in different primordial haplotypes 
now represent a significant portion of the HD gene pool, and/or (iii) a single 
HD mutation has been transferred to a different background haplotype by a 
high rate of double recombination or gene conversion (61). 
The failure to define the HD locus by genetic linkage or disequilibrium 
dictates the need for alternative strategies capable of identifying physical 
alterations in the DNA. These efforts now include saturation of the candidate 
region with potential transcripts, searches for physical rearrangements, and 
the plans for large-scale genomic sequencing. Isolation of DNA from the 
candidate regions of HD affected and normal chromosomes could provide a 
means to physically identify the HD mutation. The well characterized nature 
of the 4p16.3 region makes it an ideal test case for enzymatic cleavage of 
human genomic DNA mediated by triple helix formation. 
This chapter describes the site specific cleavage of human chromosome 
4 at the genetic marker D4510 to liberate a 3.6 Mb fragment containing both 
the proximal and distal candidate regions. It outlines several procedures for 
screening unsequenced genetic markers for triple helix target sites 
overlapping methylase/endonuclease sequences. It describes the application 
of these strategies to the identification of a target site within D4510 and the 
subsequent characterization and cleavage of that site within plasmid, yeast, 
and human genomic DNA. Finally, it describes efforts to make a flanking cut 
on chromosome 4 at a marker likely to be distal to the HD gene. These 
techniques are readily generalizable to any genetic marker for the orchestrated 
cleavage of the human genome into megabase sized fragments readily 
manipulated by standard procedures of molecular biology. 
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Part I 
Identification of Triple Helix Target Sites 
Within Unsequenced Genetic Markers 
The insertion of a triple helix target site by genetic engineering or 
homologous recombination was a relatively straightforward procedure when 
targeting plasmid, bacteriophage Aor yeast genomic DNA (1-3). Target site 
insertion into a predetermined genetic locus in a human chromosome is 
sufficiently difficult to make it highly undesirable. Selection for 
recombinants is complex and insertion is infrequent due to the low rate of 
recombination in mammalian cells (63, 64). Additionally, it would be 
necessary to insert a target site into each of two genetic markers for cleavage to 
liberate a product resolvable by pulsed field gel electrophoresis. Considering 
the difficulty of target site construction, the ability to target endogenous 
sequences in genomic DNA would be very advantageous. The triple helix 
motif is sufficiently generalizable that it should obviate the need for target site 
insertion, however some sequence information is necessary to specifically 
target sites in genetic markers. 
Although a large number of genetic markers are available for each 
human chromosome, the DNA sequence generally remains undetermined. 
Typically a short 500-1000 bp segment has been sequenced for use as a 
sequence tagged site (STS) using the polymerase chain reaction (PCR). The 
time necessary to completely sequence large segments of cloned genomic 
DNA has been steadily reduced, yet it would be desirable to screen cloned 
genetic markers for homopurine target sites that overlap methylase-
endonuclease sequences in a directed manner with minimal sequencing 
effort. 
1. Complete Sequence Determination 
Computer search to indentify target sites 
i 
Sequence 
i 
Subclone into sequencing vector 
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2. Sequence Determination Adjacent 
to Restriction Enzyme Sites. 
Examine sequence information 
for targetable sites 
i 
Sequence at ligation junction 
i 
Ligate into sequencing vector 
i 
Cut with a restriction enzyme 
compatible with enzymatic cleavage 
COS mid DNA 
(Genetic Marker) 
3. PeR Amplification of Target Sites 
Subclone cosmid into small 
insert libraries 
.j. 
PCR amplify library with vector and 
homopurine/methylase specific primers 
.j. 
Determine sequence immediately 
adjacent to the homopurine primer 
binding site 
.j. 
Design sequencing primer and 
determine sequence of target site 
4. Triple Helix Formation with . 
Degenera te Pyrimidine Oligonucleotides 
Form triplex with degenerate 
oligonucleotides/methylate 
.j. 
Disrupt triplex, inactivate methylase 
.j. 
Cut with cognate endonuclease 
.j. 
Resolve products and subclone 
.j. 
Sequence adjacent to cut ends 
Fig. 4.5. Strategies for detecting triple helix binding sites that overlap methylase-
restriction enzyme sequences. 
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Strategies for Detection of Target Sites. A number strategies to identify 
triple helix binding sites that overlap a methylase recognition site could be 
imagined (Fig. 4.5), including: (i) complete sequence determination and target 
site identification by a computer search, (ii) partial sequencing of DNA from a 
restriction enzyme library to determine the sequences immediately adjacent 
to all the sites of a given restriction enzyme, (iii) PCR amplification using 
partially degenerate primers specific to homopurine sequences overlapping a 
restriction enzyme site, and/or (iv) enzymatic cleavage of cosmid DNA 
mediated by triple helix formation with partially degenerate pyrimidine 
oligonucleotides. Each strategy has its particular strengths and weaknesses, 
but each has proven useful for identifying target sites for enzymatic cleavage 
mediated by triple helix formation. 
Complete sequence determination is easily the most laborious 
technique for target site identification, but the resulting sequence information 
can be rigorously searched for the binding sequences of all triple helix motifs 
and any overlap of these sequences with a methylase recognition site. A 
computer search can be conducted to identify sites with mismatches, 
crossovers, poly-G runs, etc. adjacent to any methylation site, both those 
commercially available and those that would require purification. Although 
this is the least imaginative strategy and the most labor intensive, it would 
identify all target sites within a genetic marker. 
A more selective sequencing effort involves the creation of a library for 
a specific restriction enzyme. All the sequences immediately adjacent to that 
restriction enzyme site could be determined by sequencing from vector 
specific primers. If a homopurine target site was not identified among the 
sequences for a particular enzyme, a library could be constructed with a 
second restriction enzyme, and the process repeated. Although this is a 
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straightforward procedure capable of identifying a wide variety of target sites, 
it is limited by the number of libraries that are constructed and fully analyzed, 
and the inability to conveniently make a continuous sequence determination 
on both sides of each restriction site. This reduces the utility of alternate 
strand triple helix formation when examining the sequence data. Despite 
these limitations, this strategy successfully identified two target sites flanking 
the Ewings sarcoma locus on chromosome 22 (65). 
The PCR assay is a rapid technique for the detection of target sites (66, 
67). In this approach at least two libraries are constructed from the genetic 
marker using unrelated restriction enzymes. Pooled plasmid DNA purified 
from the transformation culture is used as a template for the PCR using a 
vector primer and a partially degenerate primer for amplification. The 
degenerate primer is designed with a 3' end specific for the sequence of the 
methylase being targeted, an internal degenerate segment to hybridize to a 
wide variety of homopurine sequences, and a 5' anchor to improve 
amplification yield and serve as a primer site for subsequent sequence 
determination. Analysis with this system can be used to detect overlap with 
any sequence of interest, including those recognized by methylases not 
commercially available. It can also be used to detect homopurine sequences 
targetable by affinity cleaving that do not overlap a methylation site. 
Although target detection is rapid, identification of the target sequence 
is more difficult. The PCR product can not be directly used for target site 
sequence determination because the target site is directly hybridized by the 
degenerate oligonucleotide resulting in loss of the original sequence 
information during amplification. Instead, the target sequence can be 
determined by sequencing the internal portion of the amplification product 
by priming at the anchor, synthesizing a second primer complementary to a 
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sequence distal to the degenerate region, and sequencing back to the target site 
on the original cosmid clone. 
A procedure of high fidelity that enables rapid analysis of a number of 
enzyme systems utilizes partially degenerate oligonucleotides for triple helix 
formation followed by enzymatic methylation and cleavage (4, 68-70). The 
oligonucleotides contain two domains, a pyrimidine degenerate domain 
designed to bind to a wide variety of homopurine and mixed sequences, and a 
nondegenerate domain designed to overlap a restriction enzyme site. If a 
cleavage product is observed after methylation and restriction enzyme 
digestion, it indicates that a site bound by a fraction of the degenerate 
oligonucleotide mixture overlapped an enzyme recognition site. The 
sequence can be identified by subcloning the cleavage products, and 
sequencing immediately adjacent to the ligation site. The technique is 
limited to searches with methylases that are readily available. This procedure 
was used to identify the target site within D4S10 on human chromosome 4. 
Partial Sequence Determination of D4SlO. D4SlO was the first genetic 
marker linked to a human disease by RFLP analysis (24). It maps to 4p16.3 
and is approximately 4 Mb from the telomere (50). It is known to be proximal 
to the Huntington disease locus, but does not show linkage disequilibrium 
with the disease (24, 27). Cosmid clone 8Cl0I5, a 38 kb insert into the 8.1 kb 
pWE15 cosmid vector, contains the majority of the D4S10 locus, and was used 
for target site identification. Three STS's were previously identified within 
this region for RFLP analysis (71), but a computer search of this sequence 
(approximately 600 bp) did not identify a target site. 
The cosmid was partially sequenced by shotgun cloning to generate 
approximately 5.0 kb of noncontinuous sequence information. A computer 
search identified a number of homopurine target sites that were subsequently 
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targeted by affinity cleaving with oligonucleotides containing EDTAeFe(II), 
but the background cleavage was so extensive that all the chromosomes were 
degraded into megabase sized fragments and further studies of affinity 
cleaving on human chromosomal DNA were not pursued. No triple helix 
target sites that overlapped a methylase/endonuclease site were identified 
within the sequence. 
Although sequencing of 8C10I5 could have been pursued more 
extensively, it became evident that a more directed approach to target site 
identification was needed. Two strategies were employed for target site 
identification within 8C10I5: (i) PCR amplification using partially degenerate 
oligonucleotides as primers and a pool of 8C10I5 subclones as template, and 
(ii) enzymatic cleavage mediated by partially degenerate pyrimidine 
oligonucleotides for triple helix formation. The fidelity of each technique was 
initially tested on the pUCLEU2 series of plasmids. 
Detection of Triple Helix Target Sites by peR. Partially degenerate 
oligonucleotide primers were synthesized containing three domains (Fig. 4.6). 
The primers were designed to detect triple helix sites overlapping TaqI, AluI, 
HaeIII, dam, EcoRI, and MspI methylation sites. An additional primer specific 
for general homopurine sequences was also designed. For restriction 
enzymes with 5'-pyrimidine half sites (TaqI, MspI and the general 
homopurine .oligonucleotide), the second domain was degenerate in C and T, 
while for enzymes with 5'-purine half sites (AluI, HaeIII, dam, and EcoRI) the 
second domain was degenerate in A and G. 
As an initial demonstration of the ability of this procedure to identify 
the desired class of sequences, PCR amplification was performed on plasmids 
pUCLEU2, pUCLEU2A, and pUCLEU2B. The later two plasmids each contain 
a homopurine sequence at a defined location, but have different restriction 
5'-
Name 
ECO-TAG 
ALU-TAG 
DAM-TAG 
HAE-TAG 
TAQ-TAG 
MSP-TAG 
PYR-TAG 
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Anchor 
20bp 
Degenerate 
A/GorC/T 
15-17bp 
Sequence 
Enzyme 
Sequence 
4or6bp 
5,-1 TACATGCCAATGACGACTGC H (R)15 H GAATTC 1-3' 
5,-1 TACATGCCAATGACGACTGC H (R)16 H AGCT 1-3' 
5,-1 TACATGCCAATGACGACTGC H (R)16 H GATC 1-3' 
5,-1 TACATGCCAATGACGACTGC H (R)16 H GGCC 1-3' 
5,-1 TACATGCCAATGACGACTGC H (Y)16 HTCGA 1-3' 
5,-1 TACATGCCAATGACGACTGC H (Y)16 H CCGG 1-3' 
5,-1 TACATGCCAATGACGACTGC H (Y)17 ~-PD 
Fig. 4.6. Sequences of oligonucleotide primers used for the detection of 
homopurine sequences overlapping restriction enzyme sites by PCR. The 
primers contain three domains: (i) a 3' sequence complementary to the restriction 
enzyme (gray), (ii) a purine or pyrimidine degenerate domain (white), and (iii) a 
sequence tag at the 5' end for subsequent sequence identification (strip). R 
represents 50% each of A and G, and Y represents 50% each of C and T. 
LEUPCR 
~ 
LEUPCR 
~ 1070 bp 
LEUPCR 
~ 1070bp 
EcoRI 
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TAQ-TAG 
~ 
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ECO-TAG 
760bp 
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~ 
~ 760bp 
DAM-TAG 
XhoI 
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UP1200 
pUCLEU2 
(6.6 kb) 
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Fig.4.7. Orientation of the PCR primers at the predicted hybridization sites on the 
pUCLEU2 plasmid series. The point of the arrow below each primer indicates the 3' end 
of the oligonucleotide. The distance between the primer hybridization sites is indicated in 
base pairs. Primer PYR-TAG (not shown) is oriented in the same direction as TAQ-TAG 
and MSP-TAG and is predicted to amplify a 760 bp product from both pUCLEU2A and B. 
Primers ALU-TAG and HAE-TAG (not shown) are not predicted to have amplification 
products within the region of the inserted duplex. The primer sequences are indicated in 
Fig. 4.3 and in Appendix A. 
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enzyme sites at the 5' and 3' ends of the oligonucleotide binding site (Fig. 4.7). 
The plasmids served as ideal substrates for determining the ability of the assay 
to correctly distinguish general homopurine sites from the narrower class of 
sites targetable by enzymatic cleavage. Because of the orientation of the 
homopurine sequences in the pUCLEU2 plasmids, the second primer used for 
purine degenerate oligonucleotides was LEUPCR, a primer from the LEU2 
gene with the 3' end oriented toward the XhoI site (Fig. 4.7). Amplification 
with pyrimidine degenerate primers was performed with UP1200, a pUC19 
universal primer that also had its 3' end oriented toward the XhoI site (Fig. 
4.7). In this trial study, sequence assignments were not determined from the 
amplification products. Instead, the size of the product was used to determine 
the site of primer hybridization and the sequence assigned from the known 
sequence of pUCLEU2. If degenerate oligonucleotide hybridization to the 
XhoI duplex insert lead to amplification, priming by LEUPCR was expected to 
generate a 1070 bp product, while priming by UP1200 should produce a 780 bp 
fragment (Fig. 4.7). 
PCR amplification using the EcoRI specific oligonucleotide, ECO-TAG, 
and LEUPCR as primers with 1 ng of either of the three plasmids as template, 
demonstrated the strength of this technique (Fig. 4.8 A). No amplification 
was detected in the absence of template or in the presence of either the parent 
plasmid or a plasmid with a BamHI site instead of EcoRI to the 5' end of the 
homopurine sequence (lanes 1, 2 and 4). In the presence of pUCLEU2A, a 
plasmid with a 24 bp homopurine sequence overlapping an EcoRI site, a 
single 1070 bp fragment was detected in good yield (lane 3). No products of 
other sizes were observed suggesting that the reaction had high specificity for 
the desired sequence. 
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Fig. 4.8. PCR amplification of the pUCLEU2 plasmid series using a 
partially degenerate primer specific for a single methylase recognition 
sequence and either UP1200 or LEUPCR primers. All amplification reactions 
were performed in 10 mM tris-HCl, pH 8.3 (at 25° C), 50 mM KCI, 1.5 mM 
MgCI2, 0.001 % (w Iv) gelatin, 200 11M of each dNTP, 2 11M in each 
oligonucleotide primer, and 2.5 units of Taq DNA polymerase in 100 III total 
volume using 1 ng of plasmid DNA as template. Temperatures cycles were 
94° C 1.0 min., 2.0 min. at an annealing temperature dependent upon 
degenerate primer, and 72° C for 3.0 min. for 30 cycles. A. Amplification with 
ECD-TAG and LEUPCR with annealing temperature of 65° C. B. 
Amplification with TAQ-TAG and UP1200 at annealing temperature of 65° C. 
C. Amplification with DAM-TAG and LEUPCR annealed at 60° C. D. 
Amplification with MSP-TAG and UP1200 with annealing temperature of 65° 
C. E. Amplification with ALU-TAG and LEUPCR with annealing 
temperature of 65° C. F. Amplification with HAE-TAG and LEUPCR 
annealed at 65° C. G and H. Amplification with PYR-TAG and UP1200 at 
annealing temperatures of 60° C and 40° C, respectively. 
A. EcoRI B. TaqI 
{ ECO-TAG + + + + { TAQ-TAG + + + + Primers Primers 
LEUPCR + + + + UP1200 + + + + 
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High fidelity amplification was also detected with other primers, but 
the specificity of amplification for some primers was imperfect. A pattern 
similar to EcoRI was detected with a TaqI specific primer (Fig. 4.8 B). A 780 bp 
amplification product was only detected from plasmid pUCLEU2A (lane 7). 
The dam primer showed a major 1070 bp amplification product when 
pUCLEU2B was used as template (Fig. 4.8 C, lane 11), but with either of the 
other plasmids three minor products were detected with sizes of 400, 650, and 
2000 bp (lane 9, 10). Unfortunately, none of these minor sites contained a 
complete dam sequence. 
The MspI degenerate primer was the least specific of the primers tested 
(Fig. 4.8 D). It amplified the insert site from pUCLEU2B (lane 15), but also 
weakly amplified pUCLEU2A (lane 14). Plasmid pUCLEU2B contained an 
MspI site (5'-CCGG-3') overlapping a homopurine sequence, but the 
homopurine sequence in pUCLEU2A contained a 5' end that was significantly 
different than an MspI site (5'-TCGA-3'). This raised serious concerns about 
the fidelity of the MspI primers for target site identification. 
No designed target site was present for the AluI and HaeIII primers. As 
expected, no significant amplification was detected with AluI using LEUPCR 
as the second primer (Fig. 4.8 E). The HaeIII primer also showed no 
amplification at the duplex insertion site, but interestingly it showed a major 
650 bp product in all three plasmids (Fig. 4.8 F, lanes 21, 22, and 23). The 
sequence 630 bp from the LEUPCR primer (20 bp of sequence was added by the 
anchor region in the degenerate primer) contained a complete HaeIII site 
overlapping a 18 bp homopurine sequence interrupted by a single T (5'-
AAAAGGAAAGGTGAGAGGCC-3'). Two other minor amplification 
products were also detected, but neither of these products corresponded to a 
sequence with a complete HaeIII site. 
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PCR reactions were also performed using a primer specific for general 
homopurine sequences, i.e., no methylation site was specified. Amplification 
at 60° C showed a 780 bp product with both the pUCLEU2A and B plasmid 
templates, consistent with general amplification of homopurine sequences 
(Fig. 4.8 G, lanes 25 and 26). Reducing the annealing temperature to 40° C 
resulted in amplification of two other products, 1200 and 2700 bp in size, in all 
three plasmids (Fig. 4.8 H, lanes 27-29). A sequence search approximately 1200 
and 2700 bp from the UP1200 primer revealed an extensive homopurine 
sequence at each map position. The sequences 5'-AGAAAAAGGAA-
AGGTGAGAG-3' and 5'-AAGAAGGAGAAAAAGGAGGA-3' were detected 
1250 and 2696 bp from UP1200, respectively. This was a highly encouraging 
result, as it rapidly identified the major homopurine sequences near the 
nondegenerate primer. 
While the general level of fidelity was good for each primer, some 
amplification of incorrect sequences was detected. Although easily 
disregarded in this study, incorrect amplification would severely complicate 
identification of target sites if an unsequenced template were used for 
amplification. Considering the effort required to identify the homopurine 
sequence from amplification products, this low level of improper 
amplification could make the technique counterproductive. Additionally, 
the high temperature of oligonucleotide hybridization necessary to achieve 
good fidelity of sequence differentiation would favor sequences with a high 
GC content. Because such sequences are not readily targeted by triple helix 
formation, the assay could miss the sites best suited for cleavage. 
Nevertheless, experiments were conducted to identify a target site within 
D4510 using this technique. 
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Vetection of a Homopurine Target Site in D4S10 using PCR 
Amplification. The PCR was used to search cosmid clone 8C10I5 for target 
sites. Six libraries of 8ClOI5 were constructed by single and double digestion 
with HindlII, Pst!, and EcoR!, followed by ligation into pUC19 linearized with 
the appropriate enzyme(s), and transformation to recover the correct ligation 
products. Total plasmid DNA from the transformation culture was isolated 
and used as template in the PCR reaction. 
Amplification reactions were individually performed using degenerate 
primers specific for six restriction enzymes, and either of the universal 
primers from the pUC19 vector arms (UP1200 or UP1201). Reactions were 
performed on both the Pst! and HindlII libraries to improve coverage of the 
cosmid in case a target site should be too distant from a ligation site or 
incorrectly oriented within a given restriction fragment. Bands common to 
both libraries facilitated the identification of products likely resulting from 
amplification of the recircularized vector. 
No amplification was detected using EcoR!, dam, TaqI, and Hpall 
specific primers (Fig. 4.9). However, at least one discrete amplification 
product was detected in each reaction with the Alul and HaelII primers (lanes 
5-8 and 21-24). AluI amplification had proceeded with good fidelity in the 
trial studies suggesting that the products should be the result of amplification 
from a target site. The fidelity of the HaeIII primer was suspect in trial 
studies, and though the amplification was encouraging, it had to be 
considered with some skepticism. Amplification of different sized products 
was also detected in the other four libraries, consistent with the presence of a 
target site for both AluI and HaeIII. 
Attempts to identify the sequence recognized by the degenerate 
oligonucleotides were unsuccessful. This included direct sequencing of the 
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Fig. 4.9. Amplification of total 8C10I5 library DNA with a universal 
primer and a partially degenerate oligonucleotide specific for the recognition 
sequence of a single methylase. All amplification reactions were performed 
in 10 mM tris-HC!, pH 8.3 (at 25° C), 50 mM KC1, 1.5 mM MgC12, 0.001 % (w Iv) 
gelatin, 200 11M of each dNTP, 2 11M in each oligonucleotide primer, and 2.5 
units of Taq DNA polymerase in 100 III total volume using 10 ng of plasmid 
DNA as template. Temperatures cycles were 94° C 1.0 min., 60° C 2.0 min., 
and 72° C for 3.0 min. for 30 cycles. Appearance of amplification products 
suggestive of the presence of a homopurine sequence overlapping the 
methylation site. 
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{ PSt! library + - + - + - + - + - + -Templates 
HindIII library - + - + - + - + - + - + 
EeO-TAG + + + + 
ALU-TAG + + + + 
Primers DAM-TAG + + + + 
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1 2 3 4 5 6 7 8 9 1011 12 
{ Pst! library + - + - + - + - + - + -Templates 
HindIII Library + - + - + - + - + - + 
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MSP-TAG + + + + 
Primers HAE-TAG + + + + 
UP1200 + + - - + + - + + -
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purified PCR products (72) and sequencing from templates prepared by 
asymmetric PCR (73). No interpretable sequence information was obtained 
from these experiments. It should be possible, however, to access the 
sequence from the PCR products if additional effort was invested in PCR 
sequencing. 
Detection of Target Sites by Triple Helix Formation with Degenerate 
Oligonucleotides . Potential infidelity of the PCR assay combined with the 
difficulties involved in determining the sequence of the target site indicated 
that development of another procedure would be valuable. A possible 
strategy of potentially high fidelity involved enzymatic cleavage mediated by 
degenerate pyrimidine oligonucleotide directed triple helix formation (Fig. 
4.10). If a cleavage product was observed in this technique, it represented a 
site protectable by triple helix formation and cleavable by the restriction 
enzyme, the two essential criterion of the target site. Although the cleavage 
yield was not expected to be high using degenerate oligonucleotides, the 
products could be directly subcloned to determine the sequence of the target 
site. 
Partially degenerate oligonucleotides were designed with two domains: 
a nondegenerate domain two to three bases in length specific for the sequence 
recognized by a single methylase, and a 16 base degenerate domain specific for 
a wide class of homopurine and mixed sequences (Fig. 4.11). Nucleotide 
analogs and degenerate ratios were carefully chosen to optimize target site 
recognition and cleavage efficiency. Mec and Bru base analogs were chosen 
because Mec substituted oligonucleotides have higher binding affinities and 
BrU substitution results in oligonucleotides with reduced binding specificity 
(3,4,74). 
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Fig. 4.10. General scheme for identification of sequences targetable by triple helix 
mediated enzymatic cleavage. Linearlized cosmid DNA is equilibrated with a partially 
degenerate oligonucleotide containing a nondegenerate end specific for a single 
methylation site. The DNA is methylated to completion, modifying the DNA such that 
all sites not bound by the oligonucleotide are resistant to subsequent restriction enzyme 
digestion. The methylase is removed by phenol extraction, the DNA ethanol 
precipitated, and the triple helix disrupted by resuspending in a high pH restriction 
enzyme buffer. The appearance of a cleavage product upon restriction enzyme digestion 
demonstrated that a site bound by a fraction of the oligonucleotide mixture overlaps a 
methylation site. Subcloning of the cut ends and sequencing of the resulting ligation 
junction identifies the sequence of the target site. Using this sequence information and 
the general rules of oligonucleotide directed recognition of duplex DNA, an 
oligonucleotide specific for the target site can be designed. The process is repeated with 
several different enzyme combinations until a cleavage product is detected and a target 
site identified. 
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Degenerate Domain 
Oligonucleotide Sequence 
S'- Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y T Mec -3' 
S'- yyyyyy yyyyy y yy y y MeC T -3' 
S'- Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y MeC T T -3' 
S'- yyyyyyyyyyyyyyyyMec MeC-3' 
S'- Moe Moe Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y -3' 
S'- Moe T Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y -3' 
y = 60% BrU and 40% MeC 
Methylase 
Specific 
Domain 
Oligonucleotide Methylase 
Name Sequence 
Alu-Me S'-AGCT-3' 
dam-Me S'-GATC-3' 
Eco-Me S'-GAATTC-3' 
Hae-Me S'-GGCC-3' 
Msp-Me S'-CCGG-3' 
Taq-Me S'-TCGA-3' 
Fig, 4,11. (Above) Schematic of the degenerate and methylase specific 
domains comprising the oligonucleotides used in the enzymatic sequence search. 
(Below) Sequence listings of oligonucleotides specific for various methylases. Y 
represents a nucleotide ratio of 60% Bru and 40% Mec at the indicated base 
positions. 
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Sequences with high G content or contiguous G tracts are not efficiently 
targeted by the pyrimidine triple helix motif near neutral pH (1, 74). To 
minimize the concentration of oligonucleotides in the population specific for 
such sequences, a nucleotide ratio of 60% Bru and 40% Mec was used at each 
degenerate position. This was done to reduce the concentration of 
oligonucleotides in the mixture that were incapable of binding. The result 
was a pool of 65,536 unique sequences unequally represented in the 
population (Fig. 4.12 A). At this nucleotide ratio, 85% of the molecules in the 
pool had a Bru/MeC base ratio of 50% or higher. At 10 11M total 
oligonucleotide, the (BrUh6 sequence had the highest concentration at 3 nM, 
and the (MeCh6 sequence had the lowest at 4 pM. The oligonucleotide 
composition with the highest total concentration were sequences with an 
overall base content of (Bru)lO(MeC)6 at 2 11M or 0.25 nM in each sequence (Fig. 
4.12 B). 
The detection of imperfectly matched homopurine or mixed sequences 
was further improved by performing the triplex and methylation reactions at 
slightly acidic pH (I -4). This increased the fraction of oligonucleotides that 
were capable of binding a target site, bringing the effective binding 
concentration of the oligonucleotide to a level where a cleavage signal could 
be detected. 
Reactions were initially performed using a partially degenerate 
oligonucleotide specific for EcoR! methylase on plasmid pUCLEU2A. While 
it was known that triple helix formation can mediate cleavage at the 
pUCLEU2A target site, it was not known if detectable cleavage could be 
achieved using a degenerate oligonucleotide. Linearized plasmid pUCLEU2A 
DNA (3 nM) was incubated with a partially degenerate oligonucleotide 
(10ILM) specific for EcoR! in the presence of polycation to facilitate triple helix 
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Fig. 4.12. A. Oligonucleotide concentration of individual sequences as a function 
of base composition. An equal ratio of MeC to BrU in the phosphoramidite mixture would 
have resulted in an equal concentration of all oligonucleotides in the solution. The 60% 
B'O and 40% Mec ratio resulted in higher concentrations for oligonucleotides 
predominantly containing BrU. The (B'O)16 oligonucleotide was most concentrated, and 
the (MeC)16 oligonucleotide was the least concentrated. B. Oligonucleotide 
concentrations of the general seqeunce class (B'O)N(MeC)16_N as a function of base 
composition. An equal ratio of Mec to B'O in the phosphoramidite mixture would have 
generated a concentration distribution with a maxima at (BrU)s(Mec)s. This would have 
meant that more than half the oligonucleotide concentration would have had a base 
composition of 50% Mec or greater. The 60/40 ratio used in the synthesis of these 
oligonucleotides resulted in a concentration distribution in which 85% of the 
oligonucleotides have a base composition of 50% BrU or greater. Because G rich target 
sites are not readily bound by pyrimidine oligonucleotides, this ratio increases the 
oligonucleotide concentration capable of binding potential target sites. 
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formation. The DNA was methylated to completion with EcoRI methylase 
and digested with EcoRI restriction enzyme following methylase inactivation 
and triplex disruption. Reactions containing a nondegenerate MecBru 
oligonucleotide with no specificity for the target site were also performed as a 
control against general methylase inhibition. 
The degenerate oligonucleotide was able to mediate the site specific 
cleavage of pUCLEU2A at the desired target site with an efficiency 
approaching 20% at pH 6.6 (Fig. 4.13, lane 1). The efficiency increased 
inversely with the pH of the reaction mixture, as expected considering the pH 
sensitivity of triple helix formation (lanes 1-3). Very little cleavage was 
observed at pH 7.4 (lane 3). Unmethylated DNA was cut to completion 
indicating that the triplex had been efficiently disrupted (lane 4). No cleavage 
was detected using the nonspecific oligonucleotide at any pH (lanes 5-7), 
confirming that the cleavage was not due to nonspecific methylase inhibition 
by the modified oligonucleotide. 
The relative ratios of target site to oligonucleotide suggest that the 
oligonucleotide modifications and low pH were essential to detection of this 
site. At 10 J.1M total oligonucleotide, the concentration specific for the 
pUCLEU2A target site was 0.8 nM. This would produce a maximum cleavage 
yield of 28% if every oligonucleotide were bound to its target site. However, 
an oligonucleotide specific for this target site showed a pH stability up to pH 
7.8, and 0.8 nM was about a factor of ten below the dissociation concentration 
reported for triple helix formation to a similar sequence (75). The fact that 
little cleavage was seen even at pH 7.4 suggested that the target site was being 
protected by oligonucleotides with only partial sequence identity, and that this 
was essential for efficient signal detection. 
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Fig. 4.13. Site specific cleavage of plasmid pUCLEU2A using a partially 
degenerate oligonucleotide specific for EcoRI methylase. A. Sequence of 
oligonucleotides Eco-Me and JH-21. Y indicates a ratio of 60% Bru and 40% 
Mec at each indicated position. B. Map of plasmid pUCLEU2A showing the 
HindUI site used to linearize the plasmid, and the three EcoRI sites. The 
sequence of the target site is shown as an insert above the plasmid. It contains 
an EcoRI site overlapping the 24 bp homopurine sequence. C. Enzymatic 
cleavage of plasmid DNA at the target site mediated Eco-Me oligonucleotide. 
Plasmid pUCLEU2A (250 ng) was linearized with HindIII and incubated with 
10 JlM oligonucleotide Eco-Me in 2 mM spermine, 100 mM NaCI, 100 mM 
tris-HCl, pH 6.6-7.4,10 mM EDTA for 12-14 hours at 22° C. S-adenosyl 
methionine (160 JlM), BSA (100 Jlg/ml) and EcoRI methylase (40 units) were 
added to the reaction (final volume 20 J.1l) and incubated at 22° for 9.5 hours. 
The DNA was phenol extracted, ethanol precipitated, 70% ethanol washed, 
dried, and resuspended in EcoRI restriction enzyme buffer containing 100 
mM potassium glutamate, 25 mM tris-acetate pH 9.5, 10 mM magnesium 
acetate, 50 Jlg/ml BSA, 1 mM 2-mercaptoethanol, and 20 units EcoRI 
restriction enzyme. Digested the DNA to completion at 37° C for one hour. 
Resolved products on 0.8% lxTBE agarose gel containing ethidium bromide. 
Visualized products by UV excitation. The entact linearized plasmid DNA is 
6.6 kb in size, while the desired products are each 3.3 kb fragments. 
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I'CR amplification with degenerate primers detected an endogenous 
homopurine sequence overlapping a HaelII site within pUCLEU2. To 
roughly determine the range of sequences detectable with degenerate 
oligonucleotides for triple helix formation, a partially degenerate 
oligonucleotide specific for Haem was incubated with linearized pUCLEU2 
plasmid DNA. No cleavage was detected under any of the pH's tested, 
including pH 6.6. Failure to detect this site was likely caused by the high G 
content of the sequence, particularly at the 3' end near the HaeIII site. In 
addition to the two G's in the Haem site, six of the next nine bases were G, 
and one of the remaining three was a T. This sequence constitutes a good 
example of the need for several rapid strategies for detecting target sites, as 
each technique will have target sequences that are difficult to identify. 
Detection of a Target Site in D4SlO by Enzymatic Cleavage. Cos mid 
clone 8C10lS from genetic marker D4SlO was searched for a target site by 
enzymatic digestion mediated by degenerate oligonucleotide directed triple 
helix formation. Cosmid DNA was linearized with the single cutting enzyme 
Sail, and incubated with one of six different partially degenerate 
oligonucleotides to promote triple helix formation. The DNA was modified 
with the appropriate methylase and worked up as indicated (Fig. 4.14). 
Enzymatic treatment with EcoRI, Haem, HhaI, HpaII, and TaqI failed to detect 
any cleavage products. PCR had suggested that a Haem site might be present, 
but none was detected using this assay. Treatment with Alul, however, 
revealed 38 and 7 kb cleavage products cut in 4% yield (Fig. 4.14, lane 3). 
Considering the central position of the SaIl site within the pWE1S vector and 
the size of the cleavage products, the cleavage site had to be within the D4S10 
insert. Reactions performed on DNA linearized with sm, a second enzyme 
that only cuts once in the vector, showed that the 7 kb cleavage product 
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Fig. 4.14. Detection of a target site in 8CI0I5 by AluI methylation and 
digestion mediated by a partially degenerate oligonucleotide specific to Alul 
(Alu-Me). Upper. Map of cosmid 8CI0I5 containing pBR322 (solid line), 
bacteriophage A DNA (speckled line), 5V40 and neomycin resistance gene 
(stripped line), and D4510 insert DNA (white line, not drawn to scale). Also 
shown are the Sail and 5fiI restriction sites used for cosmid linearization and 
mapping of the target site. The cosmid contains approximately 37 kb of insert 
DNA from D4510 ligated into unique BamHI site of the cosmid vector 
pWEI5. The vector contains selection for ampicillin and neomycin 
resistance. Lower. Enzymatic cleavage of 8ClOI5 DNA using a partially 
degenerate oligonucleotide specific for AluI methylase. 8ClOI5 cosmid DNA 
(250 ng) was linearized with Sail and incubated with 10 JlM oligonucleotide 
Alu-Me in 1 mM spermine, 50 mM NaCl, 50 mM tris-HCl, pH 6.6, 10 mM 
EDTA, and 1 mM 2-mercaptoethanol for 12-14 hours at 22° C. S-adenosyl 
methionine (160 JlM), BSA (100 Jlg/ml) and AluI methylase (10 units) were 
added to the reaction (final volume 20 Jll) and incubated at 22° for 4.0 hours. 
The DNA was phenol extracted, ethanol precipitated, 70% ethanol washed, 
briefly dried, and resuspended in AluI restriction enzyme buffer containing 10 
mM Bis Tris Propane-HCl, 10 mM MgCl2 1 mM dithiothreitol, pH 9.5 (25° C) 
and 8 units AluI restriction enzyme. Digested the DNA to completion at 37° 
C for one hour. Resolved products on 1 % agarose pulsed field gel in O.5x TBE, 
2.0 sec. switch times, 120° switch angle, 6 V / em, at 14° C for 10 hours. 
Cleavage products were detected by ethidium bromide staining and UV 
excitation. To quantitate the cleavage efficiencty and improve the detection 
signal for reproduction, the gel was transfered to Nytran membrane and 
hybridized with total 8Cl0I5 radiolabeled DNA. 
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became_smaller, indicating that the target site was less than 2 kb distal to the 
T3 promoter of the pWE15 vector (Fig. 4.14) (76, 77). 
Sequence Identification of the Target Site by Subcloning. The identity 
of the target site was determined by subcloning the 7 kb cleavage product and 
sequencing at the ligation site. While the low cleavage efficiency made it 
difficult to obtain sufficient material for subc1oning, it was only necessary to 
subclone one of the products for complete sequence determination. The 7 kb 
product retained the majority of the pBR322 vector used in the construction 
of pWE15, including the origin of replication and the ampicillin resistance 
gene (Fig. 4.15). For this reason, the most straight forward approach to 
subcloning this fragment was to recircularize the DNA and select for 
ampicillin resistance upon transformation. AluI restriction enzyme cuts to 
leave blunt ends. The SalI site contains a four base overhang with a recessed 
3' end. The DNA was recircularized by filling in the SalI site with the Klenow 
fragment of DNA polymerase and ligating to the blunt ended AluI site. This 
ligation regenerated the SalI site, so the resulting transformants were checked 
for proper ligation by cutting with Sail, and by digestion with Sfil (Fig. 4.15). 
A single colony was identified that contained the properly sized products. 
The target site was transferred to a sequencing vector by cutting the 
recircularized product with Sail and EcoRI, an enzyme that cut once within 
the recircularized plasmid at the opposite boundary of the pWE15 vector and 
the D4S10 insert (Fig. 4.15). This product was ligated into pUC19 and the 
sequence adjacent to the SalI site determined by dideoxy sequencing from the 
universal primer UP1201. The resulting sequence contained the expected 
AluI half site partially contained within the SalI site used for ligation. The 
AluI site overlapped the 19 bp homopurine sequence 5'-AATGGA-
AAGAGAGAGAGAG-3' at the 3' end. The complete sequence on both sides 
EcoR! 
SalI 
C2 
E~T kb) 
EcoR! 
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Target Site 
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Fig. 4.15. Subcloning and sequence determination of the A1uI/triple helix 
target site in cosmid clone 8C10IS. The open arches correspond to DNA from genetic 
marker D4S10 subcloned into cosmid vector pWE1S. The striped region was 
derived from SV40 viral DNA into which the neomycin-resistance gene from 
transposon TnS was inserted. The segment containing small squares was derived 
from bacteriophage 1 and contains the cos site. The solid black line is pBR322 
plasmid DNA. The origin of replication and the ampicillin resistance gene from 
pBR322 are indicated. Total cosmid DNA was linearized with Sail and cut at the 
A1ul/triple helix site as described in Fig. 4.9. The resulting 7 kb fragment was gel 
purified and recircu1arized with T4 DNA ligase. Transformation and selection with 
ampicillin yielded plasmid C2 which contained the triple helix site adjacent to the 
Sall ligation junction. TheSall/EcoRl fragment of C2 was ligated into pUC19 for 
sequencing. The target site was adjacent to the Sall site and was identified by 
dideoxy sequencing using UP1201 as primer. Sequence on both sides of the A1uI site 
were identified by sequencing 8ClOI5 cosmid DNA from an upstream primer. 
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Fig. 4.16. (Left) Schematic diagram of human chromosome 4 showing the 
cytogenetic location of the QDPR locus at 4p15.3. (Left-Center) A physical map 
of 4p16.3 to 4pter showing the location and distance between the lod described. 
On the basis physical mapping, the size estimate from D4S10 to the telomere is 
approximately 4 Mb. The distance indicated between the loci are approximations 
from the physical map. (Right-Center) The sequence and relative orientation of 
the triple helix/ AluI-Sstl target site. The site is shown being recognized by 
oligonucleotide Alu-16. (Right) Schematic diagram of the triple helix complex. 
The pyrimidine oligonucleotide is bound in the major groove, parallel to the 
puring strand of the DNA duplex and covers the purine half of the AluI 
methylation site. 
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of the AluI site was determined by designing a primer from the sequence 
downstream of the homopyrimidine site and sequencing back in the 5' 
direction. This demonstrated that the homopurine sequence overlapped a 
complete AluI site as expected, but it also showed that the AluI site was 
contained within an SstI site, a restriction enzyme sensitive to AluI 
methylation (78). This meant that the target site could be cut by site specific 
inhibition of AluI methylase followed by digestion With the 6-bp restriction 
enzyme SstI (Fig. 4.16). Interestingly, the target site mapped to within 250 bp 
of HindIII polymorphism #1, one of the RFLP's originally used to map the 
chromosomal location of Huntington's disease (24, 71). 
Sequence Analysis of the Target Site. The sequence of the 16 bases 
following the AluI site (those recognized by the degenerate oligonucleotide 
pool) contained seven G's, eight A's, and one T in addition to the 5'-AG-3' 
nondegenerate segment within the AluI site. This sequence would be 
particularly difficult to detect because both the degenerate nucleotide ratio and 
the oligonucleotide affinity were biased against high G content target sites. At 
10 JlM total oligonucleotide, the concentration capable of binding the 
sequence with a single mismatch at the T A bp was less than 0.3 nM. If one 
additional random base mismatch was tolerated, for a total of two, the 
binding concentration would be increased to approximately 4 nM. The 
cosmid DNA concentration was 0.4 nM giving an oligonucleotide to target 
ratio of between 1:1 and 10:1 which explains the low cleavage efficiency. This 
demonstrates that the efficiency of cleavage using degenerate oligonucleotides 
depends upon both the G content and the number of pyrimidine bases in the 
candidate sequence. 
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Conclusion. 
The generalizability of triple helix formation is sufficient to eliminate 
the need for artificial target site insertion into a genetic marker. However, 
cleavage of endogenous target sites is only possible if sites of the appropriate 
sequence composition can be identified. While such sites are readily 
recognized if complete sequence information about a genetic marker is 
available, little sequence information is known for most marker clones. 
Although complete sequence determination is a possible strategy, this chapter 
described three alternatives for a more rapid identification of triple helix 
target sites. Using the test case of an unsequenced cosmid, 8C1015, that maps 
centromeric to the HD mutation, a potential triple helix target site was 
detected by PCR analysis with partially degenerate oligonucleotide primers, 
and the sequence identified using enzymatic cleavage by partially degenerate 
oligonucleotide directed triple helix formation followed by subcloning and 
sequencing. The target site maps to a region on human chromosome 4 that, if 
cut, would liberate a single 3-4 Mb fragment containing the entire HD 
candidate region. The techniques for target site identification are 
generalizable to any cloned genetic marker. 
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Part II 
Site Specific Cleavage of Human Chromosome 4 
The identification of a target site within D4SlO facilitated the design of 
an oligonucleotide to mediate site specific cleavage of human chromosome 4 
at an endogenous target site. The enzyme system to be used for cleavage had 
not previously been tested on genomic DNA, so it was necessary to optimize 
the cleavage conditions on plasmid and yeast DNA. Additionally, the use of 
AluI methylase appeared initially to be problematic due to the higher than 
statistical frequency of AluI sites in the highly repetitive interspersed repeats 
found throughout the human genome (79, 80). It was necessary to confirm 
the target site on human chromosome 4 because the site contained a small 
repetitive element that might be polymorphic in the human population. 
Each of these experimental barriers had to be overcome to site specifically cut 
a human chromosome. Cleavage reactions on human chromosome 4 were 
described in the report: S. A. Strobel, L. A. Doucette-Stamm, L. Riba, D. E. 
Housman, and P. B. Dervan; Site-Specific Cleavage of Human Chromosome 4 
Mediated by Triple Helix Formation, Science 254, 1639-42 (1991). 
Confirmation of Target Sequence in Human Chromosome 4. Because 
the site identified included a simple sequence repeat, (AG)6, there was 
concern about the possibility of DNA sequence polymorphism within the 
targeted region (81). Using peR with primers flanking the Sst! site (SSG8-1 
and SSG8-4) the target region from ten unrelated individuals were analyzed 
including an HD patient, and a somatic cell hybrid (HD113.2B) containing 
only human chromosome 4 in a mouse background (49). All eleven samples 
yielded a 213 bp fragment demonstrating there was no variation in the AG 
repeat length. All samples were subject to digestion with Sst!. Sequencing of 
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several of thesE'! PCR products generated the identical sequence to that derived 
from the 8C10I5 cosmid. This suggests that neither the Sst! site nor the (AG)6 
repeat sequence were polymorphic, and DNA from any of these cell lines 
could serve as substrate for the cleavage reaction. 
Target Site Cleavage in Plasmid and Yeast DNA. The ability of an 
oligonucleotide to effectively block the AluI target site from methylation was 
tested in plasmid and yeast genomic DNA to optimize methylation 
conditions and cleavage efficiencies. Plasmid pUCLEU2E was constructed by 
inserting an oligonucleotide duplex containing the target sequence into the 
unique XhoI site of pUCLEU2 (3). Quantitative cleavage (>98%) of pUCLEU2E 
was observed up to pH 7.0 using a 16 base oligonucleotide, Alu-16, containing 
Mec and T nucleotides (Fig. 4.17, lanes 1-3). A 19 base oligonucleotide (Alu-
19G) designed to recognize three additional base pairs at the 5' end of the 
purine run including a TA bp (82), produced identical cleavage efficiencies 
under the conditions tested (lanes 4-6). Both oligonucleotides showed 
reduced cleavage efficiency at higher pH's (lanes 3 & 6). No cleavage was 
observed at either of the other two Sst! sites on this plasmid (compare lane 7), 
nor was cleavage observed in the absence of the oligonucleotide (lane 10). 
To test for cleavage of genomic DNA, the target site was homologously 
recombined into the Saccharomyces cerevisiae genome which contains 14 Mb 
of chromosomal DNA (3). One recombinant was selected and fully 
characterized. Unfortunately, this clone contained the target site as an insert 
into either chromosome VII or XV instead of the desired chromosome III. 
The chromosome did contain an insertion of the LEU2 gene near the target 
site, so it was possible to assay for cleavage by hybridization with LEU2 (83). 
Asa function of pH, cleavage efficiencies of 80-90% were observed at the 
target site within megabase DNA (Fig. 4.18). Ethidium bromide staining of 
199 
total genomic DNA detected no secondary sites with either oligonucleotide at 
pH 7.0. 
200 
Fig. 4.17. Cleavage of human chromosome 4 target site in pUCLEU2E 
plasmid DNA. A. Sequence of oligonucleotides specific for target site. B. 
Map of plasmid pUCLEU2E showing the duplex ligated into the unique XhoI 
site. The underlined region in the duplex is the sequence recognized by 
oligonucleotide Alu-19G. Alu-16 recognizes a sequence three base pairs 
shorter at the 5' end. Both oligonucleotides partially overlap an AluI site. C. 
Enzymatic cleavage of pUCLEU2E DNA mediated by oligonucleotides Alu-16 
and Alu-19G. Plasmid DNA (450 ng) was linearized with HindIII and 
incubated with 1.0 IlM oligonucleotide Alu-16 or Alu-19G in 1 mM spermine, 
50 mM NaCl, 50 mM tris-HCl, pH 6.6-7.4,10 mM EDTA, and 1 mM 2-
mercaptoethanol for 12-14 hours at 22° C. S-adenosyl methionine (160 IlM), 
BSA (100 Ilg/ml) and AluI methylase (5 units) were added to the reaction 
(final volume 20 Ill) and incubated at 22° for 1.5 hours. The DNA was phenol 
extracted, ethanol precipitated, 70% ethanol washed, dried, and resuspended 
in Sst! restriction enzyme buffer containing 50 mM NaCl, 50 mM tris-HCl, 10 
mM MgCI2, pH 9.5 (25° C) and 10 units Sst! restriction enzyme. Digested the 
DNA to completion at 37° C for one hour. Resolved products on a 0.8% 
agarose gel in 1.0x TBE containing ethidium bromide. Visualized products by 
UVexcitation. Intact linearized plasmid DNA is 6.6 kb and the desired 
cleavage products are each 3.3 kb in size. 
201 
A. 
Alu-16 5- MeCMec T T T MeC TMec TMec TMec TMec T C -3' 
Alu-19G 5- T T G MeCMec T T T Mec TMec TMec TMec TMec T C -3' 
B. 
AluI 
5'-TCGACTCGCT MTGGAAAGAGAGAG*GC1!'\ . CG TG-3' 
3'-GAGCGATT ACCTTTCTCTCT Cq-O-Cd~dCACAdCq-RD 
L .. Sstl J 
11 
pUCLEU2E 
(6.6 kb) 
HindIII 
EeoR! 
202 
c. 
pH yKlo~yKlo~oooo \.C5t-...:t-...:\.C5t-...:t-...:t-...:t-...:t-...:t-...: 
Alu-16 + + + - - - + -
Alu-19G - - - + + + - - - -
AluI Methylase + + + + + + - - + + 
SstI Endonuclease + + + + + + + - - + 
SKSkb~ 
PKPkb~ 
1 2 3 4 5 6 7 8 9 10 
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Fig. 4.18 Cleavage of yeast genomic DNA (SEY621OE) containing the 
human chromosome 4 SstI/ AluI target site on chromosome VII or XV. Yeast 
genomic DNA in LMP agarose blocks E~UM~!F was washed twice in 1.0 ml of 
50 mM NaCl, 50 mM tris-HCl, pH 6.6-7.4, 10 mM EDTA, 1 mM spermine, and 
1 mM 2-mercaptoethanol for 10 min., decanted, and overlayed with 120 ~ of 
the same buffer. Added 2.0 ~l of 100 ~M oligonucleotide Alu-16 or Alu-19G 
and incubated 24 hours at 22° C. Added BSA (100 ~g/miF SAM (160 ~MF and 
AluI methylase (32 U) (final concentrations) and incubated an additional 8 
hours at 22° C. Inactivated methylase and disrupted triplex by adding 1.0 mL 
of 1 % lauryl sarcosyl, 100 mM tris-HCl pH 9.5, 10 mM EDTA and incubating at 
55° C for 30 min. The oligonucleotide and detergent were removed with 4x30 
min. washes (1.0 m!) with 10 mM tris-HCl pH 9.5,10 mM EDTA. The agarose 
plug was washed twice for 30 min. with 1.0 ml restriction enzyme buffer 
containing 50 mM NaCl, 50 mM tris-HCl, 10 mM MgCI2, pH 8.0, decanted, and 
overlayed with 120 ~l of the same buffer containing 20 units Sst! restriction 
enzyme. Digested at 37" C for 2 hours and resolved products of 1 % agarose 
pulsed field gel containing O.5x TBE, 120° switch angle, 6 V / cm, 14° C, at 
switch times ramped from 15-45 sec. for 15 hours followed by a ramp from 60-
90 sec. for 5 hours. DNA was transfered to Nytran membrane and hybridized 
with the KpnI/EcoRI fragment from the LEU2 gene as described in Chapter 3. 
No Oligo Alu-16 Alu-l9G 
~~~
pH 6.6 7.0 7.4 6.6 7.0 7.4 6.6 7.0 7.4 
1 234 5 6 7 8 9 
:t 1100 kb VII/XV 
1000 kb 
- - - ~ 340kbm 
~ 100kb 
cylglyccrol by such a mtthanism could impli-
cate protein kinase C as a possible rransducing 
pathway. Or, mobilization of intracellular 
Ca? + by inositol triphosphate could point to 
Ca?+ -caImodulin-d.ependent protein (CaM) 
kinases as me rransducing faCtors that couple 
dopamine stimulation of D I receptors to the 
activation of steroid m:cptors. CaM ~ 
phosphorylate and activate the cAMP rc>ponse 
dement binding-prorcin (33). 
Demonstration of "'crass*u!k" between 
membrane-associated rtteptors and intracel-
lular steroid hormone rtteprors may be of 
biomedical significance. Dual activation of 
receptors might occur in siru in brain cells. It 
may also be possible to activate mutant forms 
of steroid ttCCptors that exist in diseases (34). 
Finally, the finding that dopamine has direct 
access to the genome via this family of tran-
scription factors may aid in Wlderstanding 
learning and. memory processes. 
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Site-Specific Cleavage of Human Chromosome 4 
Mediated by Triple-Helix Formation 
Scon A. STROBEL, LYNN A_ DOUCETIE-STAMM, LAURA RIBA, 
DAVID E. HOUSl\1AN, PETER B_ DERVAN* 
Direct physical isolation of specific DNA scgmenu from the hwnan genome is a 
necessary goal in human genetics. For testing whether triple-helix mediated enzymatic 
cleavage can liberate a specific segment of a hwnan chromosome, the tip of human 
chromosome 4, which contains the entire candidate region fur the Hwuington's disease: 
gene, was chosen as a target. A 16-basc pyrimidine oligodcoxyribonuclcotidc was able to 
locate a 16-basc pair purine target site within more than 10 gigabase pairs of genomic 
DNA and mediate the exact enzymatic cleavage at that site: in more than 80 percent yield. 
The recognition motif is sufficiently generalizable that most cosmids should contain a 
sequence t:argetable by triple-helix funnation. This method may facilitate the orchestrat-
ed dissection of human chromosomes from nonnal and affected individuals into 
mcgabase sized fragments and facilitate the isolation of candidate gate loci. 
P YRIMlDll"E OLlGODEOXYRlBONU-dcotidcs bind in the major groove of DNA parallel to the purine Watson-
S. A. Strobel and P. B. Dervan., Arnold and M~bel 
Ikckmm Labor:orories of Chemical Synthesis, California 
Imtirute ofTeclmology, Pasadena. CA 91125. 
L. A. Douo;;em:-Swnm, L. oi~ D. E. Housman., Center 
for Cancer Rcsc:arch, M:wachu.scm Instirute ofT echnol-
ogy, Cambridge, MIl. 02139. 
'To whom con:cspondcno:::c: should be add=d. 
Crick strand through formation of specific 
Hoogsteen hydrogen bonds to the purine 
Watson-Crick base (1-6). Specificity is de-
rived from thymine (T) recognition of 
adenine' thymine' (AT) base pairs (TAT 
triplet); and N3-protonated cytosine (C+) 
recognition of guanine' cytosine (GC) base 
pairs (C + GC triplet) (1--8). The genera!-
izability of triple-helix formation has been 
extended bcyondpurine tracts to mixed 
REPORTS 1639 
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sequences containing all four base pairs by different sites, each occurring only once in 
the identification of novel base triplets (9), gigabase DNA (14). To teS[ whether triple 
alternate strand triple· helix formation (10), helix- mediated enzymatic cleavage is capa-
and other triple-helix motifs (11). By com- ble of site-specific cleavage at an endoge-
bining oligonucleotide-directed recognition nous sequence on a human chromosome, 
with enzymatic cleavage, near quantitative we targeted the tip of the short arm of 
cleavage at a single target site within '1 chromosome 4 (>200 Mb), which 
megabase (Mb) DNA has been achiever' 2 the Huntington'S disease (HD) 
(12). In this technique, specific triple-hel . The HD gene is located within the 
formation protects a single: overJappinl. /.nerie band 4p16.3, and a large number 
methylase site from modification (12, 1gFKD~c1oned DNA sequences have been genet-
Mer triple:-helix disruption, restriction en- ically and physically mapped to the region 
zyme digestion produced cleavage in 95% (15-16). Genetic evidence supports a loea-
yield at a single: sire within the Saccharomyces tion of the HD gene within the approxi-
cerevisiae genome (14 Mb) (12). mately 4 Mb of DNA between the genetic 
In a formal sense, a binding site size of at marker 04S10 (G8) (15) and the telomere 
least 16 bp afforded by the triple helix ofchromosome4p (17,18). Thus, a single 
motif is sufficient to target millions of cleavage at 04510 wouJd liberate a large, 
resolvable fragment that contains the entire 
HD candidate region. 
Bind dageneral8 
Oligonucleotides 
Methylate 
lnactlvale methylase 
Disropt triplex 
V 
Restriction enzyme digest 
The triple helix-recognition motif is suf-
ficiently general that each cosmid shouJd 
contain at least one endogenous site suit-
able for enzymatic cleavage (19). For 
cosmid clones that have not been se-
quenced, a strategy was developed whereby 
a pool of partially degenerate pyrimidine 
oligonucleotides was used to identify tar-
get sites (Fig. 1). Pyrimidine oligonucleo· 
tides were designed with two domains; a 
---t-t-c:r--<i ~ degenerate 16-nucleotide (nt) segment ca-y Subciooe cut ends 
Sequence ends 
j 
Design oligonucleotlde for target site 
a Restriction enzyme site, cleavable 
pable of binding thousands of purine-rich 
sequences, and a short specific 2- to 3-nt 
domain to overlap a methylase-restriction 
enzyme binding site. The degenerate oligo-
nucleotides were synthesized with 5·merh-
ylcyrosine EM~CF and 5-bromouracil (B'U) 
(4). These analogs were chosen because 
.\.tec substituted oligonucleotides have 
higher binding affinities and B'U substitu-
tions result in slightly reduced binding 
specificity (4, 12). Sequences containing 
high G content or contiguous G tracts are 
not efficiently targeted by the pyrimidine 
triplex motif near neutral pH. Because ' 
oligonucleotides in the population specific 
for such sequences would be less likely to 
bind, a nucleotide ratio of 60% B'll and 
40% MeC at each degenerate position was 
used to minimize the oligonucleotide con-
cemration specific for G-rich sequences. 
This resulted in a pool of 65,536 different 
oligodeoxyribonuclcotide sequences un-
equally represented in the popuJation (20). 
In an effort to identify potential target 
sites within 04S10, cosmid clone 8C10I5, 
which contains most of the 04S I 0 locus 
(15), was screened with five partially de-
generare pyrimidine oligonucleotides in 
combination with five methylase-restric-
tion enzyme sets (Fig. 1). While no detect-
able cleavage was observed with Eco RI, 
Msp I, Hae III, or Taq I, a degenerate 
oligonucleotide specific for AIu I blocked a 
single AIu I methylation site in 8C10I5. 
ONA sequencing immediately adjacent to 
the cleavage site identified the target as a 
16-bp purine sequence that overlapped the 
purine half sites of AIu I methylase (5'-
AGCT-3') and Sst I (5'-GAGCTC·3'), a 
restriction enzyme sensitive to AIu I meth-
ylation (Fig. 2). The ability of a target-
specific oligonucleotide to effectively bind 
and fully protect this site was optimized on 
• Methylated restriction anzyme slta, 1"101 deavab18 
o OIigonudeolide binding site 
Fig. 2. (Left) Schematic ill-
..gram of hwnan chromo-
some 4 showing the cytoge. 
netic location of the QDPR 
locus at 4pI5.3. (Left.cen-
ter) A ph~ical map of 
4p16.3 to 4p16ter showing 
the location and distance be-
tween the loci described. On 
the buis of pulsed field gcl 
mapping, the size estimate 
from D4S 1 0 to the telomel:e 
is approximately 4 Mb (17). 
The distances indicated be-
twc:c:n the loci are approxi· 
mations from the physical 
map (17). (Rlght.center) 
The sequence and relative 
orientation of the Alu l-Ssr 
I target site identified by the 
degenerate pyrimidine oli-
gonucleotide search. The 
site is recognized by a 16-
base Mecr oligonucleotide 
with M~C + GC and TAT 
base triplets (A1u-16). 
(Right) Schematic diagram 
of the triple-helix complex. 
The pyrimidine oligonucle-
4p16.3 3' 5' 
G-C 
G-C 
T-A 
'\I' Degenarala pyrimidine oligonucleotides 
Fig. 1. General scheme for identi6c.ttion of en· 
dogenous cosmid sequences urgerabk by triple-
helix mediated enzymatic cleavage with the usc: of 
a pool of partially degenerate oligonucleotides, 
Linearized cmmid DNA was equilibrated with a 
degenerate pyrimidine oligonucleotide containing 
a nondegenerate end specific for a methylase site. 
The Alu I oligonucleotide used to identify this 
target site had the sequence, 5'-Yu, TC-3', whel:e 
Y l:eprcscnt'i a nucleotide ratio of 60% B'lJ md 
40% M~cK The DNA was methylated to comple· 
tion, making all methylation sites not bound by 
the oligonucleotide mixrure resistant to subse· 
quem restriction enzyme digestion. The methyl· 
ase was removed by phenol extraction, the DNA 
was prc:cipirared with ethanol, and the triple helix 
was disrupted by resuspcnsion in a restriction 
enzyme bWfer at high pH. The appearance of a 
cleavage product upon restriction enzyme diges· 
tion demonsttated that a sire bound by a fraction 
of the oligonucleotide mixture overlaps a methyl-
ation site. Subcloning of the cut ends and se-
quencing revealed the site identity, With this 
sequence infonnation and the rules for oligonu. 
c1eotide directed rc:oognition of duplex DNA (1-
6, 9, to), an oligonucleotide specific for the target 
site was designed. 
1M() 
D4S113 
• ~ 
D4S43 
O4512S 
• ~ 
04510 
"~ . 
3' : ~ • I
T
:
A 
"'{ C+... :s 
T- • ;;: 
~CD 
T-A-
Mec + o -c 
T-A-T 
Mec +o -c 
T·A-T 
""'c+o-c 
T-A-T 
""c+o-c 
T·A-T 
T-A-T 
T-A-T 
""'c+o-c 
""c+o-c 
T-A 
A-T 
A-T 
T-A 
CoG 
3' 
otide is bound in the major groove, parallel to the purine srrand of the DNA duplex and covers the 
purine half of the Alu I methylation sire. 
SCIENCE, VOL. 254-
Rg. 3. (A) Triple-helix medi:UI::d en-
Z)'ll1:1ric cleavage of human chromo-
some 4 with reagc:na indiu.[cd above 
figure . The DNA wu prepared from 
somatic aU hybrid HDl13.lB in low 
melting point (LMP) aguosc at - 100 
lLg/ml by srandard procedures (Z7). 
Approrim:udy 80 ILl o f agarose cm-
bedded genomic DNA (-8 Il-g) wu 
c:quilibflltl:d in aiplc.hc:lix- A1u I 
methylase: buffet' (50 mM NaCl, 1 
mM spetminc-4HCl, SO mM O'is-
Hel, 10 mM EDTA, 1 m.M J'I -mc:r-
aptocthanol, pH 7.0) and incubated 
for 24 hours at room temperature 
with 5 pM A1u-16 target-specific oli-
gonucleotide. S-Adenosylmethioninc 
(SAM) (160 !1M ) md bovine serum 
albumin (BSA) ( 100 .... iVml) wen: 
added, and me DNA was mc:mybted 
to completion with 25 units of A1u I 
methylase: (New England Biolabs) at 
room temperature: for 8 hours. Meth-
ylase inactivation and aiplcx diSOlp-
rion were as described (J) . The DNA 
was recquilibrarcd in Sst t restriction 
enzyme buffer (50 mM NaCl, 50 mM 
ais-HCl, pH 7.9 , and 10 mM MgCll) 
A 
Origin -
I 
I 
E 
I 
10-
30-
40-
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and CUt to completion with 20 units of Sst I (BRL) for 2 hours at 3rc. After digestion , the enzyme was 
inactivated by hot for 10 min at 55"C and the DNA produru were revealed to a 0 .8% - l,MP agarose Ix tris, 
acetu:e, EDTA (TA£) pulsed· field gel run at 14"C, 32·min switch times, 106· switch angk. 2 .0 V/cm. for 65 
hours. Reactions were visualized by ethidium bromide sta.ining, and davage productS were detected by anaJ}'5is 
with the PCR (23). (8 ) PCR analysis of lanes 3 and 4 of gel from (A). The no-oJigonuckotide control lane (lane 
3, Fig. 3A) is represented with gray lines and open circles. The reo.ction lane (lane 4 , Fig. 3A) is represented by 
black lines with filled squares. Lanes 3 and 4 were CUt into IS sections (5-mm), placed in individual rubes, 
denatured at 96"C, vortexed., and used in 5-1.1.! portions for 50-",,1 PC R amplification reacrioru with STS's spanning 
the 4p16.3 region. The amplification conditions and primers were as described (2J- 26). Amplification products 
were blot hybridized and the amplification imensiry of eaeh fraction (juantitated by storage screens (Mokcular 
Dynamics 4005 Pho5pho rImager). The percent of total amplification (amplification in each fraction divided by 
total amplification in the: lane) was plotted as a functio n oft:hc di.nance migrated for each ohhe five STS's assayed. 
The lane origin is the fint point to the left in all traces. Amplification reactions were reproduced on fractioru from 
four different gels, resulting in [W() to eight replications per STS. The experimenw errot is :!:5% for amplification 
at each origin, and :%:2% for amplification in all other fractions . 
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plasmid (6.6 kb) and yeast genomic DNA 
(14 Mb), n=sulting in more than 98% and 
90% cleavage yields at the target site, re-
spectively. No secondary cleavage was de-
tected at other SSt I sites in either substr.lte. 
Thus, after triple-helix formation and ex-
haustive: Alu I methybtion, the: megabase 
genomic DNA couJd be cut with Sst I to 
reveal only the site bound by the oligonu· 
cleotide (Fig. 2). 
Under optimized conditions, triple-helix 
mcdiated enzymatic cleavage was used to 
target human chromosome 4 in DNA pre-
paced. from HD1l3.2B. a somatic cell hy-
brid containing only human chromosome 
4 in a mouse background (21) (Fig. 3A). 
Analysis of the reaction products within 
the rmge of 1 to 6 Mb by pulsed-field gel 
electrophoresis (22), revealed that most of 
the DNA did not migrate from the origin 
and remained intact (Janes 1, 3, and 4). 
When methylation was omitted and the 
DNA was digested with Sst I, no DNA 
remained at the origin, a result consistent 
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with complete digestion (lane 2). Reac-
tions in the presence (lane 3) or absence: 
(lane 4) of oligonucleotide appeared iden-
tical by ethidium bromide staining. Be-
cause the maximum yield of the telomeric 
segment of chromosome 4 was 2 ng (from 
- 8 ",g of tow. DNA). any cleavage prod-
uct would be Wldetcetable with cth.idium 
bromide staining, thus requiring a more 
sensitive detection system. 
Southern blot hybridization revealed a 
discrete product approximately 3.5 Mb in 
size:. To improve the sensitivity of detec-
tion, a PCR (polymerase chain reaction) 
based assay to detect small quantities of 
specific megabase DNA segments was ap-
plied to me gel products shown in Fig. 3A 
(Fig. 38). The fulllcngth of lanes 3 (with 
o ligonucleotide) and 4 (without oligonu-
cleotide) were cut into 5-mm sections per-
pendicular [Q the length of the gel and 
placed into individual tubes. Each fraction 
was analyzed for genomic DNA content by 
the PCR with the use of primer sets specific 
00 20 .. 60 
Dbtance mIgr-.I (nom) 
for sequence: tagged sites (5TS) known to 
be either tc:lomeric or centrOmeric to the 
target site. Centromeric primers would be 
expected to only amplify the gcl fraction 
containing the origin because the main 
portio n of the chromosome would be tOO 
large to migrate into the geL Telomeric 
markt:rs, however, would amplifY both the 
o rigin and any fractions containing the 
tclomeric product expected from restric-
tion mapping to be about 4 Mb in size (17, 
18). 
Amplification of 04590 (23), the most 
telomeric 4p markt:r (Fig. 2) (16, 17), was 
detected in the origin of both lanes (Fig. 
3B). The amplification signal was weaker 
in the origin of lane 3, consistent with 
chromosomal cleavage. Significanr amplifi-
cation within lane 3 was also observed in 
fractions 6 and 7, while the control lane 
containing no oligonucleotide remained 
baseline in all other fractions (lane 4). 
Fractions 6 and 7 correspond to a migra-
tion dist:rnce of 2S to 3S mm and correlate 
REPORTS 1606,1 
Ag. 4. The yidd of triple hdix-
mediated enzymatic cleavage of 
human chromosome 4. (Upper) 
Local resnittion map showing the 
location of the A1u I-Sst 1 target site 
within the 900-bp Pst I fragment. 
The target site: is located 250 bp 
centromeric to Hind III poly-
morphic::: site no. 1 (15, 25). (Low-
er) Reaction of total genomic 
HDU3.2B DNA as indicated 
above: figure and described in Fig. 
5. Pst I (80 Wlits) (New England 
Biolabs) was included in the 2-hour 
Sst I digest to generate: the desired 
fragments. Products were resolved 
by snnd~d agarose gel elecrropho-
resis (0.8% agarosc:, Ix TAE), 
blotted to a Nytran 66 membrane 
(Schleicher & Schudl) and hybrid-
ized with a SOO-bp centromeric Pst 
I-Ss[ I mgment (sniped n::gion) 
according to the protocol issued 
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with the membrane. The clcaVOIge efficiency was determined from the relative: radioactive: inte:nsiries of 
the 500- and 9OO-bp products as determined by Phosphorimager analysis. 
to a size estimate of 3.6 ::!:: 0.3 Mb, on the 
basis of a comparison to the size standard 
from Saccharomyces pombe. A similar pat-
tern of amplification was observed for 
STS's from 04S43 (16, 23) and 04S125 
(24). These loci span the candidate region 
for the HD gene, and amplification dem-
onstrates that the cleavage product con-
tains all the DNA from D4S10 to the 
telomere (Fig. 2). 
Amplification of STS's centromeric to 
the CUt site showed a different pattern. 
Approximately equal amplification was de-
tected in the origins of both lanes and oruy 
in the first fraction. No peak was detected 
with a D4S10 STS located 12 kb centro-
meric to the cut site (25), nor was a peak 
present with a QDPR STS located in 
4p15.3 (26), one cytogenetic band centro-
meric to 04SlO (Fig. 2). This result dem-
onstrated that these proximal loci are not 
found in the 3.6-Mb cleavage product, and 
indicated that contamination was not con-
tributing to the peaks seen with the telom-
eric STS's. 
The cleavage efficiency at the target site 
was determined directly by DNA (South-
ern) blotting. The Sst I target site is found 
near the center of a 900-bp Pst I fragment 
(Fig. 4, lanes 1 to 3). After Pst I digestion, 
cleavage at the Sst I site can be readily 
detected and quantitated by Southern blot 
hybridization with the 500-bp centromeric 
fragment (Fig. 4). The ratio of the number 
of COWlts at 500 bp to the total at both the 
500- and 900-bp sites is the cleavage effi-
ciency. To determine the yield of cleavage 
at the Sst I site in human chromosome 4, 
we performed reactions as described in the 
legend of Fig. 3A except that Pst I was 
included in the restriction enzyme digcs-
1M' 
tion. No 500-bp cleavage product was 
observed if oligonucleotide was omitted 
(lane 4) or if an oligonucleotide with the 
incorrect sequence was incubated with the 
DNA (lane 6). The DNA was quantitative-
ly converted to the 500·bp fragment in the 
absence of Alu I methylase (lanes 3, 5, and 
7). In the presence of A1u I methylase and 
the correct oligonucleotide, the 500-bp 
diagnostic product was produced in 80 to 
90% yield (lane 8). This is only slightly 
lower than observed at the plasmid level 
despite the presence of more than 10 bil-
lion base pairs of background DNA per 
target site. 
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Complete AluI Methylation of Mammalian Genomic DNA . Extensive 
effort was made to achieve complete AluI methylation of DNA prepared 
from the somatic cell hybrid HDl13.2B. Initial reactions were performed 
using the manufacture recommended low salt (0 mM) buffer at pH of 6.6 to 
7.4 and 1 mM spermine. This resulted in DNA digested to completion by Sst! 
endonuclease, an observation consistent with very poor methylase activity. 
Conversely, reactions performed in the absence of spermine showed complete 
methylation and no sensitivity to Sst!. A similar pattern of sensitivity was 
observed on plasmid DNA. The data was consistent with DNA precipitation 
by spermine prior to the addition of methylase, thus making it inaccessible to 
the enzyme (84). Because the chromosomal DNA was suspended in agarose, 
the high pH washes and reequilibration in restriction enzyme buffer removed 
the spermine and resuspended the DNA, making it susceptible to digestion by 
Sst!. The precipitation problem was corrected by the addition of 50 mM NaCl 
to the triple helix/methylation reaction. The sodium ions competed with the 
spermine for the anionic DNA backbone and kept the chromosomes in 
solution. The medium salt and low pH reduced the activity of the methylase, 
thus requiring more units and longer incubation times to achieve complete 
methylation. 
An additional concern was the concentration of the genomic DNA in 
the agarose blocks. Initial methylation reactions performed on DNA prepared 
from HD113.2B at 108 cells/ml were completely ineffective. The agarose block 
was too viscous with DNA and cellular debris for the methylase to efficiently 
diffuse into the matrix. Experiments performed on a range of plugs at 
different cell concentrations showed a maximum concentration of 7.5xl06 
diploid cells/ml or approximately 80 Ilg DNA/ml for efficient methylation. 
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Concentrations even twice as high showed significantly reduced methylase 
activity, independent of the number of units of enzyme added. 
Analysis of the 3.6 Mb Cleavage Product within the D4S10 Locus. PCR 
analysis of the gel fractions confirmed that the cleavage product contained 
DNA from D4S90, D4S43, and D4S125. It did not contain DNA from a 
centromeric STS in D4S10 or from QDPR (Fig. 4.16). In an effort to confirm 
that the 3.6 Mb product contained DNA from D4S10, a set of primers were 
designed from H5.52, a telomeric portion of D4S10 (43). A minimal amount 
of sequence information was determined from this region. Primers were 
designed to amplify a 550 bp fragment. PCR reactions using the H5.52 primers 
were performed on each fraction of the pulsed field gel used to resolve the 3.6 
Mb cleavage product (85). The amplified products were resolved by gel 
electrophoresis and quantitated by DNA hybridization and phosphor imager 
analysis. As reported for the telomeric STS's, amplification was detected in 
fractions 6 and 7 with primers specific to H5.52 (Fig. 4.19) (85). This 
demonstrated that H5.52 was present in the 3.6 Mb fragment, and that the 
cleavage product contained the entire region from D4S10 to the telomere. 
Site Specific Cleavage at a Target Site Telomeric to the HD Gene. 
Although there is still a chance that HD is telomeric to all informative genetic 
markers and is located within the final 100 kb of chromosome 4 (54, 55), it is 
likely that the gene is between D4SlO and D4S113 (47, 60, 61). Approximately 
1.5 Mb separates D4S113 from the telomere (50). While this extra DNA is not 
expected to interfere with efforts to map the HD mutation, a flanking cut at 
D4S113 would cleanly trim the desired fragment, and demonstrate the utility 
of this cleavage technique for genetic markers not located at the telomere. 
Over 65 kb of sequence information surrounding D4S113 has been 
determined (86). This provided an ideal database to complete a computer 
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Fig. 4.19. PCR analysis of D4S10 (ter) locus H5.52 from lanes 3 and 4 gel 
Fig. 3A in Strobel, et al. Science 254,1639-42 (1991). The no-oligonucleotide 
control lane (lane 3) is represented by gray lines and open circles. The reaction 
lane containing Alu-16 is represented by black lines and filled squares. Lanes 
3 and 4 were cut into 15 sections 5 mm in size, placed in individual tubes, 
denatured for 5 min. at 96° C, vortexed, and 5111 used for PCR amplification 
with primers specific to H5.52. The primers used for amplification were: 1. 5' 
H5.52 (2): 5'-AAAGACGTGAGGTAGTGTCC-3'; and 
2. 3' H5.52 (2): 5'-GTAGGA-AGCTGACACACCAG-3'. Amplification 
reactions were performed using the buffer and reagent conditions described in 
materials and methods. Amplification cycles were: 94° C 1.0 min., 58° C 1.0 
min., 72° C 1 min. for 30 cycles. Amplification products were transfered to 
Nytran membrane and hybridized with radiolabeled with H5.52 radiolabeled 
DNA. The amplification intensity of amplification in earn fraction was 
quantitated by phosphorimager analysis. The percent of total amplification, 
amplification in each fraction divided by total amplification in the lane, is 
plotted as a function of the distance migrated in the original pulsed field gel. 
Earn square or circle corresponds to a 5 mm fraction. The peak observed in 
lane 4 is at the same position as observed for all other telomeric 5TS's. This 
corresponds to a migration distance of 25-35 mm and a size estimate of 3.6±0.3 
Mb. The presence of H5.52 in the 3.6 Mb fraction indicates the product 
contains all the DNA from 04510 to the telomere. 
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search for sites targetable by triple helix mediated enzymatic cleavage. The 
analysis identified several potential target sites, of which two were selected 
and tested on plasmid DNA. 
The first target selected was an lS bp purine sequence that contained 
two Ts and overlapped a HindIII site (Fig. 4.20 A). Three oligonucleotides 
containing T and Mec were synthesized for the target site with either G, D3 (3-
benzamidophenylamidazole), or DS (3-napthamidophenylimidazole) 
opposite the pyrimidines (Fig. 4.20 B). HindIII restriction enzyme was 
reported to be inhibited by AluI methylation, although AluI methylase does 
not modify the same base as the cognate methylase of HindIlI (7S). Initial 
studies quickly demonstrated that AluI methylation only slowed cleavage by 
HindIII, but did not fully inhibit the activity of the enzyme. This enzyme 
combination would be insufficient to achieve site specific cleavage of human 
genomic DNA, as high fidelity endonuclease inhibition is essential. 
HindIII methylase in low concentration and moderate purity was 
obtained from New England Biolabs to complete tests on the oligonucleotides 
(Fig. 4.20 C). Oligonucleotide HND-G mediated 70% target site cleavage at pH 
6.6 (lane 2), but was highly pH sensitive and showed no protection above pH 
6.S (lane 3 and 4). Oligonucleotide HND-D3 showed less pH sensitivity (S7), 
mediating 95% cleavage at pH 6.6 (lane 5), and greater that 70% cleavage at pH 
7.0 (lane 6). Little cleavage was observed at pH 7.4 (lane 7). HND-DS showed 
still improved resistance to pH (SS), cleaving in high yield up to pH 7.0 (lanes 
Sand 9) and at 25% cleavage at pH 7.4 (lane 9). However, HND-DS and other 
oligonucleotides containing the novel base DS, showed moderate nonspecific 
inhibition of AluI methylase. Oligonucleotide HND-D3 appeared to be the 
reagent of choice, but there was not sufficient HindIlI methylase to conduct 
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Fig. 4. 20. Oligonucleotide mediated cleavage of D4S113 human 
chromosome 4 target site in pUCLEU2P plasmid DNA by HindIII methylase 
and endonuclease as a function of pH. A. Homopurine target site 
overlapping a HindIlI restriction enzyme site. B. Oligonucleotides specific for 
target site in pUCLEU2P. They contain a G or novel bases D3 and D8 for 
recognition of the two TA base pairs in the target site. C. Enzymatic cleavage 
of pUCLEU2P DNA mediated by oligonucleotides HND-G, HND-D3, or HND-
D8. Plasmid DNA (200 ng) was linearized with SalI and incubated with 1.0 
IJ.M oligonucleotide in 1 mM spermine, 50 mM NaCl, 50 mM tris-HCl, pH 6.6-
7.4,10 mM EDTA, and 1 mM 2-mercaptoethanol for 12-14 hours at 220 C. S-
adenosyl methionine (160 IJ.M), BSA (100 IJ.g/ml) and HindIII methylase (1 
unit) were added to the reaction (final volume 20 IJ.I) and incubated at 220 for 
2.0 hours . . The DNA was phenol extracted, ethanol precipitated, 70% ethanol 
washed, dried, and resuspended in Sst! restriction enzyme buffer containing 
50 mM NaCl, 50 mM tris-HCl, 10 mM MgCIz, pH 8.0 (250 C) and 20 units 
HindU! restriction enzyme. Digested the DNA to completion at 370 C for one 
hour. Resolved products on a 0.8% agarose gel in 1.0x TBE containing 
ethidium bromide. Visualized products by UV excitation. Intact linearized 
plasmid DNA is 6.6 kb and the desired cleavage products are 4.4 and 1.1 kb in 
size. 
A. 
B. 
c. 
HindIII/ Alul 
5'-CACAGAAGGA TAT AAAd~dClffqAd-PD 
3'-GTGTCTTCCTATATTTC ILCGYATC-5' 
HND-G 
HND-D3 
HND-D8 
5'- T Moe: T TMoe: Moe: TG TG T T T Moe: T TT C-3' 
5'- TMeC T TMoe: Moe: T 0 8 T 0 8 T T T Moe: T T T C-3' 
pH o\Oo.qt\Oo-.::tt\Q0-.::f'400 r'\Cir'r'\Cir'r''Clr'r'r'r' 
HND-G -+++ _______ + 
HND-D3 
HND-D8 
---+++---
------+++ 
HindllI Methylase - + + + + + + + + + + -
HindIII Endonuclease - + + + + + + + + + + + 
6.6 kb---
4.4kb---
2.2 kb---
1 2 3 4 5 6 7 8 9 10 11 12 
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dam-AG17 S'-AG G G GA TG G AGAG G G G A-3' 
S'-AC AT AG GGG AG AG GC AGG 
3'-TGTATC CC CTC TC CGTCC 
Mbol/MflI 
TG-3' 
AC-S' 
Fig. 4.21. Target site from 045113 containing a 17 base pair G rich 
homopurine sequence overlapping the dam methylation site 5'-GATC-3'. 
The dam site is contained within an MflI recognition sequence, an 
endonuclease sensitive to dam methylation. MflI recognizes the sequence 5'-
RGATCY-3'. The plasmid pUCLEU2P was constructed by inserting a duplex 
containing this sequence into the XhoI site of pUCLEU2. The sequence was 
designed to include a C instead of a T at the 3' end of the MflI site to generate 
a BamHI site. This was used to screen clones for the proper construction. 
Also shown is oligonucleotide dam-AG17, a purine oligonucleotide designed 
to bind the target duplex in the purine triple helix motif. The oligonucleotide 
uses T opposite the single CG base pair. 
the analysis on yeast or human genomic DNA. The methylase must be 
purified before additional experiments can be conducted. 
A second site within 045113 was selected for cleavage. This site 
contained a 17 bp G rich purine sequence, interrupted by one C, and 
overlapping a dam methylase/MflI endonuclease site (Fig. 4.21). A duplex 
containing the target site was ligated into pUCLEU2 to generate pUCLEU2P. 
The high G content of the site made it untargetable by the pyrimidine triple 
helix motif previously used in this report. Instead, an oligonucleotide capable 
of binding in the purine motif was designed for the target site (89-91). The 
oligonucleotide contained G opposite each GC bp, A opposite each AT bp, and 
a T opposite the CG bp (92). Restriction enzyme competition experiments (93) 
demonstrated that the oligonucleotide completely saturated its target site at 1 
~M concentrations within one hour; however, no cleavage was observed if 
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the DNA was methylated and worked up using high pH for triplex 
disruption. 
In previous experiments the pH sensitivity of the pyrimidine motif has 
been used to adjust the specificity of triple helix formation, and to displace the 
oligonucleotide following methylation (4, 68, 85). The purine motif is pH 
insensitive because there is no protonation requirement for binding (90). As 
a result the oligonucleotide was not displaced by the high pH and inhibited 
both the methylase and the restriction enzyme. While there is no 
documented low temperature procedure for removing the oligonucleotide 
from the binding site, Beal and Dervan have demonstrated that the purine 
motif is sensitive to the presence of polycations in solution, and that 
potassium inhibits triple helix formation possibly by stabilization of a four 
stranded competing structure between the oligonucleotides (90, 92). Attempts 
to remove the third strand by either of these procedures were unsuccessful. 
Addition of an oligonucleotide complementary to the third strand also failed 
to disrupt the triple helix. Thus, while the target site can be saturated with 
oligonucleotide, it remains to be demonstrated that the third strand can be 
displaced for restriction enzyme digestion. 
Conclusion 
Direct physical isolation of specific DNA segments from the human 
genome is an important objective in human genetics. Oligonucleotide-
directed triple helix formation is a recognition motif for double helical DNA 
of sufficient generality and specificity to allow single site targeting of 
endogenous sequences in gigabase DNA. To test whether triple helix 
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mediated enzymatic cleavage was capable of liberating a specific segment of a 
human chromosome, we targeted the tip of human chromosome 4. Using a 
pool of partially degenerate pyrimidine oligonucleotides, a 16 bp purine 
sequence overlapping an AluI methylase/Sst! endonuclease site was 
identified in a cosmid within a previously unsequenced locus proximal to the 
Huntington's disease gene. In the presence of an oligonucleotide specific for 
the target site, DNA isolated from a somatic cell hybrid containing human 
chromosome 4 and total mouse genomic DNA was exhaustively methylated. 
Subsequent triplex disruption and restriction enzyme digestion afforded in 
greater than 80% yield a single fragment, 3.6 Mb in size, containing the entire 
candidate region for the Huntington's disease gene. Each step in the process 
of target identification and cleavage is sufficiently generalizable that most 
cosmids should contain a sequence targetable by triple helix formation. This 
method may facilitate the orchestrated dissection of human chromosomes 
from normal and affected individuals into megabase sized fragments, and 
facilitate the isolation and analysis of candidate gene loci. 
Materials and Methods. 
Materials Restriction enzymes were obtained from New England 
BioLabs, Boehringer Mannheim, and Gibco BRL (Sst! only). All methylases 
were obtained from New England Biolabs and used without further 
purification. T4 DNA ligase and the Klenow fragment of E. coli DNA 
polymerase were obtained from New England Biolabs. Sequenase 2.0 dideoxy 
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sequencing kits were purchased from United States Biolabs. Taq DNA 
polymerase and PCR buffers were obtained from Boehringer Mannheim. 
Perfect Match for PCR was obtained from Stratagene. PCR reactions were 
performed on a Perkin Elmer Cetus thermocycler. Prep-a-Gene DNA 
purification matrix and buffers were obtained from Bio-Rad. Large scale 
plasmid purification was performed using maxi-plasmid purification kits 
from Qiagen according to manufacture suggested protocols. Radioactive 
nucleotides 32P-a-dCTP and 32P-a-dATP were obtained from Amersham [10 
mCi/ml, 3000 Ci/mmol]. Unlabeled mononucleotides were purchased from 
Pharmacia, mixed at 2.5 mM in each nucleotide, and stored in small aliquots 
for PCR reactions. Sephadex G-10 and G-50 matrices, spermine e 4HCl 
(nuclease free), ampicillin, lauryl sarcosyl, 10 mg/ml salmon sperm DNA 
(fragmented and phenol extracted), and bovine serum albumin (20 mg/mL 
nuclease free) were obtained from Sigma. Saccharomyces pombe 
chromosomal DNA and concatenated A DNA size standards and Incert low 
melting point (LMP) agarose were purchased from FMC Bioproducts. 
Electrophoresis grade agarose and LMP agarose were purchased from Gibco 
BRL. Plasmid pUC19 was obtained from Pharmacia. HD113.2B DNA 
prepared in LMP agarose was prepared by L. Riba in D. Housman's lab. 
Oligonucleotides were synthesized on an Applied Biosystems 380 B 
DNA synthesizer. Cosmid and yeast chromosomal cleavage products were 
resolved on a CHEF-DRII pulsed-field gel electrophoresis (PFGE) chamber 
from Bio-Rad. Human chromosome 4 cleavage products were resolved on a 
CHEF MAPPER PFGE chamber from Bio-Rad. DNA blotting was 
accomplished using a Stratagene Pressure Blotter. 0.45 Micron Nytran 
membrane was obtained from Schleicher and Schuell. DNA nicking was 
accomplished with a UV Products short UV TS-20 transilluminator. The 
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DNA was immobilized by UV irradiation with a Stratagene Stratalinker. 
Radioactive emissions were detected on a Beckman LS 3801 liquid 
scintillation counter. DNA hybridization (Southern blotting) was 
accomplished in a Robins Scientific rotating hybridization incubator, Model 
310. Autoradiography was performed using Kodak X-Omat AR film with an 
intensifying screen at _700 C and developed on a Kodak M35 A X-OMA T film 
processor. Densitometric traces were recorded on an LKB Bromma Ultrascan 
XL Laser Densitometer. Quantitative estimates of cleavage and PCR 
amplification were made on by storage screen phosphoresence using the 
Molecular Dynamics Phosphor Imager. 
Oligonucleotide Synthesis and Purification. Oligonucleotides used for 
triple helix formation were deprotected in concentrated NHtOH at 550 C for 
12 to 24 hours in screw cap eppendorf tubes. Following deprotection the 
ammonia was removed with argon for 30-60 min. The oligonucleotides were 
dried by lyophilization and purified on a 20% acrylamide (45% urea) lxTBE 
denaturing gel. The band was visualized by UV shadowing, cut from the gel, 
and eluted in 200 mM NaCl and 10 mM EDTA at 370 C overnight. The 
oligonucleotides were subsequently desalted by passage through a Sep-Pak 
reverse phase cartridge and eluted in 40% acetonitrile in water. The 
concentration was determined by UV absorbance and the oligonucleotide 
aliquoted into eppendorf tubes and dried for storage at -200 C. 
Oligonucleotides for duplex insertion or PCR amplification were either 
not purified and used immediately after deprotection and neutralization, or 
in the case of a few oligonucleotides, purified by FPLC using a gradient of 100 
mM triethyl ammonium acetate (TEAA) pH 7.0 and 40% acetonitrile in 
TEAA. The oligonucleotide was synthesized with the final dimethoxytrityl 
group attached at the 5' end, and the purification accomplished by separation 
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of the trityl-on material from all failure sequences. The trityl group was 
subsequently removed in 80% glacial acetic acid for 30 min., the solution 
dried, and the oligonucleotide desalted as described above. 
Oligonucleotides containing the novel bases 03 and 08 were 
deprotected in 0.1 N NaOH at 55° C instead of concentrated ammonia. All 
other purification steps were as described both for gel and FPLC purification. 
Cleavage Reactions. Complete protocols for the site specific cleavage of 
plasmid, cosmid, yeast, and somatic cell hybrid chromosomal DNA are 
included in the figure legends for the appropriate substrate. DNA 
hybridization was performed as described in Chapter 3. 
Detection of Human Chromosome 4 Cleavage Products by the PCR. 
Human chromosome 4 cleavage products were detected by resolving the 
fragments on a 0.8% LMP agarose gel in Ix TAE at 2.0 V /cm, 14°C, 106° switch 
angle, 32 min. switch times for 72 hours. The full length of the reaction lanes 
containing the cleavage product were excised from the gel and cut into 5 mm 
sections perpendicular to the length of the gel. The DNA in each fraction was 
denatured by melting the agarose at 96° C for 5 min. and vortexed to evenly 
distribute the DNA throughout the volume of the agarose. PCR reactions 
were performed using 5 III of the denatured solution in a total volume of 50 
Ill. Sequence tagged sites (STS) spanning the length of 4p16.3 (94) and an STS 
from QDPR that maps to 4p15.3 (95) were used for PCR analysis (66, 67). All 
amplification reactions were performed in in 10 mM tris-HCI, pH 8.3 (at 25° 
C), 50 mM KCl, 1.5 mM MgClz, 0.001 % (w Iv) gelatin, 200 IlM of each dNTP,2 
IlM in each oligonucleotide primer, 0.25 units of Perfect Match, and 2.5 units 
of Taq DNA polymerase in 50 III total volume. 
D4590 was the most telomeric 5T5 analyzed by the PCR (44). The 
primers used for amplification were: D4590-5',5'-GTCCAGAGGAAGATG-
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TGTAGG-GAC-3' and D4S90-3', 5'-CTACCACACCAGATCGACTAAGC-3' 
(94). Temperature conditions for amplification were 94° C 1.0 min., 60° C 1.0 
min., and 72° C for 1.0 min. for 30 cycles. Amplification intensity was 
improved using 58° C hybridization temperature, but it also raised the 
background amplification. 
D4S43 maps to the center of the HD candidate region (36). Primers 
specific for amplification of this locus were: D4S43-5', 5'-GACTGGTTG-
TTTGAGGGCGTTG-3' and D4543-3', 5'-TCCTTGACTCTGCTTCACC-3' (94). 
Amplification was accomplished using 28 cycles at 94° C 1.0 min., 60° C 1.0 
min., and 72° C 1.0 min. 
D4S125 is near the proximal boundary of the HD candidate region (48, 
60). It is a highly polymorphic loci containing variable number of terminal 
repeats (VNTR). A region to the 3' side of a VNTR was chosen for PCR 
amplification. The primers were YNZ32-5', 5'-CTCTGGTCTGAGG-
TGCTGAC-3' and YNZ32-3', 5'-CGGCAGCTGAGGAGGTGCCT-3' (48). 
Amplification was accomplished using 28 cycles at 94° C 1.0 min., 60° C 1.0 
min., and 72° C 1.0 min. The amplification was rather weak and a very strong 
primer dimer was observed at a size just smaller than the desired product. A 
hot start might improve the signal with these primers (96). 
An STS within D4S10 telomeric to the cleavage site was developed by 
partially sequencing H5.52 DNA (43). Amplification and detection of this STS 
is described in figure 4.15. 
A centromeric STS within D4S10 was also tested to determine the 
nature of the 3.6 Mb cleavage product. The primers used were: D4S10-5', 5'-
GGCACCTGGA TCTCGGGC-3' and D4SlO-3', 5'-GGAACGGGAGGCCAGC-3' 
(71). Amplification was accomplished using 30 cycles at 94° C 1.0 min., 60° C 
1.0 min., and 72° C 1.0 min. 
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QDPR was the most centromeric STS analyzed by PCR. It maps one 
cytogenetic band below the expected cleavage site (95). Primers specific for this 
site were: QDPR-5', 5'-GTCACTAACCTGTCTCAGTGTGG-3', and QDPR-3', 
5'-GTAGTCAAGATGACAGCCACTGTC-3' . Amplification was accomplished 
using 30 cycles at 94° C 1.0 min., 60° C 1.0 min., and 72° C 1.0 min. 
All amplification products were resolved on a 0.8% 1xTAE agarose gel 
and transferred to a Nytran membrane. The blot was hybridized as described 
in Chapter 3 with random primer radiolabeled product generated by 
amplification of the original clone. Amplification intensity was quantitated 
by phosphor imager analysis. The values were then standardized and plotted 
as a function of distance migrated verses percent total amplification in the 
lane. 
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Chapter V 
Proposal: Identification of the Huntington Disease 
Gene by Analysis of Oeavage Products 
Triple helix mediated enzymatic cleavage is a highly specific technique 
for efficient cleavage of human chromosomes (1, 2). By targeting the 
chromosome 4p16.3 marker, D4510, the Huntington Disease (HD) gene was 
liberated on a 3.6 Mb fragment resolvable by pulsed field gel electrophoresis 
(2). We propose to utilize this material for the physical identification of the 
HD gene. A pair of somatic cell hybrids have been created that contain 
chromosome 4 from affected and unaffected siblings (3). Despite the 
phenotypic difference between these Siblings, the chromosomes are identical 
at all informative polymorph isms throughout the 4p16.3 region (4). The 
identification of a sequence difference between these matched chromosomes 
would be a strong candidate for the HD mutation. We propose to specifically 
cut both chromosomes at D4510 and other distal genetic markers by triple 
helix mediated enzymatic cleavage, and in collaboration with Dr. David 
Housman, screen the purified telomeric material for the HD mutation. These 
screening strategies include: (i) analysis of the telomeric products for 
sequence variation by in-gel renaturation and differential 51 nuclease 
sensitivity (5, 6), and (ii) site specific cleavage of distal genetic markers on both 
chromosomes to generate 200-500 kb products for creation of a matched yeast 
artificial chromosome (Y AC) library (7). These materials and techniques 
provide a strategy to physically search 4p16.3 from D4510 to the telomere for 
the HD mutation. 
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Cleavage of Chromosome 4 at D4510 and Determination of Purity. 
D4SlO (8) was targeted for triple helix mediated enzymatic cleavage by the 
identification of a homopurine target sequence, 16 bp in length, partially 
overlapping an Sst! site (5'-GAGCTC-3') (2). Methylation by AluI (5'-AGCT-
3') in the presence of a 16 base oligonucleotide specific for the target site 
rendered all Sst! sites resistant to digestion (9), except the single site left 
unmodified due to triple helix formation. Enzymatic treatment of DNA 
isolated from somatic cell hybrid HDl13.2b containing human chromosome 4 
(>200 Mb) and total mouse genomic DNA E~1M gigabase pairs) (10) liberated a 
3.6 Mb telomeric fragment in greater than 80% yield (2). Thus, site specific 
cleavage at D4SlO liberated a large, resolvable fragment that contained both 
HD candidate regions (4). We propose to use this technique to produce 
enriched telomeric material containing the HD candidate region and 
subsequently use it to identify the HD mutation. 
Some issues about the cleavage product remain to be addressed. A 
fundamental issue is the relative purity of the isolated material. In HDl13.2B, 
approximately 2% of total DNA is human, and only 0.04% of the DNA is 
from 4p16.3. The maximum cleavage yield in any reaction is 2 ng, if all the 
DNA is cut and all the cleaved product migrates into the gel. PCR suggests 
that at least half the DNA remains at the origin dispite the high cleavage 
efficiencies. This reduces the yield to less than 1 ng per reaction. Ethidium 
bromide staining of reaction products resolved on pulsed field gels detects a 
faint smear that runs the length of the gel. Although the intensity of this 
band is light, it is significantly more DNA than the expected 1-2 ng that 
constitutes the maximum yield. Therefore, from the PCR and DNA 
hybridization analysis it is not clear to what extent the tip has been enriched. 
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P.reliminary analysis of the reaction product by Alu-PCR (11) suggests 
that the telomeric fragment is significantly contaminated with other DNA. 
Alu-PCR amplifies only human genomic DNA, and each chromosome has a 
characteristic amplification pattern (11). HD113.2B contains only 
chromosome 4, and amplification results in six major amplification products 
(11). A second somatic cell hybrid, HHW693, contains human DNA from 
4p15 to 4pter only (12). Alu-PCR of HHW693 generates four major 
amplification products, all distinct from the products generated from 
HDI13.2B. Other regions in the chromosome dominate the amplification 
reaction when subsections of the chromosome are amplified. Alu-PCR was 
performed on fractions containing the cleavage product. Significant 
enrichment was expected to generate an amplification pattern akin to 
HHW693; however, the amplification pattern was more like that of 
HDI13.2B. This suggests, but does not prove, that a significant portion of 
human chromosome 4 contaminates the cleavage product. If true, it implies 
that the DNA also contains Significant mouse chromosomal DNA. 
A slot blot assay could be used to get a better estimate of the purity of 
the cleavage product. Denatured DNA from each fraction on the gel could be 
transfered to a slot on a Nytran membrane and hybridized with either mouse 
or human repetitive sequences. Using standardized mixtures of total mouse 
and total human DNA, the relative ratios of mouse and human DNA in the 
gel fractions could be calculated. By determining the ratio of human to 
mouse DNA in the product fractions, compared to the ratio in the equivalent 
fractions from the lane that contained no oligonucleotide, the enrichment of 
4p16.3 DNA could be calculated. The assay tolerates minimal cross-
hybridization between mouse and human repetitive DNA, a stringency not 
obtained in a preliminary attempt to complete this analysis. 
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If the DNA is not sufficiently pure for subcloning and other types of 
analysis, the enrichment for 4p16.3 DNA could be improved by either (i) 
obtaining AluI methylase of higher specific activity and purity, or (ii) 
switching to the use of the cognate methylase for Sst! endonuclease. The AluI 
methylase obtained from New England Biolabs was not highly purified, and 
did not retain consistent activity between lots when assayed for complete 
methylation of genomic DNA. Purification of the methylase, taking care to 
retain only the purest fractions and passing the enzyme over a S-
homocysteine affinity column as the final step in purification, could result in 
methylase with greater specific activity and poSSibly improved product purity. 
The use of Sst! methylase might be the best approach to the preparation 
of pure product. Sst! is not commercially availiable, and it is not known if 
Sst! methylase is inhibited by triple helix formation. However, Sst! methylase 
only modifies a small subset of the sites methylated by AluI, and might be an 
enzyme of greater specific activity for the D4S10 target site. Sst! methylase has 
a six base pair recognition site which would eliminate methylation at 
statistically 16 fold fewer sites, as well as a vast number of sites in interspersed 
repetitive DNA (13, 14). This might improve the specific activity of the 
methylation reaction for the target site by 16 to 100 fold, and could 
significantly improve the purity of the resulting cleavage product. The 
development of an assay for DNA enrichment and improvements in the 
specific activity of the enzymes used for modification and cleavage are two 
critical areas that need to initially be addressed. 
Cleavage of Matched Cell Lines. The generation of a telomeric 
fragment containing the HD candidate region is not equivalent to 
identification of the HD mutation, but the ability to generate enriched 
telomeric DNA from 4p16.3 would be useful toward that goal if it could be 
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generated from both an HD affected and a normal chromosome. Analysis 
could then be undertaken to explore the HD specific physical differences 
between these relatively short megabase fragments. Because polymorphisms 
would be extensive between two unrelated individuals, chromosomal 
substrates should be chosen that have maximal homozygousity through the 
region, while remaining phenotypically distinct relative to HD. 
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Fig. 5.1. Pedigree of family 1 from which matched chromosomes were 
derived. The affected and unaffected chromosomes indicated by arrows have 
been isolated in somatic cell hybrids HHW1248 and HHWI272, respectively. 
Recombination in family 1 and two additional families (see Chapter 4) 
suggested a highly telomeric location for the HD gene because it segregated 
from all informative marker allelle from D4510 to D45111, a locus 
approximately one megabase from the telomere (Fig. 5.1) (4, 15). However, 
telomere cloning and analysis of a highly telomeric restriction length 
polymorphism (RFLP) (l00 kb) failed to detect the postulated recombination 
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(16, 17). Additional evidence, including telomere exchange (18) and linkage 
disequilibrium with internal loci (16, 17, 19, 20), suggested that an internal 
location for the HD gene is more likely (21, 22). This proximal location is 
supported by recombination in two other families (4,23). If the HD gene is 
within the internal candidate region, then the critical recombination in 
families 1-3 must have been either local double recombination or gene 
conversion (23). If the double recombination that transferred the HD gene 
covered an interval of a few kilobase pairs or more, it would also exchange a 
number of polyrnorphisms between the two parent chromosomes. 
Therefore, sequence differences between the two chromosomes would either 
be the HD mutation or tightly linked to it. If a polymorphism between the 
two chromosomes could be identified, it would direct efforts toward the 
characterization of the HD mutation. 
Triple helix mediated site specific cleavage of these two chromosomes 
could be used to prepare material for polymorphism analysis. John 
Wasmuth's group has generated a pair of somatic cell hybrids that contain 
maternal chromosome 4 from an affected and an unaffected sibling (Fig. 5.1), 
HHW1248 and HHWI272, respectively (3). peR amplification and sequencing 
indicate that both of the chromosomes contain the complete 5stIltripie helix 
target site within D4510. Generation of 3.6 Mb fragments from these matched 
chromosomes will reduce the search for the HD gene to a comparison of two 
3.6 megabase products containing a cluster of sequence differences localized to 
a narrow region. The experimental challenge becomes the development of a 
strategy to physically detect small differences between two large DNA 
fragments. 
Mutational Analysis of Megabase Fragments. Using a modification of 
the in gel renaturation technique developed by Dr. Igor Roninson (5, 6, 24), 
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the DNA differences between these two cell lines can be identified. This 
technique was originally developed to analyze cell populations where gene 
amplification was suspected, but no probes corresponding to the amplified 
gene were available (5, 6, 24). The technique facilitated the detection. of 
amplified fragments in restriction digests of total cellular DNA, identifying 
fragments that correspond to the essential gene within the amplicon. 
The telomeric fragment isolated by triple helix mediated cleavage will 
be digested with a restriction enzyme with 6-bp specificity and labeled to high 
specific activity with T4 DNA polymerase (Fig. 5.2). This labeled fragment 
will serve as the tracer (5, 6, 24). Making use of the complete yeast artificial 
chromosomal (YAC) contig of 4p16.3 (25), YAC DNAs from the region will be 
digested with the same restriction enzyme and used as driver (DNA in excess) 
(5, 6, 24), to scan 4p16.3 for any mutations or physical differences between the 
two cell lines. The tracer and driver DNAs will be mixed together and run in 
a single lane of an agarose gel, followed by a series of in gel denaturations, 
renaturations, and Sl nuclease treatments (Fig. 5.2). In order to identify 
differences between these two cell lines, each YAC will be pooled with DNA 
cut from HHW1272 in one lane and HHW1248 in a second lane. After the in 
gel hybridization and nuclease treatment, the only fragments remaining in 
the gel will be those that are homologous between the telomeric fragment 
and the YAC (Fig. 5.2). 
The second dimension of this procedure will involve two different 
gels. In the first case the nuclease treated lanes will be excised as an intact 
agarose strip, turned 90 degrees and loaded onto a second agarose gel. This 
will reveal a series of diagonal spots representing the DNA fragments present 
in the YAC used as driver. If any spots are off the diagonal, these represent 
differences between the cell line DNA and the YACs. However, if a difference 
.. 
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Fig. 5.2. Scheme for the identification of the HD or tightly linked 
mutation using differential in gel hybridization, 51 nuclease treatment, and 
two dimensional gel electrophoresis. 
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is only seen in the HD cell line, this represents a polymorphism between the 
HD and the normal chromosome. In the second class of gels proposed for 
detection of polymorphism, we will load the agarose strips on top of 
denaturing gradient gels to detect possible melting differences between the 
HD and normal chromosome hybrids with the YAC driver DNA. 
If a difference between the two cell lines can be identified, we will 
narrow the location of the polymorphism by working with smaller YACs that 
map to the same interval, and eventually conducting the assay with cosmid 
DNA generated from the YAC inserts. Although the actual HD mutation 
might not be one readily detected by differential 51 reactivity, the theory of a 
double crossover or gene conversion implies that a number of other 
physically linked, but unrelated, mutations will be present in the region. The 
detection of anyone alteration will define the region that underwent 
conversion. Once that region is identified to a single locus, sequencing will 
reveal the specific mutation .. 
Flanking Cut Sites and a Matching Y AC Library. Linkage 
disequilibrium and two recombination events place the HD gene between 
D4510 and D45168 (E4) (21, 22). Cleavage at D45168 would eliminate a large 
amount (",1 .5 Mb) of unnecessary DNA from the fragment to be searched. A 
flanking cut would reduce the fragment to approximately 2.0-2.5 Mb (21) and 
demonstrate the utility of this technique for the cleavage of loci not tightly 
linked to the telomere. 
Craig Ventor has generated over 60 kb of sequence information from 
D45113, a genetic marker just proximal to D45168, but most likely telomeric to 
HD (26). A computer search of this sequence reveals a number of possible 
target sites for triple helix mediated enzymatic cleavage. These include, but 
are not limited to, an 18 bp purine rich sequence that overlaps a HindIII site 
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(S'-AAGCTI-3') and a G-rich sequence 17 bp in length that invades a dam 
methylase (S'-GATC-3') and MflI restriction enzyme site (S'-RGATCY-3'). 
Each site requires the development of a new enzyme system for genomic 
cleavage, but sites similar to these have been well behaved at the plasmid 
level. 
If the material generated by cleavage and gel purification is insufficient 
in quantity or purity the region could be further subdivided into fragments of 
a size suitable for cloning into YAC vectors. This would require generating a 
cleavage event every 200 to 500 kb within the 2.5 Mb candidate region. 
Because a complete YAC contig is available for this critical region and much 
of the DNA is subcloned into cosmids (25), it should be a straightforward 
exercise to identify target sites that are separated by the desired interval. 
If necessary, both the matched chromosomes will be cut at target sites 
spanning the HD candidate region to generate a series of fragment pairs with 
clonable ends. The products will be cloned into YAC's to produce a set of 
clones that should be identical except at the HD locus. This library of ordered 
clone pairs would be used in the Roninson gel experiments, and could greatly 
simplify the search for the desired mutation by making the DNA easily 
accessible in large quantity. However, any sequence difference identified 
would have to be confirmed within the original uncloned DNA to insure 
that the mutation was not generated by subcloning. 
Both of these techniques provide a direct physical method for the 
identification of the mutation reSponsible for Huntington's disease. Previous 
analysis of HD has relied upon genetic mapping of random DNA fragments, 
physical mapping of these fragments,and linkage disequilibrium in HD 
families to map the HD gene. While these techniques have been invaluable 
to the localization of the mutation, the genetic data is sufficiently ambiguous 
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that they have not provided a definitive placement of the HD gene to one 
region within 4p16.3 (27). Efforts with these techniques have reached a level 
of diminishing return. The complexity of the problem requires that new 
strategies for the physical analysis of genomic DNA be developed (23). The 
site specific cleavage of human chromosome 4p16.3 into megabase and 
kilobase sized fragments provides a novel approach to identify the mutation 
responsible for Huntington's disease. 
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Appendix A 
Oligonucleotide Sequences 
Name I Sequence I Designed Application 
A IAdenoviruslPlasmid Affinity Cleaving 
A -5' S'-T"TTTLI I I I I ILl I I ICT-3' A Affinity Cleaving 
A -3' S'-TTTTCI I I I I ICTTTTCT"-3' A Affinity Cleaving 
A -S'3' S'-T"TITCI I I I I ICTTTTCT*-3' A Affinity Cleaving 
A -S'ln! 5' -T"TITC1'*'1 I I I I CTTTTCT -3' A Affinity Cleaving 
A -S'lnt2 S'-T*TTTCT* I I I I I CT"TTTCT-3' A Affinity Cleaving 
A -S'lnt23' S'-T*TITCT*TITTTCT*TTTCT"-3' A Affinity Cleaving 
A_MecBrU 5'-PBBBMBBBBBBMBBBBMB-3' A Affinity Cleaving 
A -18 S'-TTTTCI I I I IICTTTTCT-3' A Competition 
Ad-t S'-PCTICTTCTICTICTTCCCCTCC-3' Adenovirus Cleavage 
Ad-2 S'-T*II 1 1 1 1 I 1 1 I I I I I I IC-3' Adenovirus Cleavage 
Ad-3 S'-T'TCTCCTTTTCCTICTC-3' Adenovirus Cleavage 
Ad-4 S'-T*TCTCCTICCTCTTCTICTTC-3' Adenovirus Cleavage 
Ad-S 5'-T*TCTICTCCTTCTICTTCTC-3' Adenovirus Cleavage 
p3' S'-TTTTTCTCTCTCTCT*-3' pDMAGI0 Cleavage 
pS' 5'-T*TTTTCTCTCTCTCT -3' pDMAGI0 Cleavage 
pS'3' S'-T*TTTTCTCTCTCTCT*-3' pDMAGI0 Cleavage 
pt6 5'-1'*'111 I ICTCTCTCTCT-3' pDMAGI0 Mismatch 
pt7 5' -T*CTTTTTCTCTCTCTCT -3' pDMAGI0 Mismatch 
Cooperativity 
A -9 3'A' S'-TICTTTTCT"-3' Cooperativity 
A -9B S'-TTTTCTTTT-3' Cooperativity 
A-9C 5'1" S'-T*TTTCTTTT-3' Cooperativity 
A -7 3'N S'-CTTITCT"-3' Cooperativity 
A -l1B S'-TTTTCII I I I 1-3' Coopera Ii vity 
A-11M S'-TTTTCTTTTTC-3' Cooperati vi ty 
A -l1CS'P S'-T*TTTC I I I I I T-3' Cooperativity 
Coop-90 S'-TICCTTTTT-3' Cooperati vity-Base 
Stacking 
Coop-91 S'-TTTCCTTTT-3' Cooperativity-Base 
Stacking 
Coop-92 S'-TTTTCCTTT-3' Cooperativity-Base 
Stacking 
--
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Plasmid/Yeast Construction 
AG-I S'-TCGAGTCGAAGAAAAGAAGAG Yeast Construct I 
AAAGAAGAATTCGCGGCCGC-3' (Not Used) 
CT-I S'-TCGAGCGGCCGCGAATTCTI'CT Yeast Construct I 
TTCTCTTCTTTTCTTCGAC-3' (Not Used) 
AG-2 5'-TCGAGCCGGAAGAAAAGAAGAG Yeast Construct 2 
AAAGAAGATCGATGCGGCCGC-3' (Not Used) 
CT-2 S'-TCGAGCGGCCGCATCGATCTTCTT Yeast Cons truct 2 
TCTCTTCTTTTCTTCCGGC-3' (Not Used) 
AAG S'-TCGACTCGAAGAAAAGAAGAAAG Yeast Construct A 
AAAAAGAA TTCG-3' 
AcT S'-TCGACGAATTCI I I IICTTTCTTC Yeast Construct A 
TTTTCTTCGAG-3' 
BAG S'-TCGACCCGGAAGAAAAGAAGAA Yeast Construct B 
AGAAAAAGGATCCG-3' 
BCT S'-TCGACGGATCCI I I I ICTTTCTTCT Yeast Construct B 
TTTCTTCCGGG-3' 
Spe 5'-TCGACTTTTCTTTCCTTTTCTTTT Yeast Construct C 
ACTAGTAAAAGAAAAGGA 
AAGAAAAG-3' 
HindIII S'-TCGACTAGT AAAGAAAAAGCTTTC Yeast Construct D 
bistop TTCTT ACT AG-3' 
HindIII S'-TCGACTAGTAAGAAGAAAGCTTTT Yeast Construct D 
bisbot TCTTT ACT AG-3' 
SfiI Long S'-GATCGGCCTCTAGGGCCCTGCA-3' pUCSfi Construction 
Sfi Short 5' -GGGCCCT AGAGGCC-3' pUCSfi Construction 
E-top S'-TCGACTCGCTAA TGGAAAGAGA Yeast Construct E 
GAGAGAGCTCACGTG-3' 
E-bottom 5'-TCGACACGTGAGCTCTCTCTCTTT Yeast Construct E 
CCATTAGCGAG-3' 
113-Top S'-TCGACACAGAAGGATATAAAGAA Yeast Construct H 
AGCTTT AG-3' 
I 13-Bot S'-TCGACTAAAGCTTTCTTTATATCC Yeast Construct H 
TTCTGTG-3' 
YST-Purl S'-TCGACATAGGGGAGAGGCAGGGG Yeast Construct P 
ATCCGTG-3' 
YST-Pur2 S'-TCGACACGGATCCCCTGCCTCTCC Yeast Construct P 
CCTATG-3' 
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Sequencing/General PCR Primers 
LEU2 5'-CCAIIIIIAATAAGGCAATAAT-3' Yeast Insert 
Sequence Sequencing 
LEU2PCR S'-CAGT ACCTTT AGCAAA TTGTGGC-3' LEU2PCR 
UP-MID S'-AAGGCTTACTTACTGATAGTAGA-3' pUCLEU2 Sequencing 
A-MID S'-ACATACCACCCATAATGTAATAG-3' pUCLEU2 Sequencing 
Xho-23S 5'-TCT A TT ACA TT A TGGGTG Yeast PCR 
GTATGTT-3' 
Xho+2S0 S'-GGTCAAGATATTTCTTGA Yeast PCR 
ATCAGGC-3' 
UP 1200 S'-GGTTTTCCCAGTCACGACGT-3' pUC19 Sequencing/PCR 
UP 1201 S'-AGGAAACAGCTATGACCATG-3' pUC19 Sequencing/PCR 
UP-200 S'-A TACCGCACAGATGCGT AAG-3' pUC19PCR 
UP-380 5'-TCACA TGTTCTTTCCTGCGT-3' pUC19 PCR 
Yeast Cleavage 
CTT' S'-T'TCTTTTCTTCTTTCI II I 1'-3' Yeast Affinity Cleaving 
YST-P S'-T*TClI I ICTTCTTTCTTTTT-3' Yeast Affinity Cleaving 
MeCTT' S'-T*TMTTTTMTTMTTTMI I I I 1'-3' Yeast Affinity Cleaving 
MecBrup S'-PBMBBBBMBBMBBBMBBBBP-3' Yeast Affinity Cleaving 
YST_Tt S'-TtTCTTTTCTTCTTTCI I 111-3' Yeast Affinity Cleaving 
CTA S'-CTTCTTTTCTTCTTTCTTTTTCTT -3' Yeast Enzymatic 
MeCTA S'-MTTMTTTTMTTMTTT 
Cleavage 
Yeast Enzymatic 
MI I II IMTT-3' Cleavage 
MecBrUA S'-MBBMBBBBMBBMBBB Yeast Enzymatic 
MBBBBBMBB-3' Cleavage 
CTB S'-CCTTCTTTTCTTClTICTTTTTCCT-3' Yeast Enzymatic 
Cleavage 
MeCTB 5'-MTTMTTTTMTTMTTTM Yeast Enzymatic 
TTTTTMTT-3' Cleavage 
MecBrUB 5'-MBBMBBBBMBBMBBBM Yeast Enzymatic 
BBBBBMBB-3' Cleavage 
MeCTBAD S'-TMTTTMTTTTMTTTMTTM Yeast Enzymatic 
TTTTMT-3' Cleavage 
Control 
Yeast Marker PCR 
PGK.PCR1 5'-CATGTTTGACAGCTTATCAT-3' PGKI PCR 
PCK.PCR2 S'-A TGT AAGTTTCACGAGGTTC-3' PGKIPCR 
TRP3-A S'-CCTTGAA TCCCGACACA TTG-3' TRP3PCR 
TRP3-B 5'-TCTGCGTA TTTGAGAGCCTG-3' TRP3PCR 
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Human Chromosome 4 Affinity Cleaving 
HuntG-lS S'-T"MTIMTITIMGMTIT-3' HC4 Affinity Cleaving 
HuntG-24 S'-T"MTMTIGGMTMTIMTITI HC4 Affinity Cleaving 
MGMTIT-3' 
Hunt Z-lS S'-TMTIMTITIMD3MTIT-3' HC4 Affinity Cleaving 
HuntZ-24 S'-TMTMTID3D3MTMTIMTI HC4 Affinity Cleaving 
TIMD3MTIT-3' 
G81-6A2- S'-T"TGMMTITMTMTMTMTMT" HC4 Affinity Cleaving 
G2 
G81-6A2- S'-T"TD3MMTITMTMTMTMTMT-3' HC4 Affinity Cleaving 
Zl 
G81-6A2- S'-T"TD3MMTITMTMTMTMTMT"-3' HC4 Affinity Cleaving 
Z2 
G83-SBI-Gl S'-T"MMMTGMMMTIMTTITI-3' HC4 Affinity Cleaving 
G83-SBI-Zl S'-T"MMMTD3MMMTIMTTITI -3' HC4 Affinity Cleaving 
G83-SBI-Z2 S'-T"MMMTD3MMMTIMTf1T"T-3' HC4 Affinity Cleaving 
G83-SBl- S'-T"-PIPIPITD3PIPIPITIMI I I I 1-3' HC4 Affinity Cleaving 
PIZI 
G82-4C-lSl S'-T"TCTITCI I I ICTIT-3' HC4 Affinity Cleaving 
G82-4C-lS2 S'-T"TCTITC I I I ICTIT"-3' HC4 Affinity Cleaving 
G82-4C-231 S'-T"TCTICCCTICTITCTITICTIT-3' HC4 Affinity Cleaving 
G82-4C-232 S'-T"TCTICCCTICTITCTITICTIT"-3' HC4 Affinity Cleaving 
Target Site Search by PCR 
TAG-PCR S'-TACA TGCCAATGACGACTGC-3' PCRAnchor 
Eco-Seq S'-GGGTITICCCAGTCACGAC-3' Sequencing Primer 
EC012PCR S'-TACATGCCAATGACGACTGCGT EcoRI Purine Site 
GAA TICYYYYYYYYYYYY -3' Search (PCR) 
DAM-TAG S'-TACATGCCAA TGACGACTGC dam Purine Site 
RRRRRRRRRRRRRRRRGA TC-3' Search (PCR) 
MSP-TAG S'-TACATGCCAATGACGACTGC Mspl Purine Site 
YYYYYYYYYYYYYYYYCCGG-3' Search (PCR) 
ECG-TAG S'-TACATGCCAA TGACGACTGC EcoRI Purine Site 
RRRRRRRRRRRRRRRGAA TIC-3' Search (PCR) 
TAQ-TAG S'-TACATGCCAA TGACGACTGC Taql Purine Site 
YYYYYYYYYYYYYYYYTCGA-3' Search (PCR) 
ALU-TAG S'-TACATGCCAATGACGACTGC Alul Purine Site 
RRRRRRRRRRRRRRRRAGTC-3' Search (PCR) 
HAE-TAG S'-TACATGCCAATGACGACTGC HaeIII Purine Si te 
RRRRRRRRRRRRRRRRGGCC-3' Search (PCR) 
PYR-TAG S'-TACATGCCAA TGACGACTGC Purine Site Search (PCR) 
YYYYYYYYYYYYYYYYY A-3' 
HPH-TAG S'-TACATGCCAATGACGACTGC Hphl Purine Site 
YYYYYYYYYYYYYYYYTCACC-3' Search (PCR) 
PST-TAG S'-TACATGCCAATGACGACTGC PstI Purine Site 
YYYYYYYYYYYYYYYYCTGCAG-3' Search (PCR) 
CLA-TAG S'-TACATGCCAATGACGACTGC Clal Purine Site 
YYYYYYYYYYYYYYYY A TCGAT -3' Sea rch (PCR) 
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AG-DAMI6 5' -RRRRRRRRRRRRRRRRGA TC-3' dam Purine Site Search 
No Anchor (PCR) 
AG-ALUI6 5'-RRRRRRRRRRRRRRRRAGCT-3' Alul Purine Site Search 
No Anchor (PCR) 
AG-HAE16 5'-RRRRRRRRRRRRRRRRGGCC-3' HaeIlI Purine Site Search 
No Anchor (PCR) 
AG-15-ECO 5' -RRRRRRRRRRRRRRRGAA TIC-3' EcoRI Purine Site Search 
No Anchor (PCR) 
CT16-TAQ 5'-YYYYYYYYYYYYYYYYTCGA-3' Taqi Purine Site Search 
No Anchor (PCR) 
CTl6-MSP 5'-YYYYYYYYYYYYYYYYCCGG-3' MspI Purine Site Search 
No Anchor (PCR) 
CT-18 5'-YYYYYYYYYYYYYYYYYT -3' Purine Site Search 
No Anchor (PCR) 
Target S.ite Search by AchiIles Heel (AC) 
Eco-Me 5'-DDDDDDDDDDDDDDDDMTI-3' EcoRI Purine Search (AC) 
dam-Me 5'-DDDDDDDDDDDDDDDDMT-3' dam Purine Search (AC) 
Msp-Me 5'-MMDDDDDDDDDDDDDDDDT-3' MspI Purine Search (AC) 
Hae-Me 5'-DDDDDDDDDDDDDDDDMC-3' HaeIlI Purine Search 
(AC) 
Alu-Me 5'-DDDDDDDDDDDDDDDDTC-3' AluI Purine Search (AC) 
Taq-Me 5'-MTDDDDDDDDDDDDDDDDT-3' TaqI Purine Search (AC) 
Hha-Me 5'-DDDDDDDDDDDDDDDDC-3' HhaI Purine Search (AC) 
Alu-Taq 5'-GAPPPPPPPPPPPPPPPPAG-3' AluI or TaqI Purine Site 
Search (AC) 
Hpa-Hae 5'-GGPPPPPPPPPPPPPPPPGG-3' HpaII or HaeIII Purine 
Site Search (AC) 
Human Chromosome 4 Enzymatic 
Cleavage 
Alu-16 5'-MMTTTMTMTMTMTMTC-3' HC4 Enzymatic Cleavage 
(D4SIO) 
Alu-19G 5'-TTGMMTITMTMTMTMTMTC-3' HC4 Enzymatic Cleavage 
(D4SIO) 
Alu-GAI6 5'-GAGAGAGAGAGAAAGG-3' HC4 Enzymatic Cleavage 
(D4S10) 
Alu-16Pl 5'-Pl PI TITPI TPI TPI TPI TPI TC-3' HC4 Enzymatic Cleavage 
(D4S10) 
HND- 5'-TMTTMMTGTGTTTMTTTC-3' HC4 Enzymatic Cleavage 
A62.8 (D4S113-HindIII Site) 
(HND-G) 
HND-D3 5'-TMTTMMTD3TD3TITMTTTC-3' HC4 Enzymatic Cleavage 
(D4S113-HindIII Site) 
HND-D8 5'-TMTTMMTDSTDSTITMTTTC-3' HC4 Enzymatic Cleavage 
(D4S113-HindIII Site) 
dam-17AG 5'-AGGGGATGGAGAGGGGA-3' HC4 Enzymatic Cleavage 
(D4S113) 
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Human Chromosomal PCR Primers 
04510-5' 5'-GGCACCfGGA TCI'CGGGC-3' HC4 04510 PCR 
04510-3' 5'-GGAACGGGAGGCCAGC-3' HC4 04510 PCR 
55G8-1 5'-CGGGcrGGGTICCAGCAAGG-3' HC4 04510 PCR 
(Sequence Confirmation) 
5SG8-4 5'-CATA TGTI'GAAGTCcrGCCG-3' HC4 04510 PCR 
(Sequence Confirmation) 
H5.52-3' 5'-GTCATCGCCTCTITGTGGAT-3' HC4 04510 PCR 
(Did not Amplify) 
H5.52-5' 5'-CCCAGAGCfGTAGCTGCCAC-3' HC4 04510 PCR 
(Did not Amplify) 
5'-H5.52 (2) 5'-AAAGACGTGAGGTAGTGTCC-3' HC4 04510 PCR 
5'-H5.52 (2) 5'-GTAGGAAGCTGACACACCAG-3' HC4 04510 PCR 
G83-O.4 3' 5'-AAGCTTGCATGCCTGCAGGT-3' HC4 04510 PCR 
G83-O.4 5' 5'-GGCTTCfGGCCfCCACAACf-3' HC4 04510 PCR 
YNZ32-5' 5'-CTCTGGTCfGAGGTGcrGAC-3' HC4 045125 PCR 
YNZ32-3' 5'-CGGCAGcrGAGGAGGTGCCf-3' HC4 045125 PCR 
04595-5' 5'-GAGTCTACCGGTGCCAAA-3' HC4 04595 PCR 
04595-3' 5'-TGGCCfCfCCAGATGGAATGT HC4 04595 PCR 
GCTC-3' 
04543-5' 5'-GACfGGTTGTTTGAGGGCGTIG-3' HC4 04543 PCR 
04543-3' 5'-TCCTTGACTCfGCTTCACC-3' HC4 04543 PCR 
04599-5' 5'-AAAGGTAGCAGTCCAGGC-3' HC4 04599 PCR 
04599-3' 5'-TGTGTGTCCCAGGCAG-3' HC4 04599 PCR 
045115-5' 5'-ATCAAGTCGAGGGACCfGGGCf-3' HC4 045115 PCR 
045115-3' 5'-CAGACAGCAGAGTCCACGGACAG-3' HC4 045115 PCR 
04597-5' 5'-GGTAGGGAGAGCfGCACGTG-3' HC4 04597 PCR 
04597-3' 5'-CAGACAGCAGAGTCCACGGACAG-3' HC4 04597 PCR 
04590-5' 5'-GTCCAGAGGAAGATGTG HC4 04590 PCR 
TAGGGAC-3' 
04590-3' 5'-CTACCACACCAGATCGACfAAGC-3' HC4 04590 PCR 
QOPR-5' 5'-GTCACf AACCTGTCTCAGTGTGG-3' HC4QOPRPCR 
QOPR-3' 5'-GTAGTCAAGATGACAGCCA HC4QOPRPCR 
CTGTC-3' 
TC65 5'-TTGCAGTGAGCCAAGAT-3' Alu-PCR 
TC65R 5'-ATCTCAGCTCACfGCAA-3' Alu-PCR 
Enzymatic Cleavage at Misc. 5ites 
myc-dam 5'-MMMMMTITTM I I I I IIMT-3' c-myc Enzymatic 
Cleavage 
myc-Alu 5'-MTMTMTITMTTMTTTTC-3' c-myc Enzymatic 
Cleavage 
EGFR-Eco 5'-TTMTTMTTTD3MMTP1PIP1 PI T EGFR Enzymatic 
GMTT-3' Cleavage 
LIF-Alu 5'-MMGTTTMMTTTTC-3' HC22 Enzymatic 
Cleavage 
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Triole Helix SDeciiicitv Assav (SELEX) 
DEG-17 S'-ACCTGCTGCAGLLLLLLLLLLLLLLLLL Triple Helix SELEX 
GAA TI'CGCAGTCGTCA (Template) 
TTGGCATGTA-3' 
64-mer S'-TTGGCATCCTGCAGTCGAACTGAA Triple Helix SELEX 
TTCNNNNNNNNNNNNNNNNGC (Template) 
TGAGCTCCCGTI'CCGA TGG-3' 
64-mer 3' S'-CCATCGGAACGGGAGCTC-3' Triple Helix SELEX 
(Primer) 
64-mer S' S'-TTGGCA TCCTGCAGTCGA-3' Triple Helix SELEX 
(Primer) 
Oligonucleotide sequences are listed with the following base 
abbreviations: T* (thymine-EOTAeFe(II», M (5-methy!cytosine), B (5-
bromouracil), Pl (3-methy!-5-amino-1H-pyrazo!o-[4,3-dlpyrimidine-7-one), 03 
(3-benzamido)phenylimidizo!e), 08 (3-napthamido)phenylimidizo!e), Y (50% 
T, 50% C), R (50% A, 50% G), L (40% G, 40% A, 10% T, 10% C), N (25% A, 25% 
G, 25% C, 25% T), 
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Nonenzymatic Double Strand Cleavage of a 
Yeast Chromosome at a Single Site in High 
Yield by Triple Helix Formation. 
Thomas J. Povsic, Scott A. Strobel and Peter B. Dervan* 
Arnold and Mabel Beckman Laboratories of Chemical Synthesis 
California Institute of Technology 
Pasadena, California 91125 
Abstract: N-Bromoacetyloligodeoxyribonucleotides bind adjacent binding 
sites on double helical DNA by triple helix formation and alkyl ate single 
guanine positions on opposite strands in high yield. After depurination, the 
double strand cleavage yields in a plasmid (6 kbp in size) are greater than 85% 
and provide DNA fragments with termini that are ligatable with DNA 
fragments generated by restriction endonuclease digestion. The nonenzymatic 
double strand cleavage at a single site in a yeast chromosome, 340,000 base 
pairs in size, occurs in 85-90% yield. 
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Reliable models for the sequence-specific recognition of double helical 
DNA by low molecular weight peptides that bind in the minor groove,l,2 small 
protein-DNA binding domains,3,4 and oligonucleotide triple helix motifs 5-7 
now exist. This is due, in part, to a combination of footprinting/affinity 
cleaving methods 1 for determining sequence specificities, major and minor 
groove locations, and binding orientations of ligands on DNA, and the direct 
structural characterization of some of these complexes by nuclear magnetic 
resonance spectroscopy 8 and x-ray diffraction analyses. 9 The design of 
sequence-specific DNA cleaving molecules requires the integration of two 
separate functions, recognition and cleavage. It should be possible to combine 
DNA binding motifs with mechanism-based reactive functionalities capable of 
oxidation of the deoxyribose,lO,n electrophilic modification of the bases,l2 or 
hydrolysis ofthe phosphodiester backbone.13 
Two criteria for successful bifunctional design are sequence specific 
reactions at designated single atoms within the bound complex and cleavage 
yields that are quantitative under physiological relevant conditions (neutral 
pH, 37 DC). In order to maximize stoichiometric reactions on DNA, the 
"cleaving functionality" must be sufficiently reactive to proceed at reasonable 
rates on DNA at 37 DC, be inert to aqueous media and buffer components, and 
not suffer unimolecular decomposition in competition with the desired reaction 
on DNA. In order to locate reactive moieties within angstroms of designated 
single atoms within a DNA binding site by designed synthetic molecules, 
information on groove location and relative base pair position within the 
ligand-DNA complexes is pivotal. In the absence of direct NMR or x-ray data, 
structural information can be provided by the affinity cleaving technique 
which relies on the generation of a nonspecific diffusible oxidant (hydroxyl 
radical) at a discrete location within a bound ligand-DNA complex by the 
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attachment of EDTA·Fe within a DNA binding motif.1 Replacement of a 
diffusible nonspecific DNA cleaving moiety generated by EDTA-Fe(1I) useful 
for studying DNA recognition (affinity cleaving) to a nondiffusible base-
specific moiety 11 ,12 is a key issue with respect to the design of sequence-
specific DNA cleaving molecules. Sequence-dependent recognition can be 
coupled with sequence-dependent cleavage. One example is the conversion of 
distamycin-EDTA'Fe to N -bromoacety ldistamycin. 12 N-
Bromoacetyldistamycin binds DNA in the minor groove at a five base pair A,T 
rich site and alkylates a single adenine position at N3 within those sites at 37 
°C.1 2 
Triple helix motif for DNA recognition . Pyrimidine 
oligodeoxyribonucleotide bind in the major groove of DNA parallel to the 
purine Watson-Crick strand through formation of specific Hoogsteen hydrogen 
bonds to the purine Watson-Crick base.5,6 Specificity is derived from thymine 
(T) recognition of adenine·thymine (AT) base pairs (TAT triplet); and N3-
protonated cytosine (C +) recognition of guanine'cytosine (GC) base pairs 
(C + GC triplet) . The generalizability of triple-helix formation has been 
extended beyond purine tracts to mixed sequences containing all four base 
pairs by the identification of other natural base triplets,5c,7 alternate strand 
triple-helix formation,5d and designed nonnatural triple-helix motifs.1 4 
Oligonucleotides equipped with EDTA-Fe can bind specifically to duplex 
DNA by triple-helix formation and produce double-strand cleavage at single 
sites in large DNA.5 Oligonucleotide-directed triple-helix recognition was 
shown to be a viable nonenzymatic approach for the site-specific cleavage of 
megabase DNA when an oligonucleotide-EDTA-Fe was targeted to a 20-base 
pair sequence in the 340-kilobase pair chromosome III of Saccharomyces 
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cerevisiae.15 Double-strand cleavage products of the correct size and location 
were observed, indicating that the oligonucleotide bound and cleaved the 
target site among almost 14 megabase pairs of DNA.15 Because 
oligonucleotide-directed triple-helix formation has the potential to be a 
general solution for DNA recognition, this result had implications for physical 
mapping of chromosomes. 
The chemical yields for double strand cleavage by oligonucleotide-
EDTA-Fe are typically low.5 In the case of plasmid (6 kb)5a and A phage (48.5 
kb)5b DNA, the yields for site-specific double strand cleavage are 15-25% 
respectively. This is adequate for the purposes of addressing questions related 
to molecular recognition, such as binding specificites, site size, and 
orientation. In the case of mega base DNA, the yields decline further 6%.15 If 
the full potential of oligonucleotide-directed recognition of double helical DNA 
is to be realized for site-specific cleavage of mega base DNA of high complexity, 
the design of oligonucleotides equipped with moieties capable of quantitative 
and base specific modification of DNA is an area for further development. 
Sequence specific alkylation of double helical DNA by triple helix 
formation. We recently reported the design and synthesis of an 
oligodeoxyribonucleotide equipped with an N-bromoacetamide at the 5'-
terminal thymidine that binds sequence specifically to a 19 base pair site in 
double-helical DNA by triple-helix formation and at 37 °C alkylates 
predominantly at a single guanine nucleotide adjacent to the target DNA 
sequence in high yield.16,17 Model building of triple-helical complexes 
indicated that pyrimidine oligodeoxyribonucleotides bound in the major 
groove parallel to the purine strand of the duplex and when equipped with a 
bromoacetyl moiety at the 5'-end, position the electrophile proximal to a 
guanine base two base pairs to the 5'-side of the target sequence. Reaction of 
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the electrophilic carbon with N-7 atom of guanine adjacent to the local triple 
helix results in covalent attachment of the oligonucleotide to the target 
sequence. Upon warming in the presence of base, depurination at the position 
of alkylation occurs and cleavage of one strand of the DNA backbone is 
observed. The DNA termini are 5' and 3' phosphoryl (Figure 1).18 
Despite the high yields, N-bromoacetyloligonucleotide-directed sequence 
specific alkylation of a single GC base pair in the major groove is limited to 
cleavage of one strand of the DNA binding site. The question arises whether 
this chemistry could be extended to cleavage of both strands of the double 
helical DNA target site. For example, two adjacent triple helix sites with two 
bromoacetyloligonucleotides bound on opposite strands would afford 
alkylation/cleavage on both strands. This should result in DNA fragments 
with sequence specific overhangs suitable for ligation by restriction enzymes. 
If the overall yields are sufficiently high for double strand cleavage, this 
nonenzymatic approach to recognition and cleavage might be realized at single 
sites in megabase DNA. 
We report here that two adjacent inverted oligonucleotide binding sites 
on double helical DNA, each containing a guanine residue two base pairs to 
the 5' side of each triple helix binding site affords double strand cleavage of 
DNA at a single site in high yield (Figure 2). From analysis of cleavage 
patterns on high resolution sequencing gels, the cleavage on each strand is at a 
single position. Analysis of a 6.7 kb plasmid revealed that double strand 
cleavage is achieved at a single site in 85% yield. Base work up results in DNA 
termini that are ligatable with complementary DNA fragments produced by 
restriction enzyme digestion. Within chromosomal DNA of high complexity, 
the nonenzymatic reaction is sufficiently efficient and specific that it produces 
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double strand cleavage at a single site in high yield within a yeast 
chromosome, 340,000 bp in size. 
Results and Discussion 
Synthesis of N-bromoacetyloligodeoxyribonucleotide (5) The synthesis 
of 5'-O-DMT-3'-phosphoramidite 3 follows in two steps from the previously 
described aminonucleoside 1 19 (Figure 3). Protection of the primary amine 
with flourenylmethyl chloroformate, followed by activation of the 3' hydroxyl 
with {3-cyanoethyl-N,N-diisopropylchlorophosphoramidite 20 affords a 
thymidine derivative containing an appropriately protected linker-amine 
suitable for use in standard automated oligodeoxyribonucleotide synthesis. 
Incorporation at the 5' terminal base of an oligonucleotide was achieved in 
high yield. Deprotection of the amine occurs quantitatively under standard 
deprotection conditions (concentrated NH40H, 55 °C, 20 hr.), as analyzed by 
reverse-phase and anion-exchange HPLC, and polyacrylamide electrophoresis. 
Oligodeoxyribonucleotide-amine 4 was allowed to react with the N-
hydroxysuccinimide of bromoacetic acid to afford N -
bromoacetyloligodeoxyribonucleotide 5 which was purified by anion exchange 
HPLC.16,18 
Construction of target sequence. We previously demonstrated that 
efficient alkylation could be achieved at guanine two base pairs to the 5' side 
on the purine strand of a triple helical binding site using an N-
bromoacetyloligonucleotide.16 By extension, adjacent inverted triple 
helix/alkylation sites would afford opposite strand alkylation and cleavage. 
Consideration of the cleavage patterns produced by triplex mediated 
alkylation indicates that a target sequence of the type 5' -
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(pyrimidine)mNC(N)nGN-(purine)m-3' which contains two inverted binding 
sites for triple helix formation may be suitable for double strand cleavage. 
This places cleavage positions on both strands of adjacent binding sites 
separated by n bases. Juxtaposition of the two inverted binding sites results in 
the formation of a local four-stranded structure at the junction of the binding 
sites (Figure 4). Therefore, the two sites of alkylation were separated by a few 
base pairs (n=2). 
The target site was designed with a single guanine two base pairs to the 
5' side of each triplex binding site, the position most efficiently alkylated by 
the bound N-bromoacetyloligonucleotide 5. A single G flanked by A,T or C 
promotes cleavage specific to a single nucleotide position on each strand. Upon 
base workup 3, overhangs of size n + 1 are produced reminiscent of the type 
generated by several restriction enzymes. The double strand cleavage could 
result in DNA termini compatible for ligation with those produced via 
cleavage with a restriction endonuclease. 
Based on the above considerations, the sequence 5'-
CTTTTCTTTCCTI'I'I'CTTT 
TACTAGTAAAAGAAAAGGAAAGAAAAG-3' was cloned into the pUCLEU2 
plasmid to generate pUCLEU2C. This sequence contains binding sites on each 
strand for the N-bromoacetyloligonucleotide 5 (5'-T4MeCT4MeC2T3MeCT4-3') 
previously shown to efficiently modify the purine strand.I6 After modification 
of the targeted guanine by the N-bromoacetyloligonucleotide, base treatment, 
depurination of guanine, and strand scission, the resulting 3'- overhang (CTA-
3') is compatible with one of the ends (TAG-3') generated by Sfi I cleavage at 
the site (5'-GGCCTCTAJ GGGCC-3'). Finally, by cloning the site into a 
plasmid containing the LEU2 gene,21 a gene essential for biosynthesis of 
leucine, it will be possible to specifically introduce this site into yeast 
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chromosome ill. This will facilitate the study of the specificity of cleavage 
afforded by N-bromoacetyloligonucleotides from the single base pair to the 
mega base pair level. 
High resolution analysis of opposite strand cleavage specificity. To 
insure that the oligonucleotide bound and efficiently modified the DNA solely 
at the targeted guanine bases, a 974 base pair NarllEcoRI restriction fragment 
from pUCLEU2C containing the triple helix sites was radiolabeled with 32P 
approximately 210 base pairs from the target sites. DNA labeled on either 
strand (3' or 5' end-labeled) was allowed to react with N -
bromoacetyloligonucleotide 5 at 1 pM concentration at 37°C for 36 hr. (0.8 mM 
Co(NH3)+3, 20 mM Hepes pH 7.4).1S,22 After workup (0.1 M piperidine, 90 °C, 
30 min.), analysis of the high resolution polyacrylamide gel reveals that 
modification occurred solely at a guanine nucleotide located two bases to the 5' 
side of each oligonucleotide binding site (Figure 5). From phosphorImager 
analyses, the cleavage yields were > 96% on each strand. A plot of 
In[DNA]intactl[DNA]total vs. time (pseudo-first order conditions) indicates 
the reaction between oligonucleotide 5 and double helical DNA is first order in 
DNA target concentration with pseudo-first order rate constants that 
correspond to a halflife for alkylation within the triplex of 5.5 and 6.5 hr. for 3' 
and 5' end labeled strand, respectively. IS The measured rates are not 
significantly different from that reported for reaction of the N-
bromoacetyloligonucleotide when only a single binding site is present. IS 
Double strand cleavage of plasmid DNA. To determine the yield of double 
strand cleavage, bromoacetyloligonucleotide 5 at 1 pM concentration (0.8 mM 
Co(NH3)S+3, 20 mM Hepes pH 7.4) was allowed to reactfor 36 hr. at 37°C with 
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a linearized plasmid DNA, 6.7 kbp in size. Cleavage at the adjacent triple helix 
target sites should produce DNA fragments 3.3 and 3.4 kilobase pairs in size 
which could be analyzed by nondenaturing gel electrophoresis. Treatment of 
the alklyated plasmid with 0.1% piperidine at 55 °C for 12 hr. in a buffer 
containing 10 mM EDTA, 10 mM Tris pH 8.0 and 100 mM NaCI resulted in 
two DNA fragments (Figure 6). Radiolabeled DNA was used to determine the 
efficiency of double helical cleavage. The 32P end labeled products were 
separated by agarose gel electrophoresis and phosphorImager analyses 
indicated double helical cleavage efficiencies of 85%. No cleavage was 
observed in the absence of N-bromoacetyloligonucleotide 5. 
Enzymatic ligation of DNA products reSUlting from double strand 
cleavage by N-bromoacetyloligonucleotides. Cleavage of pUCLEU2C 
with N-bromoacetyloligonucleotide 5 produced ends with the 3' overhanging 
sequence 5'-CTA-3' (Figure 7). End product analysis following piperidine 
workup indicated that the 3' and recessed 5' termini of both ends contain 
phosphate groups.lB Ligation reactions between restriction enzyme digested 
products involve joining of 5' phosphate to the 3' hydroxyl of complementary 
sequences. Digestion of the plasmid pUCSfiI with SfiI produced the 3' 
overhanging sequence, 5'-TAG-3', which is complementary to the end of the 
oligonucleotide digested product. Because the 3' end of the SfiI product 
contains a free hydroxyl group, it could be ligated to the 5' phosphate of the N-
bromoacetyloligonucleotide digested DNA. It is unlikely that the 3' phosphate 
end of the oligonucleotide digested product is ligatable to the 5' phosphate of 
the restriction enzyme cut DNA; however, the remaining single strand nick 
could readily be repaired in vivo following transformation. The oligonucleotide 
cleavage products of pUCLEU2C (EcoRl cut) were ligated into the SfillEcoRI 
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fragment of pUCSfiI by T4 DNA ligase. The colonies were screened by Q-
complementation and five of each of the resultant plasmids were sequenced. 
All products were consistent with simple ligation of each of the N-
bromoacetyloligonucleotidelEcoRI cut fragments into the StiIlEcoRI sites of 
pUCSfiI. None of the products contained the G postulated to be lost upon 
modification and base workup. Thus, this synthetic cleavage agent produced 
DNA cleavage products that can be ligated into restriction enzyme digested 
DNA. 
Double strand cleavage of a yeast chromosome 340 base pairs in size at 
a single site with N-bromoacetyloligonucleotides. Oligonucleotides 
equipped with the nonspecific DNA cleaving moiety EDTAFe(II) are capable 
of binding to and cleaving DNA at a single site within a yeast chromosome but 
in low yield. Moreover, unless conditions are carefully chosen, oligonucleotide-
EDTA·Fe bind and cleave at partially homologous secondary sites. Coupling of 
a base specific cleaving moiety to an oligonucleotide capable of binding by 
triple helix formation may result in a molecule that may bind at secondary 
sites, but not react in the absence of a guanine residue two base pairs to the 5' 
side of the local triplex. Further specificity would be obtained by the 
requirement that triple helix sites be present on both strands of the DNA 
within a reasonable number « 20-30) of base pairs for double strand 
modification, cleavage and denaturation to occur. 
To test the specificity of cleavage by N-bromoacetyloligonucleotides in 
megabase DNA, we constructed a yeast strain containing the double strand 
alkylation target site present in pUCLEU2C. The plasmid contains the target 
site adjacent to the LEU2 gene, which encodes ll-isopropylmalate 
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dehydrogenase, an enzyme that catalyzes the third step in leucine 
biosynthesis. A defect in this gene prohibits growth of yeast on leucine 
deficient minimal media. The PsU fragment from pUCLEU2 containing both 
the LEU2 gene and the target sequence was homologously recombined into 
chromosome ill of a leu2 deficient yeast strain (SEY6210). Recombinants were 
selected by growth on minimal media lacking leucine. The target site was 
verified through use of the polymerase chain reaction (PCR) to amplify the 
target site insertion.23 The target site is positioned on chromosome ill such 
that cleavage should produce 230 and no kb products. 
Chromosomal DNA from the appropriate strain, SEY6210C, was prepared in 
low melting point (LMP) agarose to prevent mechanical shearing of the DNA. 
The DNA was reacted with the N-bromoacetyloligonucleotide 5 using two 
cleavage cycles. This was accomplished by reacting the chromosomal DNA 
with oligonucleotide 5 as described above, followed by several washes in a low 
salt, high pH buffer to disrupt the triple helix and remove unreacted 
oligonucleotide from the solution. The DNA was reequilibrated in triple helix 
alkylation buffer, and a second aliquot of N-bromoacetyloligonuc1eotide 5 
added. The DNA was then treated with 0.1% piperidine at 55 °C for 12 hr. to 
affect double strand cleavage. The cleavage products were resolved by pulsed 
field gel electrophoresis and visualized by ethidium bromide staining and by 
Southern blotting with the chromosome ill specific marker, HIS4 .24 
Incubation of total yeast chromosomal DNA with N-
bromoacetyloligonucleotide 5 resulted in the cleavage of chromosome ill to 
produce 230 and no kb products (Fig. 8). Ethidium bromide staining detected 
no other cleavage products within 14 megabase pairs of total yeast genomic 
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DNA, nor was there evidence of random degradation of total genomic DNA by 
the piperidine treatment. As a control, no cleavage products were detected on 
DNA from a yeast strain lacking a target site. No cleavage was observed in 
the absence of oligonucleotide. The cleavage efficiency was accurately 
quantitated by Southern blotting with the HIS4 marker specific to the 110 kb 
product. A double strand cleavage efficiency of 90% was observed at the target 
site after two 20 hr. reaction cycles, and no low efficiency secondary cleavage 
sites were detected on chromosome III. Slightly reduced cleavage efficiency 
(85%) was detected if only one cleavage cycle was performed. These 
efficiencies for single site cleavage of chromosome III are in sharp contrast to 
oligonucleotide mediated affinity cleaving which cut at four secondary sites 
within chromosome III at a maximum overall yield of 6%. The specificity and 
efficiency of the nonenzymatic oligonucleotide-directed alkylation of DNA are 
comparable to that achieved by oligonucleotide mediated enzymatic 
cleavage.25 
Conclusion. We have examined oligonucleotide-directed alkylation of double 
helical DNA at inverted dimeric binding sites. The specificity of the cleavage 
reaction is derived from the requirement of two properly positioned 
oligonucleotide binding sites that each contained a G two base pairs to the 5' 
side of the triple helix site. This specified a total recognition/reaction site of 40 
bp. The chemical cleavage reaction resulted in termini that were ligatable 
into compatible ends generated from restriction enzyme digestion. Thus, using 
a fully nonenzymatic approach to recognition and cleavage of single sites in 
megabase DNA, efficiencies comparable and specificities exceeding those 
attained by enzymatic cleavage of yeast genomic DNA mediated by triple helix 
formation were achieved. 
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Experimental 
Collidine, fIuorenylmethyl chloroformate and 2-cyano-N,N-
diisopropylchlorophosphoramidite were purchased from Aldrich and used 
without further purification. Diisopropylethylamine (Aldrich) was distilled 
from CaH2 prior to use. Dry solvents (DMF, methylene chloride, dioxane) were 
obtained from Fluka. Restriction enzymes were obtained from New England 
BioLabs, and used with the manufacturer's supplied buffers. Polynucleotide 
kinase, T4 DNA ligase and the Klenow fragment of DNA polymerase were 
obtained from Boehringer Mannheim. Radioactive nucleotides w e r e 
purchased from Amersham. Prep-a-Gene matrix was purchased from Bio-Rad. 
Plasmids were purified using Maxi-plasmid purification kits from Qiagen. 
Dideoxy-sequencing kits were obtained from US Biochemicals. Yeast strain 
SEY6210 was obtained from Scott Emr. The HIS4 marker used from Southern 
blotting was the gift of Randy Schekman. Cobalt (Ill) hexamine trichloride 
was obtained from Kodak. Incert LMP agarose was obtained from FMC 
Biochemicals. 
Deoxyribonucleoside 2. Aminonucleoside 1 (820 mgs., 1.27 mmoles 
lyophilized from dioxane) was dissolved in 5 ml of dry dioxane. Colli dine (500 
mI., 3.9 mmoles, 3 equivalents) was added, and the solution chilled to 0 °C. 
Flourenylmethyl chloroformate (670 mgs., 2.6 mmoles, 2 equivalents, 
dissolved in 5 ml dry dioxane) was added over a ten minute period, and the 
reaction warmed to room temperature. After 20 min., tIc (5% MeOH in MeCI2) 
showed one product. The solution was frozen and lyophilized. 
Chromatography in 2% MeOH in MeCl2 afforded pure product (1.02 gms, 92% 
yield). IH NMR (CDCI3): Ii 7.72 (m, 2H), 7.55 (m, 2H). 7.13-7.39 (m, 14H), 6.80 
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(q, 4H). 6.35 (t, IH, HI'), 4.48 (m, IH, H3'), 4.37 (d, 2H), 4.15 (t, IH), 4.04 (m, 
IH, H4'), 3.74 (s, 6H, OCH3), 3.38 (m, 2H, H5'), 3.06-3.20 (m, 4H), 2.37 (m, 2H, 
H2') 2.18 (m, 4H). IR (KBr) cm- I : 3307, 3065, 2933, 1701, 1508, 1448, 1251, 
1177, 1091, 1032,909, 829, 759, 714. HRMS (FAB) calculated for 
C50H5IOlON4 (M+H+): 867.3607. Found 867.3580. 
Phosphoramidite 3. Deoxyriboucleoside 2 (150 mgs., 176 mmoles) was 
dissolved in 3 mls dry methylene chloride. Diisopropylethylamine (350 mIs, 2 
mmoles) and 2-Cyano-N,N-diisopropylchlorophosphoramidite (100 ml, 448 
mmoles) were added, and the reaction stirred for 3 hr. The reaction was 
quenched with the addition of ethanol (0.5 ml) and diluted with ethyl acetate. 
The organic layer was washed with satd. NaHC03, water, and twice with satd. 
NaCl. After drying over Na2S04 and concentration, flash chromatography 
using 500:15:5 methylene chloride:isopropanol:triethylamine solvent mixture 
afforded 110 mgs. of product (60% yield). IH NMR (CDCI3): S 8.40 (bs, 1H), 
7.72 (t, J = 7.3 Hz, 2H), 7.55 (m, 3H), 7.13-7.39 (m, 13H), 6.79 (m, 4H), 6.33 (m, 
1H, Hd, 5.49 (m, 1H), 4.59 (m, 1H, H3'), 4.39 (d, 2H-Fmoc, J = 6.6 Hz), 4.15 (m, 
1H), 4.09 (m, 1H), 3.77 (s, 6H, OCH3), 3.54 (m, 2H, H5'), 3.52-3.65 (m, 4H), 
3.12-3.24 (m, 4H), 2.57 (t, J = 6.1 Hz, 1H), 2.37 (t, J = 6.1 Hz, 1H), 2.26 (m, 2H), 
1.98-2.06 (m, 4H), 1.00-1.14 (m, 12H). IR (KBr) cm-I : 3385, 3065, 2966, 2930, 
1715, 1508, 1458, 1251, 1180, 1081, 1032, 979, 830, 760, 743, 700 3IP NMR 
(CDCI3): S 149.081, 148.812. HRMS calculated for C59HS7NSOllPl 
(M·Na +):1089.4536. Found 1089.4503. 
Oligodeoxyribonucleotide·amine 4. Oligonucleotide 4 was synthesized on 
an Applied Biosystems 380B automated DNA synthesizer, and deprotected 
with concentrated NH40H at 55° for 20 hr. After lyophilization, the 
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oligonucleotide was purified by electrophoresis through a 20% denaturing 
polyacrylamide gel. The oligonucleotide was eluted from the excised band 
with 200 mM NaCl, 1 mM EDTA for 24 hr. at 37°C, dialyzed against Millipore 
Ultra-pure water, and its concentration determined based on its UV 
absorbance (extinction coefficients were determined by summing the values 
for the individual nucleosides using values of C260 = 8800 for T and Talk, 
C260 = 5700 for MeC, C280 = 6400 for T and C280 = 8300 for MeC). 
N-Bromoacetyloligonucleotide 5. Ten nanomoles of the oligonucleotide 
were dissolved in 10 pI of 200 mM borate buffer, pH 8.9. An equal volume of 
250 mM N-hydroxysuccinimidylbromoacetate 14 in DMF was added. After 10 
min., the solution was injected onto a Hewlett-Packard 1090 HPLC equipped 
with a Vyadac oligonucleotide anion exchange 4.6 x 200 mm column. The 
probe was eluted in 20 mM Na2HP04, 20% acetonitrile buffer, using a gradient 
of 40-80% N aCl over 60 min.. Elution times were 15.4 min. for the 
underivitized oligonucleotide 4, and 18.2 min. for the N-
bromoacetyloligonucleotide 5. The product peak was collected and extracted 
with butanol to remove the acetonitrile. Salts were removed using a 3 ml 
Sephadex G-50-80 spin column, and the eluent precipitated with 3 volumes of 
NaOAc/ethanoland washed with 70% ethanol. The probe was diluted in water 
to an appropriate concentration and stored at -20°C until needed. 
Cloning of plasmids pUCLEU2C and pUCSfiI. The plasmid pUCLEU2C 
was obtained by ligating a duplex of the inverted repeat oligonucleotide 5'-
T C G ACT T T T C T T T C C T 
TrTCTITrACTAGTAAAAGAAAAGGAAAGAAAAG-3' into the XhoI site of 
plasmid pUCLEU2. The ligation mixture was digested with XhoI prior to 
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transformation to relinearize plasmid DNA lacking a duplex insert. Plasmid 
pUCSfi was obtained by forming a duplex from the oligonucleotides 5'_ 
GATCGGCCTCTAGGGC-CCTGCA-3' and 5'-GGGCCCTAGAGGCC-3' and 
ligating into BamHI and Pst! cut pUC19. The insert was designed to retain in 
frame translation of the lacZ gene so that a-complementation could 
subsequently be used for subcloning into the SfiI site. Transformation was 
performed using competent E. coli strain XL-1 blue (Stratagene). Plasmids 
were screened by digestion with SpeI (pUCLEU2C) or SfiI (pUCSfiI) and 
confirmed by dideoxy sequencing. Plasmids were purified from 500 ml 
cultures using a Qiagen maxi-purification column according to manufacturer's 
protocols. 
Analysis at nucleotide resolution. pUCLEU2C was radiolabeled by first 
digesting with Nar J, to produce 5.6 and 1.1 kb fragments. The DNA was 5' 
end-labeled using Polynucleotide kinase and y_32P ATP, and 3' end-labeled 
using the Klenow fragment to incorporate a-32P-dCTP and a-32P-dGTP. After 
labeling, unincorporated nucleotides were removed using a 1 ml Sephadex G-
50-80 spin column. The DNA was digested with EcoR I, producing bands 4.5, 
1.1,9.0 and -160 base pairs in size. The 1.0 kb band, containing the target 
sequence, was separated by 5% polyacrylamide gel electrophoresis, excised, 
and eluted at 37° using a solution of 200 mM NaCI, 1 mM EDTA. The DNA 
was purified by filtration through a 0.45 mM filter, butanol extraction and two 
ethanol precipitations. 
Radiolabeled DNA was incubated in 20 pL reactions containing 0.8 mM 
Co(NH3)6+3, 10 mM Hepes pH 7.4 and 100 nM N-bromoacetyloligonucleotide 
5. After 24 hr., the reaction was precipitated with the addition of N aOAc and 
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EtOH, 70% ethanol washed, and treated with 1.0% piperidine at 90 °C for 30 
min. The samples were lyophilized, suspended in formamide buffer, and 
loaded onto a 6% denaturing polyacrylamide gel for analysis. Cleavage 
efficiencies were determined by phosphorimaging, using a model 4008 
phosphorImager and IQ software. 
Rate constants for the reaction of N-bromoacetyloligonucleotide 5 with each 
strand were determined by running 10 parallel reactions, and quenching 
reactions by EtOH precipitation at desired time intervals. After piperidine 
treatment and gel electrophoresis, phosphorImaging was used to determine 
the fraction of intact DNA. Plotting In(fraction of intact DNA) vs. time yielded 
pseudo first-order plots from which rate constants were derived.12 
Double stranded cleavage of plasmid DNA. Plasmid pUCLEU2C was 
linearized with Hind III and radiolabeled using Klenow and -a32PdATP, 
resulting in a 6.7 kb DNA fragment labeled at both ends with the target site 
located approximately an equal distance from each end . The DNA was 
incubated in a solution (final volume 20 Ill) containing 0.8 mM Co(NH3)6 + 3, 
10 mM Hepes pH 7.4, and 100 nM N-bromoacetyloligonucleotide for 24 hr. at 
37°. The DNA was precipitated with NaOAc/ethanol, washed in 70% ethanol, 
dried, and treated with 100 III of 0.1 % piperidine, 100 roM NaCl, 10 roM Tris 
pH 7.4, 10 roM EDTA at 55° for 12 hr. The DNA was loaded onto a 0.8% 
ethidiuro containing agarose gel and electrophoresed for 5 hr. at 100 V. 
Cleavage efficiencies were determined by phosphorImaging. 
Enzymatic ligation of double strand cleavage products. pUCLEU2C 
DNA was digested with EcoRI to completion and subjected to cleavage with N-
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bromoacetyloligonucleotide 5. The resulting 450 and 600 bp fragments were 
gel purified and cleaned with Prep-a-Gene matrix according to manufacturer 
protocol. 5 pg of pUCSfi DNA was cut with SfiI and EcoRI, and the 2.8 kb 
product gel purified and cleaned as above. 10 ng ofpUCSfiI DNA in 10 pI T4 
DNA ligase buffer (0.5 mM ATP, 20 mM Tris-HCI pH 7.4, 5mM MgCI2, 5mM 
dithiothreibol, 50 llg/ml BSA) was added to 2 molar equivalents of either of the 
oligo/EcoRI fragments from pUCLEU2C, heated to 55°C for 5 min. to denature 
all sticky ends, cooled to 16°C, and allowed to react with 10 units T4 DNA 
ligase for 4 hr. The ligation mixture was used to transform compotent E. coli 
(XLI-Blue, Stratagene) according to manufacturer's protocol and 
transformants selected on media containing ampicillin (50 mg/ml), and X-gal 
and IPTG for a-complementation. Growth overnight at 37°C produced white 
colonies which were minipreped by SDS/NaOH lysis and sequenced by 
dideoxynucleotide chain termination using the USB Sequenase 2.0 kit. 
Homologous recombination and production of alternate yeast strain. 
Haploid yeast strain SEY6210 (MATa leu2·3 112 ura3-52· his 3 -tl200 trp·tl901 
ly s2-801 suc2-tl9 GAL) was grown in a 200 mlliquid culture to an OD600 of 
0.7, harvested by centrifugation at 5,000 rpm for 5 min. at 50°C, washed in 
sterile H20, centrifuged, resuspended in 40 mls 0.1 M LiO Ac, 10 mM Tris-HCI 
pH 8.0, 1 mM EDTA and incubated at 30°C for 1 hr. Cells were again 
harvested by centrifugation, resuspended in 2 mls of LiOAc solution and 50 pI 
of competent cells aliquoted into sterile microcentrifuge tubes. 5 pg of PsU 
digested pUCLEU2C was added to the yeast solution and incubated at 30°C 
for 1 hr. The cells were heat shocked for 5 min. at 37 °C and harvested by brief 
(3 s.) centrifugation. The supernatant was removed, the cells resuspended in 
125 ml of sterile H20 and plated on yeast minimal media plates lacking 
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leucine. Recombinants were detected after two days at 30°C, selected colonies 
restreaked on a second minimal media plate, grown an additional two days at 
30°C, and screened for proper insertion of the oligonucleotide target sites 
adjacent to the LEU2 gene by PCR amplification and DNA hybridization. 
PCR amplification was performed using two oligonucleotides that hybridize 
approximately 250 bp on either side of the oligonucleotide insertion site (Xho-
235 5'-TCTATTACATTATGGGTGGTATGTT-3' and Xho + 250 5'-
GGTCAAGATATTTCTTGAATCAGGC-3'). Chromosomal DNA was prepared 
from 0.5 mls of yeast liquid culture by glass bead lysis followed by PCR 
amplification with Taq DNA polymerase (Perkin Elmer Cetus) according to 
manufactures protocol. The 500 bp amplified products were digested with 
either XhoI or SpeI. Proper insertion of the oligonucleotide target sites would 
yield a PCR product cut only with SpeI, whereas an improperly modified strain 
would be XhoI cut. Intact chromosomal DNA from SpeI cut transformants was 
prepared in an agarose matrix,26 separated on a pulsed-field gel and screened 
for unique insertion of the LEU2 gene within chromosome III by Southern 
blotting with the random primer labeled EcoRIIKpnI fragment from 
pUCLEU2C. DNA from a yeast strain meeting these criterion was then used 
in alkylation reactions with the oligonucleotide. 
Cleavage of yeast chromosomal DNA. DNA from yeast strains SEY6210 
(no target site) and SEY6210C (+ target site) was isolated in low melting 
point agarose. 26 Agarose plugs containing yeast strain SEY6210C and 
SEY6210 were cut to approximately 2 mm thickness (volume approximately 
80 pI) and placed in 2 ml Eppendorf tubes. The plugs were washed 4 times 
with 900 pI of 1 mM Co(NH3)6+3, 20 mM Hepes pH 7.2, and 5 mM EDTA 
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(triplex/alkylation buffer). After removal of the last wash, the plugs were 
incubated with 120 III of triplex/alkylation buffer, N-
bromoacetyloligonucleotide 5 was added to a final concentration of 111M, and 
the plugs incubated at 37°C. After 20 hr., the plugs were washed 4x 30 min. in 
900 III of pH 9.5, 10 mM Tris, 10 mM EDTA, allowing the N-
brornoacetyloligonucleotide to fully diffuse out of the agarose. The plugs were 
then washed 4 times for 15 min. each with 900 III of triplex/alkylation buffer, 
and incubated with 120 III triplex/alkylation buffer and N-
bromoacetyloligonucleotide as before. After this second 20 hr. incubation, the 
agarose embedded DNA were washed 3 times in 900 III of 0.1 % piperidine, 100 
mM NaCl, 10mMTris, pH 8.0,10 mMEDTA. After removal of the final wash, 
the DNA was heated in 900 III of the above piperidine solution at 55°C for 12 
hr. The plugs were transfered directly without melting to a 0.5x TBE 1.0% 
agarose gel and products separated by pulsed field gel electrophoresis using a 
BioRad Chef-DRTM II system. Electrophoresis was performed at 200 V for 24 
hr., with switch times ramped from 10 to 40 s. over the first 18 hr., and from 60 
to 90 s. over the last 6 hr. The gel was stained with ethidium bromide and 
photographed. 
Southern blotting. The DNA was fragmented for efficient transfer by a 40 s. 
exposure of the gel with 254 nm UV transilluminator. The gel was soaked in 
1.0 M NaCl, 0.5 M NaOH for 30 min. to denature the DNA, and then 
equilibrated in 1.5 M NaCI, 0.5 M Tris, pH 7.4 to neutralize the gel. The DNA 
was transferred using a Stratagene Pressure Control Station in 6xSSPE. HIS4 
hybridization was performed with a 250 bp SalIlEcoRI fragment derived from 
HIS4-SUC2 fusion plasmid YCp503. 24 The fragment was labeled using 
random probe hybridization with degenerate 6mers and Q-32P-dCTP. The 
271 JACS (In Preparation) 
membrane was prehybridized with 5 mls of a solution containing 6x SSPE, lOx 
Denhardt's, 1% SDS, 50 mg/ml Salmon sperm DNA solution at 42 °C for 2-4 
hr. After removal of this solution, the membrane was washed with 2 mls of 6x 
SSPE, 50% formamide, 1 %SDS, 50 mg/ml salmon sperm DNA solution at 42 °C 
for 30-60 min. The labeled probe was denatured by incubation at 37 °C for 5 
min. with 1/10 volume of 0.1 M NaOH, and incubated with the membrane in 2 
mls of 6x SSPE, 50% formamide, 1% SDS, 50 mg/ml salmon sperm DNA 
solution at 42 °C overnight. The blot was washed 4 times in 25 mls of Ix SSPE 
buffer, 1% SDS at 42 °C, exposed to film, and cleavage efficiencies quantitated 
using phosphorImaging. 
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Figure Legends 
Fig. 1. The N-bromoacetamide electrophile is localized in the major 
groove by triple helix formation proximal to a guanine (G) in the 
Watson-Crick duplex target site. Alkylation at N7 of G followed by 
depurination results in backbone cleavage to afford 5' and 3' phosphate 
termini. 
Fig. 2. Oligodeoxyribonucleotides bind to adjacent inverted binding 
sites on double helical DNA by triple helix formation and 
alkylate/depurinate at single guanine positions on opposite strands. 
Fig. 3. Scheme for construction of Fmoc-protected thymidine 2-
cyanoethyl-N ,N-diisopropylphosphoramidite 3 used in the synthesis of 
oligonucleotide 4. Modification of oligonucleotide 4 with N-
hydroxysuccinimidy I bromoacetate afforded the 
bromoacetyloligonucleotide 5. 
Fig. 4. Ribbon model of N-bromoacetyloligonucleotide-directed double 
strand cleavage of DNA by triple helix formation at inverted adjacent 
half sites. 
Fig. 5. (left) Autoradiogram of a high-resolution 6% denaturing 
polyacrylamide gel of cleavage products from reaction of N-
bromoacetyloligonucleotide 5 with 32P 3'- or 5'-end-Iabeled 0.9 kbp 
restriction fragment from plasmid pUCLEU2C. Lanes 1-4 are 5'-end-
labeled DNA. Lanes 5-8 contain 3' end-labeled DNA. Lanes 1 and 8 are 
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~-specific chemical sequencing reactions for the 5' and 3' end-labeled 
fragments. Lanes 2 and 7 are G-specific chemical sequencing reactions 
for the 5' and 3' end-labeled fragments.28 Lanes 3 and 6 contain DNA 
incubated for 36 hr. in the absence of 5'-N- bromoacetyloligonucleotide 
5, followed by piperidine treatment. Lanes 4 and 5 contain DNA 
incubated for 36 hr. with 5'-N-bromoacetyloligonucleotide 5, followed by 
piperidine treatment. (right). Sequence of the oligonucleotide and 
DNA target site. The major sites of modification are indicated. 
Fig. 6. (left) Diagram of linearized plasmid pUCLEU2C indicating 
location and sequence of triple helical oligonucleotide binding sites. The 
sites of alkylation and subsequent DNA cleavage are indicated. 
(right). Autoradiogram of a 1.0% agarose gel of cleavage products from 
the reaction of oligonucleotide 5 with 32P 3'-doubly end-labeled HindUI 
plasmid pUCLEU2C (6.7 kbp in length). Cleavage products were 
analyzed on a 1% agarose gel. Lane 1: DNA size markers obtained by 
digestion with restriction endonucleases. Sizes are indicated to left of 
band. Lane 2: DNA incubated in the absence of oligonucleotide 5, 
precipitated, and piperidine treated. Lane 3: DNA incubated with 
oligonucleotide 5, precipitated, and piperidine treated. 
Fig. 7. Scheme for the ligation of alkylation cleavage products from 
plasmid pUCLEU2C into the complementary Sfi I site of plasmid 
pUCSfiI. Incubation of plasmid pUCLEU2C with N-
bromoacetyloligonucleotide 3, followed by piperidine treatment results 
in double strand cleavage products with a 3' overhang (CTA-3'). 
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Digestion with the restriction endonuclease EcoR I produces two 
fragments containing one 5'-AATI and one CTA-3' overhang. Both of 
these products are complementary with the Sfi I1EcoR I digestion 
product of pUCSfil (5'-AATT and TAG-3' overhangs). After 
circularization and transformation of bacterial cells with the new 
plasmid, DNA was isolated and sequenced to verify the production of 
ligatable ends. 
Fig. 8. Cleavage of yeast chromosome III by N-
bromoacetyloligonucleotide 5. 
(left). Diagram of yeast chromosome III indicating location and 
sequence of triple helical oligonucleotide binding sites and the HIS4 
locus used for cleavage analysis. The binding site sequence and sites of 
alkylation and subsequent DNA cleavage are indicated. 
(right). DNA from yeast strains SEY6210 (no target site) and 
SEY6210C (+ target site) were equilibrated in 1.0 mM Co(NH3+3, 20 
mM Hepes pH 7.4, 10 mM EDTA, and 2 pM N-
bromoacetyloligonucleotide 5. After 24 hr., the plugs were washed with 
a Tris pH 9.5 (10 mM), EDTA (10 mM) solution three times (10 min. 
each wash). Plugs were re-equilibrated with 1.0 mM Co(NH3l+3, 20 mM 
Hepes pH 7.4,10 mM EDTA, and 2 pM N-bromoacetyloligonudeotide 5. 
After a second 24 hr. incubation (37°C), the plugs were washed in 0.1 % 
piperidine, 100 mM N aCI, 10 mM EDTA, 10 mM Tris pH 8.0, (3 washes 
10 min. each) and incubated in 900 pI of this solution for 12 hr. at 55°C. 
The plugs were equilibrated with 0.5 x TBE buffer, and loaded into a 
1.0% agarose gel for pulsed field gel electrophoresis. The gel was run for 
24 hr. at 200 V. Pulsed times were ramped from 10-60 s. for the first 18 
hr., and from 60-90 s. over the last 6 hr. 
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A. Ethidium Bromide stained pulsed field agarose gel. Lane 1: DNA 
from yeast strain SEY6210 lacking triple helical target site incubated 
with N-bromoacetyloligonucleotide 5. Lane 2: DNA from yeast strain 
SEY6210C incubated and piperidine treated in the absence of N-
bromoacetyloligonucleotide 5. Lane 3: DNA from yeast strain 
SEY6210C incubated with N-bromoacetyloligonucleotide 5 and 
piperidine treated. 
B. Autoradiogram of a DNA blot hybridization experiment of gel in A 
with a 250 bp HIS 4 fragment radiolabeled with 32P by random-primer 
extension. Locations of the intact chromosome III (340 kbp) and the 110 
kbp cleavage fragment are indicated. 
Triple Helix Site E J" 
".------"---- (, y r iii iii i ii ii i i i i! i ii ii i i ii i i ~ i ij i ii ii i ii i i ! i i ! i i ! iii! i ~K 
i) \ ) 
y' ' I Tnpl' H;lix ,I<, 
~: iii if! iii ii i i i i iii i ! iii ii i ii i i ! i i i i j ! i i i i i i j ! j j ! j j ! j j ~I 
, :to _ ,., l' 
TTTTCTTTTCCTTTCTTTT I e 
;:~FR:I-gK 
}iEe1~4 ~ 
• H 
I on .... d-KD~ .. 
,. 
281 
r • 
, 
• 
l 
~ 
~ ; 
\ 
r r • • 
282 
1 J • 
, 
• 1 • 
5' J' "p 
A G + + G A ( 1 J 
·W- --- ~ D R • 01110 + l ' S ' 
-. l' t:i i r T:" 
6.1kb 
----
" a j T' ... ~ 4.' kill -•• , !, "'-1 T ' "-T T· A-T T' A-f ,. H !.A-T -a· ,., 
--
T' "'-1' ~ T. '\-1' l . .I kb - _f J..lII;b 
K~ ' " G-C 
T' "'-1' J. I kill 
-T. "'-f ~ T 'It-"\' '" 1.Jk b 
:z: T · A-1 
.., -, ., .. Ukb 
-T' 1.-1 
~ -, ., .. 
--
. " G-C 
T' A-T l.O lib 
-
. 
' , . ... I 
! . "-T 
T ' A- I T ' A-T 
Iii 
T' A-T 
T' A- l ' ,. , .. T' A- T' "'-1: a· T' A· " "-f 1.1 kb ' ,. , .. - .. T' A-T T. "'-1 .- T'A-t e ..... T. T:" 
-
• 
T.A-T --, .. 
e .. • ... r • '1':" ,-, 
-
-. 
N 
-. 
- a .. ,-, --
iii- "" 
,., T:'" .T"'E 
N 
-- -
e-a --
T-A·T 
":,, .1"'" 2 
T -'" '1 
• S • 
~~:~ ... 
T-A . , 
• 
.! i T-A 
., 
N ., 
;J r-II • T .. 
,. , ., 
,. , ., 
~ 
-- •• 
-a e H ". T-A ., 
• .;:; J H ., .. 
,.., .,-
! 
~ ,·0 ., il T-A ., " H ., .. r T-A ". ~ H ., i: e .. • e  N ., C-G e CoO . .-\ T-A 
., N ., 
~:: 
T-A . , To> 
., 
T-A ., H 
., 
= 
--
.. c' -
., 
T-A ., o-a j. 
T-A ., 
H 
~- '" ., - ., 
-
C-G \. S ' ). ;- '" ", 
• 5' ] . 
'" 
p", ~aKK"I p·dAqCddC~CCqCCAKKr 
PD-CC
L...... J 
"~ 
'=J 
J SIUIEo>Rl Cu' 
pUCsaI 
'" 
... TAG.3' 
wgatiolllRKi.rculariutiOQ 
M1~udtotfdKDp11i 
LiI;alioD Sit. 
,s •• .•. CCCCC':rAai'AAM-.. 3' 
3'· •.• ~Aqlqi·RD 
283 
Chrornowme III 
S \ 
\ 
I 
. 
I 
) . 5 ' 
) . -r -A 
. --
--:,. A-T 
~ : i ~=~ 
T -I'-T 
-·C · G- C 
7 . IA_T 
, -I'-T 
T oIA- '! 
-ec . jG-C 
-erllD~=~ 
r· A- T 
-Dr l ~~~ 
7 .A-T 
T·I -
,(' T-A 
-G-C 
A-T 
T-' 
C- G -
r= ... . '("E 
T -A ·r 
T-A or 
~=~ : ~~ 
T-A 'T 
T - A -r 
T-A or 
1'-A· T ... 
e-G • c~K 
e-G · C 
T-A . r 
T-A . T 
T - A' T 
e -G • c~· 
T -A ' T 
T-A ·r 
T - A ·r 
- - T 
e-G ~ I 
A-T 
A. 
, ' J 
Tarttl Site - + + 
Olilonucleolidc + • + 
"30 kb (IX) 
JJO kb (Ill) 
230 kb (I) 
IIOkb 
B_ HIS4 
J 
Tarpl Site + + 
OliJOnudeoltde + + 
J JOkbUII) _ ~ ~ 
1I0kb _ _ 
